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ABSTRACT
This study confirms that animal cells in culture produce 
factors other than metabolic by-products which affect their own 
growth and the growth of other cells in culture.
In order to characterise these factors a number of commonly 
used animal cell lines namely the AFP-27 hybridoma, Chinese 
hamster ovary (CHO), baby hamster kidney (BHK-21), human 
osteosarcoma (MG-63) and African green monkey kidney (Vero) 
cells, were adapted to grow in serum-free conditions in HL-1
/(Ventrex, USA) low protein (< 30 /i/ml) medium. The adaptation all / 
cell lines except the AFP-27 hybridomas, which normally grown in 
suspension, resulted in two cell subpopulations, one growing in 
suspension and the other remaining anchorage-dependent.
The HL-1 adapted suspension BHK, Vero and MG-63 cell lines were 
grown to high cell concentrations in serum-free conditions using 
an Acusyst-Jr (Endotronics, USA) hollow fibre system. In general 
cell concentrations over 10® cell/ml were achieved, as calculated 
from the oxygen consumption values of the bioreactors. The hollow 
fibre conditioned media (HF-CM) obtained from these cultures 
contained a maximum protein concentration^ of 2.2 and 1.2 mg/ml cj^ 
for the MG-63 and Vero cell cultures respectively.
The HF-CM and their 1 kDa ultrafiltration filtrates and 
retentâtes were assessed (by adding 10% of these to the cell 
culture media containing 2.25% FCS) for their effects on cell 
growth, metabolism and the strength of cell adhesion.
All HF-CM had a growth promoting effect on BHK cells. The BHK 
HF-CM, Vero HF-CM and MG-63 HF-CM showed growth inhibiting 
effects on Vero, MG-63 and LL-24 cells in this order. No growth 
promoting/inhibiting effects were found in the filtrates 
resulting from 1 kDa cut-off membrane ultrafiltration of the HF- 
CM and therefore could not be due to low molecular weight 
metabolites but to proteinaceous materials.
The metabolic activity of BHK cells was determined by an MTT 
conversion assay. BHK cells grown in the presence of the Vero HF- 
CM showed a reduced metabolic activity in comparison to BHK cells 
grown in culture medium.
The strength of cell adhesion of Vero and MG-63 cells was not 
significantly affected by the presence of the various HF-CM. 
LL-24 and BHK cells showed a 20 to 35% reduction in the strength 
of cell adhesion when cells were grown in the presence of Vero 
HF-CM, BHK HF-CM and MG-63 HF-CM. In BHK cells this reduction was 
the same as that caused by HL-1 and therefore could not be 
attributed to cell secreted factors present in the HF-CM.
The factors in the Vero HF-CM responsible for the increased 
growth rates and the reduction in the strength of cell adhesion 
of BHK cells were found to be molecules larger than 65 kDa in 
molecular weight.
Overall, for BHK cells grown in the presence of Vero HF-CM and 
its ultrafiltration fractions, increased growth was matched with 
a decrease in the strength of cell adhesion. Thus it appeared 
that increased growth caused a reduction in the strength of cell 
adhesion.
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But perhaps some day, when we are ready to die of 
exhaustion and ignorance, I shall be able to disown 
our garish tombs, and learn for the last time what I 
know.
Albert Camus
Return to Tipasa (1952).
Introduction
1.0. INTRODUCTION
In the process of vertebrate embryo development, a single 
fertilized egg gives rise to a multicellular organism consisting 
of about 200 cell types. This process involves, cell division to 
increase cell numbers, cell differentiation by which new cell 
types are generated, and morphogenesis and organogenesis by which 
cells are organised spatially forming different tissues and 
organs.
Control over these processes is exerted by means of intercellular 
communications which may be exerted through close contacts, by 
means of gap junctions, and by local diffusible and surface-bound 
growth factors. Growth factors may exert their activities in an 
autocrine fashion, on cells of their own type, or in a paracrine 
fashion, on cells of a different type from those which produce 
it (Jessel and Melton, 1992).
During early stages of embryonic development, diffusible growth 
factors exert their action by forming concentration gradients 
which modulate activities of the surrounding cells. In the later 
stages of foetal development and in the adult organism, the 
effects of autocrine and paracrine growth factors are 
orchestrated in a more systematic way by means of systemic 
factors, hormones, produced by specialized cells. The concerted 
action of these growth factors ensures a dynamic equilibrium 
between cell death and growth necessary to maintain the balance
—1—
Introduction
between cell number and tissue size. Furthermore, growth factors 
and their receptors , and the intracellular signals that they 
generate have been increasingly implicated in tumorigenesis 
(Josephs et al., 1984; Hunter, 1991; Rusch et al., 1993).
During the 1960's and 1970's, growth factor activities were 
identified in natural biological fluids such as serum, lymph or 
colostrum and in extracts obtained from animal tissue 
homogenates, by observing their effects in vivo or in vitro on 
tissue slices (for example, Cohen, 1962; Antoniades, 1979; 
Assoian, 1983).
Subsequent advancements in our understanding in the animal cell 
biology and physiology and in the techniques to grow and maintain 
animal cells in culture, however, revolutionised the field of 
research on growth factors. In vitro cell culture systems 
provided^with a means to obtain cell conditioned media for the| 
isolation of growth factors, and with sensitive methods of 
detecting growth factor activities (for example, Marquard and 
Todaro, 1982; Massagué, 1984; Lyons et al., 1988; Matsumoto et 
al., 1991).
Traditionally, cell culture media included a number of 
undefined biological fluids such as serum, lymph or colostrum. 
Their function, as providers of factors essential for cell 
growth, was soon recognised (Sato, 1975). Modern media 
formulations aim to be fully defined and replace these undefined 
biologicals with specific growth factors.
- 2 -
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A common observation upon seeding of cells in vitro is that 
cells do not grow unless they are seeded at "critical minimal 
cell concentration" (Earle, 1951). It is now accepted that this 
phenomenon is due to conditioning of the medium by growing cells 
through the secretion of soluble autocrine growth factors (Sporn 
and Roberts, 1985a; Lauffenburger and Cozens, 1989). Cell- 
conditioned media with growth stimulatory effects on a variety 
of cells are now available commercially (Sigma Chemical Co. Ltd., 
1993).
In vitro, the requirement of cells for exogenous growth factors 
and the minimum seeding cell concentration greatly depend on the 
transformed nature of the growing cells. Non-transformed cells 
generally require high seeding cell concentrations and the 
provision of exogenous growth factors. These cells are also, to 
a degree, able to inhibit their own growth. Inhibition occurs 
through contact inhibition (Abercrombie, et al., 1971) and 
soluble growth inhibiting factors may also be involved (Iversen, 
1991). In comparison, transformed cells may be seeded at low cell 
concentrations and have little or no requirement for exogenous 
growth factors. This behaviour is similar to that of tumour cells 
in vivo and is related to the disruption of intracellular growth 
control mechanisms. Overexpression of growth promoting factors 
and their receptors is a common phenomenon in transformed cells 
(Sporn and Roberts, 1985b).
—3 —
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Early cell culture systems used in the sixties for the 
production of biologicals included stirred-tank and airlift 
designs, and achieved cell concentrations in the order of 10^ to 
10*^  cells/ml. Modern cell culture systems are capable of 
obtaining cell concentrations of 10® cells/ml, and may be run in 
perfusion culture to retain cells and proteinaceous materials 
while continually removing waste products. In such systems, there 
is a marked reduction in the requirement for serum and growth 
factors by the cells (Shconherr et al., 1986). The cells usually 
involved in biotechnological processes are to some degree 
transformed and thus it is likely that at high concentrations 
they are producing growth promoting factors in quantities 
sufficient to influence their own growth. In addition, there is 
mounting evidence that transformed cell lines growing in such 
conditions may also be producing growth inhibiting molecules 
other than metabolic waste products such as lactate, ammonia and 
some amino acids. (Thorpe, 1989; Ronning, 1990).
The aim of the present work is to use cells grown in defined 
culture conditions at high concentrations, to isolate factors 
that affect the growth of cells in culture.
The following introductory section will deal with the 
literature survey and techniques related to this subject.
—4 —
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1.1. THE CELL CYCLE
The animal cell cycle, first described by Howard and Pelc 
(1951), relates the various stages in the life cycle of animal 
cells (Figure 1.1.1.). The cell cycle consists of a round of 
chromosomal DNA replication, which involves a DNA synthesis phase 
(S phase), followed by the segregation of replicated chromosomes 
into two daughter cells during mitosis (M phase) . The Gap phases, 
termed and G2 , are interspaced between M and S and between S 
and M respectively.
M phase
Q phase
MITOSIS Q phase
phase
CELL CYCLE
DNA SYNTHESIS
phase
Figure 1.1.1.: The animal cell cycle.
The Gj phase is the longest and most variable phase in the cell 
cycle, lasting from few hours to days, years, or throughout their 
lifetime. To proceed through the cell cycle, cells have a strict
—5—
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requirement for growth factors at a point in Gj called the V 
point (Pledger, 1978). In the absence of growth factors (Temin, 
1971; Pardee, 1974; Zetteberg and Larson, 1985), or under 
nutrient limitation (Tobey and Ley, 1970) , or overcrowding of 
cells (Zetteberg and Auer, 1970) , the cell cycle is arrested and 
cells may enter a state of quiescence termed Gq phase. There is 
evidence that some eukaryotic cells may enter the Gq phase via 
points in the cell cycle other than the G; phase (Wei et al., 
1993), but how often this occurs is not yet clear. During the Gq 
phase there is a change in the pattern of gene expression. Cells 
synthesize low levels of protein and RNA, and the protooncogenes 
c-fos and c-jun are either not or hardly expressed (Greenberg and 
Ziff, 1984; Kelly et al., 1983; Ryseck et al., 1988). Some genes 
found to be involved in the maintenance of Gq phase, acting as 
negative growth regulators, have come to be known as the growth- 
arrest-specific (gas) genes (Schneider et al., 1988). Cell cycle 
arrest and entry into Gq phase also depend on the cell type. 
Transformed cells are usually less sensitive to the requirement 
for growth factors and in suboptimal conditions do not enter Gq 
phase but proceed through the cell cycle albeit at a slower rate, 
continuing to divide until the cells die as a result of a 
deterioration of environmental conditions (Medrano and Pardee, 
1980) . Normal cells held in Gq phase can be made to re-enter the 
cycle when conditions are again optimal for cell division. 
BALBC/3T3 mouse embryo fibroblasts re-enter the cycle at Gj phase
—6—
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when stimulated by a competence factor such as platelet derived 
growth factor (PDGF) but not by epidermal growth factor (EGF) or 
insulin (Stiles et al., 1979; Zetterberg and Larson, 1985). 
Overexpression of the c-myc oncogene can replace the need for 
PDGF (Armelin et al., 1984). Once in Gj phase, progression 
through the V point is strictly dependent on the synergistic 
action of other growth factors referred to as progression 
factors such as the insulin-like-growth factor (IGF) and^(EGF) 
(Pledger et al., 1978). Again, constitutive expression of the c- 
myb oncogene can substitute the IGF requirement (Travali, 1991). 
After progression through the V point, the cell cycle reaches the 
restriction point (R), where cells become independent of serum 
components and are committed to enter the S phase (Pardee, 1974). 
Separate experiments have identified a further regulatory point 
named W, where cells still require serum factors for entry into 
the S phase (Pledger et al., 1978).
The S phase begins when the DNA synthesis starts and it ends 
when the DNA content of the nucleus has doubled and the 
chromosomes have replicated. In the short G2 phase, in which the 
cell has twice the amount of normal DNA content, the necessary 
changes for mitosis occur. The mitotic phase (M) occurs after Gj 
phase. It begins with mitosis and ends with cytokinesis (cell 
separation). During this process the replicated chromosomes 
condense, the nuclear envelope breaks down, and as the nuclear 
contents are divided, the sister chromatids are pulled apart. Two 
new nuclear envelopes are then formed and the cell divides to
-7-
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generate two daughter cells. Mitosis is followed by and/or Gq 
phases thus accomplishing the cycle.
The progression through the cell cycle is controlled by 
intracellular molecular mechanisms during the gap phases, when 
cells commit themselves to enter the S or the M phase (reviewed 
by Norbury and Nurse, 1992) . The transition from G2 to M phase is 
governed by the intracellular maturation-promoting factor (MPF) , 
composed of a protein kinase catalytic subunit p34*''^‘'^, itself 
subject to phosphorylation/dephosphorylation, and a B-cyclin 
protein. Control in Gj phase is not yet clear, and it may involve 
p 3 c^rfc2 and/or other cyclins.
Loss of cellular control due to failure to control the 
progression through the cell cycle may lead to malignancy. The 
oncogenes myc, fos, jun, and rel have been suggested to encode 
proteins that are required to initiate the cascade of induction 
events that eventually lead a cell through G^  to S phase 
(reviewed by Hunter, 1991). The constitutive expression of these 
genes would be expected to incite continuous uncontrolled cell 
cycling. There is evidence that the p53 (Hartwell, 1992) and the 
Retinoblastoma (Rb) proteins (Huang et al., 1990) may act as 
negative regulators of transition from the G^  to S phase. The 
cell cycle progresses once these proteins have been inactivated 
through phosphorylation (Buchovich et al., 1989). The absence of 
p53 or Rb, and hence the failure to control the cell cycle, have 
been reported to be directly involved in the transformation
—8 —
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process (reviewed by Levine and Momand, 1990).
Overall, soluble growth factors and their intracellular signal 
transduction mechanisms appear to be intimately involved in the 
progression of animal cells through the cell cycle. Hence, growth 
factors provide a mechanism by which cells probe their external 
environment for the presence of the adequate signals, before 
committing themselves to divide. Linked to the process of 
proliferation, and also dependent on growth factor stimulus, is 
the process of cell differentiation.
-9-
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1.2. CELL DIFFERENTIATION
Associated with the increase in size and complexity of 
organisms, the constituent cells go through a process of 
specialization termed differentiation. Adult humans contain about 
200 different cell types and an approximate total of 10^  ^cells. 
With few exceptions, the process of differentiation does not 
involve a loss of genes but switching on or off the genes whose 
products are expressed by different cell types. The process of 
differentiation is usually coupled with a slow down or complete 
halt in cell division. Quiescent and terminally differentiated 
cells in vivo are often compared with cells in culture in the Gq 
phase but it is not clearly understood whether or not the two 
underlying molecular mechanisms are similar. Upon proliferation, 
cells may loose their differentiated state but they return to the 
original cell type when re-differentiating. In adult organisms, 
the differentiated cells in most tissues remain capable of cell 
division. However, in some tissues, the terminally differentiated 
cells cannot divide and are renewed by the proliferation of a 
distinct, less differentiated, subpopulation of stem cells. Stem 
cells may be pluripotential and give rise to a number of 
differentiated cell types. This occurs in haemopoiesis, where 
stem cells in the bone marrow give rise to lymphocytes, 
macrophages and erythrocytes (Metcalf, 1989) . Stem cells may also 
be unipotential and only give rise to one cell type. This is the 
case in the epidermis where stem cells only differentiate into
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epidermal kératinocytes (Hall and Watt, 1989).
Overt cellular differentiation is known to be preceded by a 
determination or commitment to differentiate. The commitment to 
differentiate may not become immediately apparent, as is the case 
of cultured C2/C12 myoblast cells which proliferate indefinitely 
in foetal calf serum but when made to differentiate in a growth 
factor deficient medium they only form muscle cells (reviewed by 
Gurdon 1992). During the development of vertebrate embryos, cells 
appear to follow a stepwise series of decisions towards their 
final differentiation. Each commitment step excludes a number of 
options and further restricts differentiation to the remaining 
options (Gurdon, 1992). An example of this may be found in bone 
marrow cells which in some cases can generate the full range of 
blood cells, as expected from an early stem cell, whilst in 
others, where cells are assumed to be more advanced in the 
differentiation process, they only give rise to one cell type 
(Metcalf, 1989). A similar example is also found in the neural 
crest cells (Barroffio et al., 1988).
The different differentiation patterns occurring during embryo 
development are the result of cell-cell interactions and 
asymmetric cell divisions (reviewed by Gurdon, 1992; Horvitz and 
Herskowitz, 1992). The influence of neighbouring cells upon 
differentiation has been demonstrated in transplant experiments 
on developing embryos (Jacobson, 1966; Gurdon, 1987). The cell 
interactions involve the exposure of cells to soluble and 
membrane bound factors and the receptors that affect the cell
—11—
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susceptibility to such stimuli. The soluble growth factors 
involved in vertebrate development have been reviewed (Jessell 
and Melton, 1992) and are summarised in Table 1.2.1.
Target Tissue Inducer Reference
Xenopus Nieuwkoop centre wnt RoeI ink and Nusse, 1991 
Gavin et al .. 1990
Xenopus mesoderm FGF Amaya et a I 1991 
Slack et al .. 1989 
Kimelman et al .. 1988
TGF-B* Asashima et al.. 1991
Xenopus midbrain wnt-1 Wilkinson et al., 1987
Mouse neural tube BMP Jones et al., 1991
FGF (int-2) Wilkinson et al.. 1988
wnt* Wilkinson et al.. 1987 
Gavin et al.. 1990 
Roelink and Nusse, 1991
Chick limb Retinoic acid Thaller and Eichele, 1990
3,4-didehydro-retinoic acid Thaller and Eichele, 1990
Haematopoietic and Neural cells Stem cell factor Witte, 1990
Sympathetic neurons Leukaemia inhibitory factor Patterson, 1990 
Yamamori, 1991
Rat optic nerve Ciliary neurotrophic factor Lillien and Raff, 1990
Table 1.2.1: Inductive interactions during development (*: no clear evidence; 
wnt: products from the wnt gene family, wnt is the current accepted
nomenclature for lnt-1 (target for insertional activation by the mouse mammary 
tumour virus in mammary carcinomas) related genes (Nusse et ai., 1991); FGF: 
fibroblast growth factors; TBF-B: transforming growth factor B; BMP: bone 
morphogenic proteins).
The factors involved in cell differentiation and development 
may also be found on the cell surface in a transmembrane form. 
The stem cell factor (Zsebo et al., 1990; Huang et al., 1990; 
Anderson et al., 1990), the ciliary neurotrophic factor, EGF and 
transforming growth factor a (TGF-a) may all be found in cell 
surface-associated forms where they are liable to proteolytic
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cleavage and are converted to soluble forms (Massagué, 1990).
Embryonic cells are able to reorganise themselves after random 
mixing (Townes and Holtfreter, 1955) and considerable movements 
take place during normal development (reviewed by Hynes and 
Lander, 1992) . Cell sorting and cell movement greatly depend on 
the extracellular matrix properties and the cell surface 
characteristics. This is supported by the evidence that, in 
Drosophila, embryonic development is severely disrupted by 
mutations in the lethal myospheroid gene encoding for the cell 
surface molecule 5-integrin (Leptin at al., 1989).
There are many examples of regulation by growth factors of the 
differentiated state of primary and established cells in culture 
(Sporn and Roberts, 1987; Gospodarowicz at al., 1987; Sporn at 
al., 1986; Froesch at al., 1985). In many cases growth factors 
can either stimulate or inhibit cell differentiation, depending 
on the cell type or its physiological state. Transforming growth 
factor B (TGF-B), for example, stimulates the differentiation of 
bronchial epithelial cells and inhibits terminal differentiation 
of B cells and the adipogenesis of 3T3 fibroblasts (Ignotz and 
Massagué 1985; Sporn at al., 1986). TGF-B can also enhance the 
expression of a differentiated cartilaginous phenotype in 
primitive mesenchymal cells but suppresses expression of 
cartilage markers in differentiated cells of mesenchymal origin 
(Rosen at al., 1988). The fibroblast growth factor (FGF) has been 
found to delay differentiation of myoblasts (Gospodarowicz at 
al., 1976) but it stimulates differentiation or stabilizes the
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differentiated characteristics of a variety of cell types, 
including chondrocytes, endothelial cells and a rat 
pheochromocytoma cell line (PC12) (reviewed by Gospodarowicz at 
al., 1987).
The effects of growth factors on cell differentiation, either 
positive or negative, may or may not be coupled to regulation of 
cell proliferation. PDGF potently inhibits the differentiation 
of oligodendrocyte/type 2  astrocyte progenitor cells by 
maintaining the continued proliferation (Noble at al., 1988; Raff 
at al., 1988). Alternatively, the inhibition of B-cell 
proliferation by TGF-B appears to inhibit the expression of 
differentiated characteristics (Kehrl at al., 1985). In kidney 
epithelial cells, TGF-B appears to stabilize their differentiated 
state by inhibiting cell proliferation (Fine at al., 1985) while 
the enhancement of glial cell differentiation by FGF is 
associated with stimulated mitogenesis (Morrison et al 198 6 ). By 
contrast, in the case of stimulation of neurite outgrowth in PC12 
cells by FGF (Togari et al 1983) and inhibition of 3T3 cell 
differentiation to adipocytes by TGF-B, (Ignotz and Massagué 
1985), growth factor effects on the cell differentiation do not 
appear to be coupled to the effects on cell proliferation.
Growth factors also appear to be involved in the regulation of 
other cellular functions. Both FGF and TGF-B can affect the 
formation of the extracellular matrix (Gospodarowicz at al., 
1987; Sporn at al., 1987). FGF has also been found to regulate 
secretion by pituitary cells (reviewed by Baird et al., 1986).
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Cell movement has also been found to be regulated by growth 
factors. EGF stimulates the non-directed movement of 
kératinocytes (Barrandon and Green, 1987), while PDGF and TGF-B 
are both chemotactic for fibroblasts and other cell types 
(Grotendorst et al., 1981; Sepa et al., 1982; Postlethwaite et 
al., 1987; Wahl et al., 1987). In vivo these functions probably 
play a role in cellular differentiation.
As most differentiated cells do not differ in their genetic 
make up, the development and maintenance of the differentiated 
state is thought to be dependent on the pattern of gene 
expression. Maintenance of the differentiated state has been seen 
to be largely dependent on nucleus-cytoplasm interactions 
(Gurdon, 1992). The transplant of a cell nucleus into another 
cell's cytoplasm greatly affects the pattern of differentiation 
of the inserted nucleus. A muscle cell nucleus transplanted into 
an egg cytoplasm results in the generation of all major cell 
types of a complete embryo (Gurdon, 1986). It has been proposed 
that the stable state of cell determination is maintained by 
continued transcription of regulatory genes, which are translated 
into their respective transcription factors in the cytoplasm and 
which in turn migrate back to the nucleus to maintain the 
transcription of the same genes in an autoregulatory fashion 
(Gurdon, 1992). It may be possible that growth factor receptors 
on the cell membrane and their second messengers, present in the 
cytoplasm, may also be responsible for the maintenance of the 
phenotype of the receiving egg in nuclear transplant experiments.
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DNA méthylation may help to confirm the inactive state of genes 
but this is thought to be a secondary condition after the initial 
selection of active and inactive genes (Bird at al., 1986).
On the whole, the dichotomy between cell growth and 
differentiation appears to be crucial in the development and 
maintenance of the homeostatic balance of higher organisms and 
thus must be tightly controlled. In vitro cell culture has proved 
to be an invaluable tool for the isolation and study of 
particular cell types and their mechanisms of control of 
differentiation.
— 16—
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1.3. GROWTH FACTORS
Growth factors have been defined as proteinaceous materials 
which affect cell proliferation and differentiation. Growth 
factors produced by the target cells themselves are known as 
autocrine growth factors. When growth factors are produced by 
other cells they are known as paracrine growth factors. Initially 
growth factors were detected in homogenised tissue extracts and 
a large number of them were purified to homogeneity. Tissue 
extracts are complex mixtures containing intracellular and 
extracellular materials from different cell types, in different 
physiological stages, together with contaminating body fluids. 
Because of this complexity and the inherently low concentrations 
of the growth factors, purification to homogeneity proved to be 
an arduous process.
To overcome the problems associated with using tissue extracts, 
cells grown in vitro and their supernatants were used as a source 
for isolation of growth factors. A review of all known growth 
factors is beyond the scope of this introduction but those which 
have been better characterized are summarized in Appendix I.
1.3.1. GROWTH FACTOR ACTIVITY FROM TISSUE EXTRACTS
In the 19 60's and 1970's, extraction of growth factors was 
carried out by surgical removal of the tissue of interest and its 
homogenization to obtain crude extracts which would be tested in 
powder form or in aqueous suspension. An illustrative example is
-17-
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that of Hondius-Boldingh and Laurence (1968) who in search of 
epidermal growth factors, obtained crude pig skin extracts by 
immersing slaughtered pigs in a water bath at 60sc, subsequently 
burning off their hairs and then separating the epidermis 
together with some collagenous dermis. After freeze-drying and 
grinding, the resulting material was tested in vivo for the 
inhibition of growth. Before adequate protein purification tools 
and methods were developed, growth factor activities were 
reported from many other tissue extracts such as mouse epidermis, 
small intestine epithelium, embryo skin, placenta, liver, kidney, 
erythrocytes, eye lens and testis extracts) (reviewed by Iversen, 
1981; Iversen, 1991).
Most of the now well recognised growth factors were originally 
isolated from such tissue extracts. EGF (Cohen, 1962) and nerve 
growth factor (NGF) (Cohen, 1960; Varon, 1967) were isolated from 
mouse submaxillary gland extracts; PDGF from human platelets 
(Antoniades at al., 1979; Heldin at al., 1979; Ross at al., 
1979); FGF from bovine pituitary gland extracts (Gospodarowicz, 
1975) and brain (Gospodarowicz, 1978) ; and TGF-B from
acid/ethanol extracts of human platelets (Assoian at al., 1983), 
placenta (Frolik at al., 1983) and bovine kidney extracts 
(Roberts at al., 1983). Other growth factors were isolated from 
biological fluids. IGF from human plasma (Rinderknecht and 
Humbel, 1976), NGF from humoral fluids produced by tumour cells 
(Levi-Montalcini and Hamburger, 1951), and erythropoietin (EPO) 
from human urine (Miyake at al., 1977).
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1.3.2. GROWTH FACTOR ACTIVITY FROM CELLS IN CULTURE
Growth factors have been detected and isolated from many in 
vitro cell cultures. TGF-a was first purified from the 
conditioned medium of a human melanoma tumour line (Marquard and 
Todaro, 1982) and has since been isolated from conditioned medium 
of a variety of transformed and normal cells, including 
carcinomas and sarcoma cell lines (Derynck et al., 1987), normal 
skin kératinocytes (Coffey et al., 1987), and normal brain cells 
(Wilcox and Derynck, 1988). TGF-B has also been purified from a 
variety of tumour cell line conditioned media (Massagué, 1984). 
A variety of interleukins have been isolated from transformed and 
non-transformed cell culture conditioned media (reviewed by Sporn 
and Roberts 1990).
Most of the reported isolation of growth factors and growth 
factor activities from in vitro cell culture conditioned media 
have included serum in their media formulations. Growth 
inhibitory activity has been reported from media conditioned by 
WI-38 human fibroblasts grown in Dulbecco's minimal essential 
medium (DMEM) +10% foetal calf serum (Shirasuna at al., 1988). 
In such conditioned media it cannot be ruled out that the 
observed growth factor activities may be due to serum components 
and not due to the materials produced by the cells in culture.
To overcome the problems associated with the presence of an 
undefined media supplement, such as serum, cells are usually 
rinsed in basal media prior to collection of the conditioned
— 19 —
Introduction
media. Cells may be allowed to grow to 80-90% confluency in the 
presence of serum and subsequently rinsed and left with basal 
media to collect the secreted factors. Such media may be 
collected and exchanged regularly every 2-3 days. This is 
currently the most common method, either using static flasks 
(Chen at al., 1991; Djakien at al. , 1991; Matsumoto at al., 1991; 
Unterman at al., 1991; Silleti at al., 1991; Gaffney at al.,
1983) or roller bottles (Iwata at al., 1985; Lyons at al., 1988). 
Although this approach has proved very useful in the isolation 
of a variety of growth factors, this procedure can not ensure 
that factors associated with the original serum have been 
completely removed, as they may be carried over either bound to 
the cell surface or intracellularly. In addition, removal of 
serum may also have an effect upon the cells which, in the serum 
free basal medium, may markedly change their behaviour with 
respect to the synthesis and secretion of growth factors. The use 
of low cell concentration batch cultivation systems in which the 
serum containing growth media is substituted with a defined media 
for the collection of growth factors is therefore not suitable 
for the study of cell produced materials.
Completely defined media have not been extensively used in the 
isolation of growth factors. However, as fully defined media 
become more easily available and cheaper, they will, on many 
occasions, replace undefined media formulations. Finally, it must 
be stressed that most of the culture systems used for growth 
factor studies only achieve low cell concentrations and the
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growth factors produced at low concentrations may escape 
detection. It is also possible, that the pattern of production 
of growth factors may vary at high cell concentrations in cell 
culture systems which maintain better homeostatic control than 
batch cultivation systems. The potential advantage of high
concentration perfusion cultures of animal cells for growth
factor research have not yet been exploited.
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1.4. GROWTH FACTOR RECEPTORS
The biological action of growth factors upon cells is mediated 
by the binding and activation of specific cell surface receptors. 
Growth factor cell surface receptors were first observed in 
binding studies using labelled ligands, usually the growth factor 
itself, and have been characterized, mostly through the isolation 
of cDNA clones encoding for them (Morgan et al., 1987; Coussens 
at al., 1985; Yarden et al., 1986; Sherr et al., 1985; MacDonald 
et al., 1988). Many different growth factor receptors show 
binding affinities for the same growth factors, and many growth 
factors will bind multiple receptor structures with different 
affinities (See Table 1.4.1). Four subclasses of related growth 
factor receptor proteins have been identified (reviewed by Ulrich 
and Schlessinger, 1990). Subclass I are characterised by sharing 
two cysteine-rich sequences in the monomeric extracellular domain 
and includes the EGF receptor, Her2/neu, Her3/c-erjbB-3 Xmrk. 
Subclass II is characterised by disulfide-linked heterotetrameric 
structures and includes the insulin receptor and IGF-1 receptor. 
Subclass III share five extracellular immunoglobulin-like repeats 
and an intracellular kinase insert region, and includes PDGF- 
receptor-A, PDGF-receptor-B, the macrophage colony stimulating 
factor (M-CSF) receptor, and c-kit. Subclass IV is similar to 
subclass III but has only three immunoglobulin-like domains and 
includes the FGF receptor, fig, and bek. Some growth factor 
receptors, as the IGF-II/manose-6 -phosphate receptor (Morgan et
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al., 1987; MacDonald et al., 1988), the IL-2 receptor (Leonard 
et al., 1984; Nikaido et al., 1984) and the NGF receptor (Johnson 
et al., 1986) fail to fit into any of the above growth factor 
receptor families.
Most growth factor receptors are composed of a large 
glycosylated extracellular ligand binding domain, a single 
transmembrane hydrophobic peptide region, and a single linear 
peptide sequence residing in the cell cytoplasm (reviewed by 
Ulrich and Schlessinger, 1990; Czech et al., 1990).
The growth factor binding regions of the EGF receptors have 
been located within regions flanked by conserved cysteine-rich 
segments (Lax et al. , 1988), the function of these cysteine-rich 
regions remains unclear. Extracellular domains of growth factor 
receptors may be found free in serum in a soluble form preserving 
their growth factor binding activity. This has been reported for 
the IL-2 (Baran et al., 1988) , transferrin (Beguin et al., 1988) , 
EGF (Weber et al., 1984) and IGF-II/Man-6 -P (Kiess et al., 1987; 
Mac Donald et al., 1989) receptors. In addition, insulin (Gavin 
et al., 1972) and growth hormone (Baumann et al., 1986) receptors 
have been observed to be secreted by cells in culture. IL-2 
receptor levels in serum have been shown to be elevated in 
patients with malignant lymphomas (Harrington et al., 1988), 
suggesting a possible in vivo secretion mechanism. The function 
of these soluble receptors in vivo is not clear. They may act as 
growth factor carrier proteins or in a regulatory fashion by 
neutralising growth factors.
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GroLf) Type Designation Tyrosine
kinase
Relative affinity for 
ligands
Insulin-1 ike I Insulin receptor Yes Insulin»IGF-I I>IGF-I
growth factor I IGF-I receptor Yes IGF-I>IGF-I I»insulin
receptors II IGF-II/Man-6-P receptor No IGF-II»IGF-I
EGF receptors 1 EGF receptor Yes EGF=TGF-@
2 neu/EGF receptor Yes ?
PDGF receptors A PDGF receptor Yes PDGF-AB>PDGF-AA>PDGF-BB
B PDGF receptor Yes PDGF-AA=PDGF-BB
TGF-B receptors 1 TGF-B receptor ? TGF-B1>TGF-B1.2>TGF-B2
2 TGF-B receptor ? TGF-B1>TGF-B1.2>TGF-B2
3 TGF-B receptor ? TGF-B1=TGF-B1.2=TGF-B2
4 TGF-B receptor ? TGF-B1>TGF-B2
Table 1.4.1: Multiple ligand binding capabilities of growth factor receptors 
(Adapted from Czech, 1990).
The growth factor receptor transmembrane domain links the 
extracellular domain with the cytoplasmic domain and transmits 
the signal initiated by the growth factor. The manner in which 
the signal is transmitted is not yet understood. There is 
evidence that conformational changes of the ectoplasmic domain, 
due to binding of the growth factor, could lead to dimerization 
of receptors and a juxtaposition of cytoplasmic domains would 
activate each other or another protein (reviewed by Ullrich and 
Schlessinger, 1990).
The cytoplasmic domain of many growth factor receptors has
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intrinsic tyrosine kinase activity (Table 1.4.1.) which is 
activated upon ligand binding and is indispensable for 
intracellular signal transduction. The tyrosine kinase domain is 
highly conserved, and amongst other conserved sequences it 
contains a consensus sequence, Gly-X-Gly-X-X-Gly-X-(15-2 0)-Lys 
(Yarden and Ullrich, 1988; Schlessinger, 1988; Hanks at al.,
1988) , which functions as part of a binding site for ATP. The 
mechanism by which the conserved sequences might exert their 
action is not yet clear. They may catalyse the phosphorylation 
of secondary intracellular messengers or the autophosphorylation 
of the receptor itself inducing a change in conformation through 
which the receptor can interact with other molecules (Czech et 
al ., 1990). Several receptor tyrosine kinase substrates with 
signal transduction potential have been identified and include 
phosholipase-C (Margolis et al., 1989; Meisenhelder et al., 1989; 
Wahl et al., 1989) phosphatidylinositol 3-kinase (Varticovski et 
al., 1989), the ras GTPase-activating protein (Molloy et al.,
1989) and the c-raf proto-oncogene product (Morrisin et al., 
1989), and a multiple signalling pathway has been proposed 
(Ullrich and Schlessinger, 1990). For receptors lacking a 
tyrosine kinase domain, such as the lGF-ll/Man-6 -P, lL-2, and NGF 
receptors, there is no information available about their 
signalling mechanism, but it is thought that other kinases may 
be involved (Czech et al., 1990).
Following ligand binding, receptor aggregates present in coated 
pits are rapidly internalized. Receptors with kinase activity are
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rapidly degraded while those lacking tyrosine kinase activity are 
recycled to the cell surface for their re-utilization (Honegger 
et al., 1990). Various mechanisms are involved in the regulation 
of growth factor binding to their receptors. These include 
increased or decreased synthesis of receptors, changes in the 
alternative distribution of receptors on the cell surface versus 
internal membranes and possible conformational changes altering 
their affinity for growth factors (Czech et al., 1990). Binding 
of the growth factor to its receptor usually leads to cellular 
downregulation by any of these mechanisms and an increased rate 
of receptor degradation (Green and Olefsky, 1982).
A number of growth factor receptor structural alterations have 
been found to lead to constitutive activation of the tyrosine 
kinase activity (Woolford et al., 1988; Roussel et al., 1988; 
Bargman et al., 1986) or constitutive receptor oligomerization 
(Weiner et al., 1989) and may be involved in transformation and 
cancer.
Overall, growth factor receptors play a crucial role in the 
specific transduction of the external signals from growth factors 
to the cell cytoplasm. The high specificity of growth factor 
receptors for their ligands may also serve as a tool for the 
isolation and purification of growth factors or their receptors 
from either in vivo or in vitro sources.
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1.5. TUMORIGENESIS
It is a well established phenomenon that cells in culture 
require a minimum seeding concentration (Earle, 1951) . The reason 
for this remains unclear, but it is assumed that they require 
factors produced by themselves in an autocrine fashion. Cancer 
cells grown in vitro have not only a reduced requirement for 
growth factors but can also be inoculated at much lower cell 
concentrations. The reason being that cancer cells usually 
present an over-expression of growth factors and/or their 
receptors or the components of the intracellular pathways 
involved in the transmission of their signal.
Growth factors alone seem have a relatively low ability to 
induce transformation. For example, the addition of PDGF alone 
does not cause transformation of mouse fibroblasts, but the over­
expression of the c-sis protooncogene encoding for PDGF has a 
strong transforming activity (Josephs et al., 1984). This 
suggests that cells may regulate the signals exerted by 
extracellular growth factors, probably by means of their 
receptors. Soluble growth factor induced transformation has not 
been described so far.
Overexpression of growth factor receptors in tumour cells has 
also been extensively reported. The EGF receptor is overproduced 
in squamous cell carcinomas (Hendler et al., 1985), brain 
tumours (Wong et al., 1992), breast (Murphy and Dotzlav, 1989) 
and colon adenocarcinomas (Bradley et al., 1986).
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Simultaneous increase in the expression of growth factors and 
their receptors has also been observed. In the benign placental 
hydatidiform mole, the PDGF- 6  receptor gene is found to be more 
active than in normal placenta and transition to malignant 
choriocarcinoma correlates with the co-overexpression of the 
PDGF-B gene (Holmgren et al 1993). Similar control misfunctions 
have been proposed in lung cancers, involving overexpression of 
the EGF receptor and its ligands, TGF-a, EGF and amphiregulin 
(Rusch et al., 1993).
A number of viral and cellular oncogenes appear to encode for 
growth factor like proteins involved in the progression of 
malignancy. The v-sis oncogene encodes for the PDGF B-chain and 
the products of the hst and int oncogenes are related to FGF.
Growth factor receptor analogues have also been found to be 
coded by some viral oncogenes. A truncated version of the EGF- 
receptor is encoded by the v-erbB oncogene (Downward et ai.,
1984) and a mutant form of the M-CSF-1 receptor is encoded by v- 
fms. A number of other oncogenes, such as ras, fos and myc, code 
for proteins involved in the mitogenic growth factor 
intracellular signalling pathways and are also implicated in 
transformation (reviewed by Hunter 1991). As described earlier 
in Section 1.1. the p53 and Rb protooncogenes negatively regulate 
cell proliferation, and tumour development has also been related 
to mutations in these genes. Overall the development of 
malignancy appears to involve the loss of cellular control over 
the multiple pathways involved in the regulation of growth and
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differentiation. Low concentration in vitro cell cultures have 
provided with an invaluable tool for the study of growth factors, 
their effects and their involvement in cell proliferation and 
malignancy. High concentration continuous cultures have not been 
extensively used in this area and they may provide better models 
for the understanding of these phenomena.
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2.0 ANIMAL CELLS IN CULTURE
The first recorded method of tissue culture is attributed to 
Wilhelm Roux who in 1885 is reported to have maintained the 
medullary plate of a chick embryo in warm saline for a few days. 
By 1907 Ross Harrison demonstrated that embryonic nerve cells 
could be grown in a hanging drop of clotted lymph. To overcome 
the problem of contamination by microorganisms, tedious aseptic 
techniques were borrowed from medical surgery and applied to cell 
culture by Alexis Carrel. He is reported to have maintained a 
culture of chick embryo heart cells for 34 years and thus 
developed the first continuous cell line (Carrel, 1912, 1913,
1926) . The use of antibiotics in the late 1940's eased the 
handling of cell cultures.
Early cell culture media included embryo extracts, plasma and 
other undefined biological fluids. The recent trend has been 
towards the use of more defined media components and the 
development of fully defined cell culture media. Since the turn 
of the twentieth century cell lines have been developed from many 
different cell types and grown in a variety of cell culture 
systems to produce vaccines, monoclonal antibodies, interferons, 
growth factors and many other biologicals.
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2.1. CELL LINES
Most animal cells found in suspension in body fluids, such as 
haemopoietic cells and lymphocytes, and transformed cells can be 
maintained in free suspension in vitro. These are known as 
anchorage-independent cells or suspension cells. Most other 
normal mammalian cells are found in vivo forming compact tissues 
and when grown in vitro are anchorage-dependent, requiring a 
surface or substratum for growth.
The term contact inhibition was first used by Abercrombie and 
Heaysman (1954) to describe the cessation of growth in confluent 
monolayer cultures as a result of contact with adjacent cells. 
Contact inhibition is a reversible process as demonstrated in 
cell monolayer wounding experiments where cells next to the wound 
are found to proliferate and occupy the neighbouring empty space 
(Gurney, 1969). The degree of contact inhibition is dependent 
upon the cell type, the nature of the substrate surface and 
environmental conditions such as the presence of growth and 
attachment factors. Escape from in vitro contact inhibition and 
anchorage-dependency has normally been associated with 
tumourigenicity in vivo (Freedman and Shin, 1974).
Cells are said to be normal when they do not differ from cells 
found in a healthy intact organism. Their characteristics are 
summarized in Table 2.1.1. Non-transformed cells include normal 
cells and others which may have an altered chromosomal complement 
and life span but do not present transformed properties.
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Transformed cells exhibit altered karyotypes and malignant 
properties, usually forming tumours in test animals. 
Transformation is not a one step event and cells are thus said 
to exhibit certain degrees of transformation.
Normal cells Non-Transformed cells Transformed cells
Diploid Diploid or Aneuploid Altered karyotype
Finite life span Finite or Infinite life span Infinite life span
Anchorage dependent Anchorage dependent Grow attached or in suspension
Density inhibited Density inhibited Not density inhibited
Non tumorigenic Non tumorigenic Tumourigenic
Reduced requirement for growth
factors
ie., WI-38 and MRC-5 ie.. Mouse BALBc\3T3 ie., HeLa
Table 2.1.1.: Characteristics of normal, non-transformed and transformed
cells.
Cells taken directly from a tissue form an in vitro primary 
culture. A secondary culture can be formed by sub-culture from 
this primary culture and a cell line may be established by 
repeated sub-culture. For some cell lines this process may be 
continued indefinitely whereas in other cases there is a finite 
growth capacity (see Figure 2.1.1).
Most normal cells do not give rise to continuous cell lines. 
Human fibroblasts remain euploid throughout their life-span and 
stop dividing at around 50 generations (Hayflick and Moorhead, 
1961) . Cell lines with finite growth usually follow three
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distinctive phases. An initial phase of slow growth followed by 
a period of exponential growth, in which cells may be subcultured 
for a number of generations, and after this a senescent phase, 
in which viable cell numbers decline (Hayflick and Moorhead, 
1961). This finite number of cell divisions, which varies between 
cell lines, suggests an intrinsic ageing process, parallel to 
that occurring in normal cells in vivo. The mechanism is not yet 
understood and it has been suggested that it may be due to an 
accumulation of errors occurred during DNA replication (Orgel, 
1963) or changes in the pattern of DNA méthylation (Wilson and 
Jones, 1983).
T o t a l  c e l l T r a n s f o r m e d
n
N u m b e r  o f
0 50
g e n e r a l i o n s
Figure 2.1.1.: Establishment of transformed cell lines (adapted from Hayflick 
and Morehead 1961).
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Cell lines associated with tumours grow rapidly and are readily 
established in culture. These cells usually present genetic 
abnormalities and appear to escape entering the senescence phase 
and they are referred to as immortal. A continuous cell line may 
also result from the process of transformation of a finite cell 
line. Transformation may occur spontaneously or may be induced 
by exposure to carcinogens or selected viruses.
Cell lines can be more easily isolated from rats, mice and 
rabbits than human tissues (Mayne, 1990), the reason is not yet 
clear but it may be due to inadequate media compositions. A 
continuous cell line may or may not be associated with changes 
in other characteristics of normal cells and the resulting cells 
vary in their degree of transformation. Frequently transformation 
causes changes in the chromosome complement resulting in 
aneuploid or heteroploid cells. As described in Table 2.1.1., 
transformed cells usually have lower serum and growth factor 
requirements, they may escape from normal cell contact inhibition 
and may also become able to grow free in suspension. The process 
of transformation leads to rapid cell proliferation and de­
differentiation. A strong parallel exists between transformation 
in vitro and tumorigenicity in vivo and many cell lines 
transformed in culture are tumourigenic.
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2.2. CELL CULTURE CONDITIONS
Claude Bernard (1813-1878) held the view that a cell outside 
the normal environment of an animal would seek to maintain its 
internal conditions, and it would be more likely to grow and 
divide if the difference between its internal and external 
environment was minimal. Successful cell growth in culture is 
greatly dependent on the maintenance of appropriate 
physicochemical conditions. The nature of the substrate and cell 
spatial distribution, the maintenance of the appropriate pH, 
temperature and the provision of oxygen, nutrients and growth 
factors are all crucial.
2.2.1. GROWTH SUBSTRATE AND CELL ADHESION
For successful attachment and spreading, anchorage-dependent 
cells require growth substrates with certain characteristics 
(reviewed by Handa-Corrigan et al., 1992). Cells prefer rigid 
substrates (Maroudas, 1973) with high surface energy (Grinnell 
et al., 1972), a surface charge (Rappaport, 1960) and available 
and reactive molecular groups such as carboxyls, hydroxyls and 
aldehydes. Glass is often used but it is being replaced by 
disposable polystyrene surfaces which upon formation are 
hydrophobic but when treated with chemicals, "^-irradiation or 
electric plasmas produce a charged hydrophillic surface suitable 
for the culture of anchorage-dependent animal cells. 
Polycarbonate (PVC), polyvinylchloride, polytetrafluoroethylene
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(PTFE), thermanox (TPX) and other plastics are also used 
(Reviewed by Freshney 1983).
The process of cell adhesion involves the initial wetting of 
the substratum and the adsorption of small and large molecules 
present in the culture media. Their adsorption and arrangement 
is greatly affected by their own nature and the nature of the 
substratum. Fibronectin for example, has been found to adsorb 
more strongly to hydrophobic than hydrophillic substrata (Grinell 
and Feld, 1981).
Within 30-120 seconds after seeding of a culture flask with 
anchorage-dependent cells, the process of cell adhesion begins 
(Baier, 1975). At first cells passively adsorb to the substratum 
and adsorbed molecules in a non-specific manner (Suzuki and 
Sakai, 1992). After this cells actively attach and spread, 
changing from a spherical to a flattened shape in a more specific 
process which takes several hours (Witkowski and Brighton, 1971) . 
Focal adhesions (Abercrombie et al., 1971) are then formed as 
macromolecular bridges between the cell cytoskeleton and the 
substrate. Focal adhesions are formed of vitronectin, fibronectin 
and heparan sulphate proteoglycan on the extracellular side; of 
integrins, 3 0B6 antigen and HSV-D glycoprotein crossing the 
cytoplasmic membrane; and actin, a-actinin, fimbrin, vinculin, 
talin, tensin and other proteins on the cytoplasmic face 
(reviewed by Burridge et al., 1988).
Cell attachment to surfaces may be improved by pre-conditioning 
of the substrate by its previous use for cell culture (Culp,
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1974), by treatment with cell culture spent medium (Stampfer et 
al., 1980) or by the addition of cell specific adhesion molecules 
(CAM's) such as collagen (Elsdale and Bard 1972), fibronectin 
(Maciag et al., 1980, Gilchrest et al., 1980) and other 
extracellular matrix (ECM) proteins as tenascin, entactin, 
vitronectin and laminin. In undefined media, serum, commonly used 
as a supplement, contains the necessary adhesion and spreading 
factors. Addition of ECM proteins to cell cultures not only 
promotes cell attachment but have also been found to affect the 
regulation of gene expression, differentiation and other cellular 
functions (Bissell, 1981; Carey, 1991). There is strong evidence 
that these effects are mediated via cell surface receptors known 
as integrins (Schwartz, 1993). Integrins appear to be the major 
cell receptors by which cell-substrate and some cell-cell 
interactions take place (reviewed by Hynes, 1992) . Blockage of 
integrin ligand interactions by monoclonal antibodies often 
induces the complete detachment of cells in culture from their 
substratum (Hayman et al., 1985; Knudsen et al. , 1981) and growth 
inhibition of anchorage-dependent cells (Hayman et al. , 1985;
Ingber et al., 1990). Integrins are transmembrane cell membrane 
glycoproteins composed of an a and B subunit. The types of 
subunit govern their affinity for their different ligands. 
Integrins are internally associated with the cell cytoskeleton 
and have an affinity for ECM proteins thus serving as cellular 
structural anchorage points. Some integrins have also been found 
to mediate cell-cell adhesion by binding to fibrinogen and some
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integral membrane proteins of the immunoglobulin adhesion 
receptor family (ICAM-1, ICAM-2 and VCAM-1) (Stauton et al., 
1988, 1989; Slices et al., 1990).
There is increasing evidence that the association of integrins 
with their ligands has specific intracellular effects which are 
similar but dissociated from those induced by growth factors or 
oncogenes (Schwartz, 1993). Tyrosine phosphorylation events 
triggered via integrins have been identified in platelets 
(reviewed by Shattil and Brugge, 1991), fibroblasts (Guan et al. , 
1991) and carcinoma cells (Kornberg et ai., 1991). The adhesion 
of fibroblasts, endothelial cells, and lymphocytes to fibronectin 
has been seen to cause cytoplasmic alkalinization (Schwartz et 
al., 1991; Ingber et al. , 1991) and it has been demonstrated that 
this also occurs via integrins and is independent of the effects 
of spreading or growth (Schwartz et ai., 1991). Integrins have 
also been found to be involved in T-lymphocyte activation, in the 
stimulation of secretion in synovial fibroblasts, monocytes and 
neutrophils, and in the differentiation of myoblasts and 
kératinocytes (reviewed by Hynes 1992).
This evidence suggests common intracellular pathways involving 
cell-substrate attachment, cell growth control and 
differentiation. This is supported by the evidence that cell 
adhesion to ECM proteins can promote growth in the presence of 
minimal growth factors (Ingber et al., 1990) or enhance cellular 
responses to soluble factors (Tucker et al. , 1981). Also, growth 
factors have been found to be involved in the regulation of
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integrin expression. In MG-63 human osteosarcoma cells TGF-B 
induces a decrease in integrin oc^ subunit expression and an 
increase in « 2  subunit expression, and this effect is increased 
upon addition of interleukin-lB (Heino and Massagué, 1989). Human 
skin fibroblasts and MG-63 cells have also been found to increase 
their expression of integrin subunit upon exposure to
interleukin-lB (IL-IB) or TGF-a (Santala and Heino, 1991).
While integrins are the main mediators in cell-substrate 
adhesion, three other major groups of adhesion molecules have 
been identified in cell-cell interactions. The cadherins 
(reviewed by Takeichi, 1990) are calcium dependent adhesion 
molecules which mediate hemophilic (like with like) adhesion 
between cells. There are at least 12 different cadherins (Suzuki 
et al., 1991) and cells expressing different cadherins segregate 
to form aggregates (Nose et ai., 1988). Another major group of 
cell-cell adhesion receptors are members of the immunoglobulin 
family (reviewed by Williams and Barclay, 1988). The first to be 
described was the neural cell adhesion molecule (N-CAM) 
(Cunningham et al., 1987) and it is now recognised as part of a 
large family. The non-lymphocyte members of this family contain 
a number of immunoglobulin-related domains and, in many cases, 
by several membrane proximal repeats of a second type of protein 
module, known as a fibronectin type III repeat, first identified 
in fibronectin (Frei et al. , 1992). Binding of the immunoglobulin 
superfamily adhesion receptors may be homophilic, such as occurs 
with N-CAM (Cunningham et al., 1987) or heterophilic, binding to
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integrin receptors on adjacent cells. Thus the immunoglobulin 
attachment receptors may mediate adhesion of cells of the same 
type or of different types. The third class of cell-cell adhesion 
receptors have been called LECAM's or selectins (Bevilacqua et 
al. , 1991). Three selectins are now recognised. They are composed 
of a calcium c-type lectin domain, an EGF like repeat, and a 
number of repeats related to the consensus repeats of complement 
binding proteins.
Recently a cell adhesion regulatory gene, the car gene, has 
been identified and found to be absent in malignant cells which 
can be made to become anchorage-dependent by the re-incorporation 
of the gene (Pullman and Bodmer, 1992) . The car gene is not a 
gene for CAM's and its product has been proposed to be a cell 
adhesion regulatory protein. The possibility of cancer treatment 
by targeting malignant cells with the car gene remains to be 
investigated.
Overall, cell adhesion and growth control appear to be closely 
interrelated. Whereas the search for biological molecules with 
growth factor activity has commonly focused on the measurement 
of cellular metabolic rates or cell number, and not on their 
potential for affecting cell adhesion, it would be of interest 
to extend this search into the area of cell adhesion molecules.
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2.2.2. PHYSICAL CONDITIONS
The temperature of mammalian cells in culture is normally kept 
at 36.5 2 c which is close, but for safety reasons lower, to their 
normal in vivo temperature, 37.42C. Cells can tolerate 
temperature drops, and can survive for several days at 42c, but 
they are very sensitive to elevated temperatures and can only 
survive a few hours at 392 c (Freshney, 1983).
The pH of cell cultures is usually kept between 6.8 and 7.4 and 
the optimun pH for growth will vary slightly for different cell 
lines. This pH is maintained by using HEPES, TRIS or HCO3/CO2 
buffering systems and phenol red is commonly used as a colour 
indicator (reviewed by Griffiths, 1992). Carbon dioxide plays a 
complex role in cell culture as it affects the pH and HCO^ 
concentration and is required for cell growth (Itagaki and 
Kimura, 1974). Cell culture incubators are usually maintained 
with a gas phase containing 5% CO2 in air.
Animal cells are quite tolerant to a range of osmotic pressures 
and in practice osmolarities between 2 60 mOsm/Kg and 32 0 mOsm/Kg 
are acceptable (Waymouth, 1970). Hypertonic media have been 
reported to cause a growth depression and an increase in 
hybridoma cell volumes together with an increased antibody 
production per cell (Ozturk and Palsson, 1991).
Cell cultures vary in their oxygen requirement with typical 
consumption values in the range of 2-10 jitg/10^  cells/hr (Spier 
and Griffiths 1984). Oxygen is not very soluble in culture media.
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medium in equilibrium with air will contain 7.6 jitg/ml (Benson and 
Krause Jr., 1976; Schumpe et al., 1978), and if not aerated a 
typical culture containing 2  x 1 0  ^ cells/ml would deplete the 
available oxygen in less than 1 hr. Suitable oxygen levels are 
maintained using gas mixtures containing between 10-90% dissolved 
oxygen in air (reviewed by Griffiths 1992) and in most cases 
oxygen becomes the cell growth limiting parameter.
Many different bioreactor designs have been developed to 
maintain the adequate physicochemical and nutritional conditions 
and they will be described later in Section 2.3.
2.2.3. MEDIUM CONSTITUTION AND CELL METABOLISM
The first animal cell culture media used included embryo 
extracts, plasma and other undefined biological fluids. Early 
attempts were made at devising chemically defined liquid media 
(Lewis and Lewis, 1911; Lewis and Carrel, 1926; Vogelaar and 
Erlichman, 1933) and by 1946 White developed the first chemically 
defined medium that supported the short-term survival of a number 
of primary cells. In 1955 Eagle developed his minimal essential 
media (MEM) which contained the required nutritional factors for 
growth of mouse L cells in the presence of small amounts of 
serum. Eagle's MEM supplemented with 2.5-10% serum became a 
standard growth medium in cell culture but efforts in formulating 
totally defined media, devoid of serum, continued (Evans et al., 
1964; Morgan et al., 1950; Parker, 1961; Waymouth, 1959). Serum
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was identified as a provider of growth factors (Sato, 1975) but 
early attempts in purifying them mostly proved unsuccessful. 
Later a different approach was taken by others, who aimed to 
identify the necessary hormonal, nutritional and adhesion factors 
by adding such factors to defined medium. Following this strategy 
many cell lines and primary cultures were successfully maintained 
in hormonaly defined media (reviewed by Taub 1989).
Apart from the provision of growth factors, serum is now 
recognised as playing many roles for animal cells in culture 
(Table 2.2.3.1.).
Roles of serun in culture Disadvantages in the use of serum
Provision of cell division factors (EGF, IGF, 
PDGF, FGF, TGF-B).
Provision of attachment factors (fibronectin, 
fetuin, vitronectin).
Trypsin neutralizer.
Source of trace elements (Fe, Ca, Mo, Zn, V, Se, 
Cr, Co, Mn and carriers for them (transferrin). 
Protection against physical damage (albumin). 
Provision of materials for membrane biosynthesis 
(linoleic acid, cholesterol).
- High cost.
- Availability.
- Variability of batches.
- Extensive testing required to ensure 
sterility.
- Lack of definition.
- Interference in cell nutrition and 
physiology experiments.
- Interference with downstream 
processing.
- Potential source of contamination
Table 2.2.3.1.: Roles of serum in cell culture and its disadvantages.
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The disadvantages of using serum are many (also summarised in 
Table 2.2.3.1.) and it has even been found to inhibit the 
proliferation of mouse embryo serum free cells and eventually 
induce their transformation (Rawson et ai., 1991). Despite this, 
serum is still widely used as an additive to many basal media 
like Dulbecco's minimal essential media (DMEM) (Dulbecco and 
Freeman, 1959), Ham's F12 media (Ham, 1965) and RPMI-1640 (Moore 
et ai., 1967) . The reasons for this are to do with the high cost 
of developing and formulating completely defined media, their 
high market prices and the maintenance of their formulations as 
commercial secrets. However, current trends are towards the 
reduction of serum use and the development of fully defined 
media. Common additives included in defined media include growth 
factors such as EGF, PDGF, fetuin, FGF, IGF and NGF; hormones 
such as glucagon, insulin and progesterone; cell attachment 
factors like collagen, fibronectin and vitronectin; transport 
binding proteins like albumin and transferrin; and other factors 
such as liposomes, cadmium and prostaglandins (reviewed by Taub, 
1989 and Maurer, 1992).
Most animal cells in culture require both glucose, in the range 
of 5 mM to 2 0 mM, and glutamine, in the range of 0.7 mM to 5 mM, 
as energy and carbon sources (see Figure 2.2.3.1.). Glucose is 
metabolised through glycolysis to produce 2  molecules of 
pyruvate, which can in turn be metabolised to lactate without the 
need of Oj, or to CO2 and H2O through oxidation by the 
tricarboxylic acid cycle (TCA) (Lehninger, 1975; Glacken 1988).
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Figure 2.2.3.1: Main metabolic pathways in cell metabolism.
Mammalian cells typically oxidise less than 5% of metabolised 
glucose (Glacken, 1988) making lactate the main waste product. 
The effects of lactate accumulation are variable and greatly 
depend on the cell line. Concentrations of 40 mM of lactate have 
been reported to have no effect on the cell growth of AB2-143.2 
mouse hybridoma (Miller et al., 1988) or to cause a 50% reduction 
in the growth rate of the CRL-1606 hybridoma (Glacken, 1988) . 
Other experiments have demonstrated lactate concentrations up to 
22 mM being stimulatory for growth of VII H - 8  hybridomas (Reuveny 
et al., 1987) and 10 mM not having any effect on 321 hybridomas
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(Thorpe et al., 1987). In the 167.4G5.3 mouse hybridoma, lactate 
concentrations of 55 mM have been found to cause a 50% reduction 
in the growth rate but an increase in cellular metabolic rates 
and a two fold increase in cell specific antibody productivity 
(Ozturk et al., 1991). The acidification of the media due to the 
accumulation of lactate does not appear to be the direct cause 
of these effects which have also been suggested to be due to 
changes in the osmolarity of the environment (Ozturk et al., 
1991). Experiments on HeLa cells and human fibroblasts growing 
in media devoid of glucose and supplemented with ribonucleosides 
have led to the idea that glucose may only be required for 
nucleic acid synthesis and excess glucose is "dumped" down 
through the glycolytic pathway, leading to pyruvate and lactate 
(Glacken, 1988). To overcome the problems associated with the 
excess production of lactate, carbon sources other than glucose 
such as galactose (Reitzer, 1979), fructose (Imamura et al., 
1980) and uridine or cytidine (Wice et al., 1981) have been used.
Glutamine acts as the primary source of nitrogen (Glacken, 
1988) and the proportion of cellular ATP derived from glutamine 
oxidation has been found to vary greatly for different cell 
types. Glutamine oxidation accounts for 40% of the ATP formed in 
Chinese hamster cells (Donnelly and Scheffler, 1976), 30% for
human fibroblasts (Zielke et al., 1978), and 70% for HeLa cells 
(Reitzer, et al., 1979). Glutamine is unstable in culture media 
and decomposes to form pyrrolidine, carboxylic acid and ammonia 
(Trisch and Moore, 1962). Cells metabolize glutamine through
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glutaminelysis which may lead to the production of lactate, CO2 , 
or to alanine and aspartate (Lehningher, 1975; Glacken 1988). The 
first two routes occur via glutamate, with the consequent 
formation of ammonia. Ammonia accumulation is well recognised as 
having a negative effect on cell growth, but cell lines vary in 
their sensitivity. A 50% growth inhibition has been reported in 
SB-4082 hybridoma cultures containing 2 mM ammonia (Truskey et 
al., 1990), in the 167.4G5.3 hybridoma with 4 mM ammonia (Ozturk 
at al., 1992) and in the ATCC TIB 131 hybridoma in 10 mM ammonia 
(Me Queen and Bailey, 1990) . Non-hybridoma cells appear to be 
less tolerant to ammonia. Inhibition of 3T3 cells was observed 
below 1 mM ammonia and the extent of inhibition decreased upon 
transformation with SV-40 (Visek at al., 1972). Ammonia 
concentrations below 1 mM have also been reported to inhibit 
mouse L cells (Ryan and Cardin, 1966) and BHK cells (Butler and 
Spier, 1984). High ammonia levels also have the effect of 
accelerating cell metabolism. In hybridomas, in high ammonia 
conditions, a decrease in lactate and ammonia yields from glucose 
and glutamine respectively is accompanied by an increase in 
alanine yield from glutamine. Specific antibody production and 
oxygen uptake do not seem to be affected (Ozturk et al., 1992). 
The proposed mechanism by which ammonia exerts these effects 
involves permeation of NH3 and into the cell causing a drop
in intracellular pH (Boron and De-Weer, 1976; McQueen and Bailey, 
1990).
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There is evidence that glycolysis and glutaminolysis are 
jointly regulated, increases in glucose concentrations leading 
to a decrease in glutamine uptake rate (Glacken, 1988), and 
optimal media formulations should be well balanced and aim to 
reduce the depletion of a single nutrient or accumulation of one 
waste product.
Amino acids are also included in cell culture media 
formulations and a number of them have been found to be essential 
for cell growth (Eagle, 1955). Uptake of amino acids is variable 
and greatly depends on the cell line to be grown (McCarty, 1962) . 
Specific culture media were designed to cover the needs of 
individual cell lines (Ham, 1965). Amino acid depletion has been 
found to be one of the factors limiting cell growth in batch and 
continuous cultures (Buntemeyer, 1991) and has even been proposed 
as the cause of cell death in batch cultures (Luan et al., 1987) .
Amino acids are not only consumed in cell culture but also 
accumulate in the medium as a result of cell metabolism. Common 
"waste" amino acids include alanine, glycine and glutamate, but 
this is also variable amongst cell lines (Duval et al., 1991; 
Buntemeyer, 1991). The addition of 10 mM exogenous alanine has 
been reported to have no effect on hybridoma cell proliferation 
(Duval et al., 1991) and there are no reports suggesting that 
accumulating "waste" amino acids have a negative effect on cell 
cultures.
Other basal cell culture media components include amino acids 
(Eagle, 1959), B group vitamins (Blaker 1971 and Higuchi, 1973),
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nucleotides (Lambert, 1985) and inorganic ions (Ham, 1981).
In order to reduce the risk of contamination by microorganisms 
antibiotics are common additives in culture media. Ideally 
antibiotics should be avoided since in the long term resistant 
microorganisms may develop and they may have adverse effects on 
cell growth, yield and longevity (Goetz, 1979), and may interfere 
with the desired product.
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2.3. CELL CULTURE SYSTEMS AND METHODS
Modern cell culture systems (see Table 2.3.0.1.) have aimed to 
fulfil the physico-chemical and biological requirements of animal 
cells. Some systems are however able to achieve these objectives 
better than others (reviewed by Handa-Corrigan, 1988; Mizrahi, 
1989; Griffiths, 1988).
2.3.1. CULTURE SYSTEMS
Homogeneous systems have been developed as adaptations from 
microbial fermenters (Stanbury and Witaker, 1984) and their aim 
is to be well mixed. Homogeneous systems include stirred tanks, 
in which oxygen is delivered by a sparger situated underneath a 
rotating impeller (Hu and Dodge, 1955), and airlift systems in 
which oxygenation and mixing is carried out by a column of rising 
bubbles (Katinger et ai., 1979; Birch et ai., 1985; Merchuk, 
1990). Shear forces generated within the culture fluid upon 
aerating and mixing have traditionally been regarded as damaging 
to cells. In stirred tanks oxygen delivery via direct sparging 
is thought to result in cell damaging shear forces created by 
bubble break-up and dispersion. To reduce shear forces associated 
with the mixing devices, impellers with different geometries have 
been developed (Feder and Tolbert, 1983). In airlift systems 
mixing is achieved by the stream of rising bubbles and the shear 
forces created through mechanical mixing are prevented. The 
degree of mixing in airlift bioreactors is poor and may lead to
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Cell Concentration MCA* pg/ml Scale (L) References
HOMOGENEOUS SYSTEMS
BATCH
Stirred tank
suspension 1-5 X 10® cell/ml 10-100 0.1-8000 Philips et al.. 1985
microcarriers 1-2 X 10® cell/ml - Tolbert, 1985; Butler, 1988
Airlift 1-4 X 10® cell/ml 40-500 3-1000 Birch et al.. 1987
CONTINUOUS
Stirred tank
Chemostat 1-4 X 10® cell/ml 17 - Birch et al.. 1985
PERFUSION
Stirred tank
Spin filter
suspension 1-6 X 10^ cell/ml - - Himmelfarb et al., 1969
microcarriers 1-5 X 10’ cell/ml - - Butler, 1988
Hollow fibre 1-5 X 10’ cell/ml - - Griffiths, 1985
HETEROGENEOUS
SYSTEMS
BATCH
Static flasks
atatched 1-5 X 10® cell/cm’ - 0.01-0.1 Griffiths, 1992
suspension 1-5 X 10® cell/ml 10-100 0.01-0.1 Panina, 1985
Roller bottle 1-5 X 10® cel I/cm’ - 0.3-0.5 Panina, 1985
PERFUSION
Roller bottle 4.5 X 10® cell/cm’ 0.3-0.5 Kruse et al.. 1970
Fluidised bed 1-4 X 10® cell/ml - 0.5-24 Runsdtadler and Cernek, 1985
Hollow fibre 10® cell/ml - Schonher and van Gelder, 1988
Encapsulation 1-5 X 10® cell/ml - Littlefield et al.. 1984
Ceramic matrix 1-3 X 10® cell/ml 3-13 xIO® - Berg and Bodeker, 1985
Flat membranes - -
Fibrous beads 50-185 -
Table 2.3.0.1.: Common animal cell culture systems and the cell densities and antibody concentrations achieved 
(*: For processes involving hybridoma cells).
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problems in pH control.
Direct contact with the rising bubbles has also been reported 
as damaging for cells (Kilburn and Webb, 1968) but it is now 
apparent that the damage occurs at the culture surface at the 
point of bubble disengagement and through the formation of foams 
(Handa-Corrigan et al., 1987). In spin filters (Himmelfarb et 
al., 1969; Tolbert et al., 1985) cells are protected by a porous 
mesh from the high shear forces produced next to the impeller and 
the rising bubbles. In such systems, oxygen transfer is still 
limited by the degree of mixing achieved within the bioreactor 
and mainly by the bubble surface areas achieved through sparging 
(Zhang, 1993) .
The cell concentrations achieved in stirred tanks and airlift 
bioreactors vary between 1 0 ® cells/ml for batch cultures and 1 0 ? 
cell/ml for perfused cultures (Table 2.3.0.1.). At 10® cell/ml 
the oxygen demand is in the range of 1 - 1 0 0  mg O2 /litre/hour 
(assuming an average O2 consumption of 1-10 /xg/lO® cell/hour) and 
can be easily provided through sparging (Spier, 1992). Because 
of their homogeneous nature, stirred tanks and airlift fermenters 
have been amenable for scale up of anchorage-independent cell 
cultures. Stirred tanks have been scaled up to 8,000 litres of 
culture volume for the production of interferon from Namalwa 
lymphoblastoids (Phillips at al., 1985) and airlift fermenters 
have been scaled up to 1 , 0 0 0  litres for the production of 
monoclonal antibodies from hybridoma cells (Birch at al., 1985). 
Anchorage-dependent cells may also be grown in homogeneous
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systems, either in the form of aggregates (Tolbert et al., 1981) 
or attached on to microcarriers. The first used microcarrier for 
animal cell culture was the commercial ion-exchange resin DEAE- 
Sephadex A50 (van Wezel, 1967). Different types of microcarriers 
have since been developed, including polystyrene beads (Johansson 
and Nielsen, 1980), hollow glass beads (Varani et al., 1983), 
cellulose beads (Reuveney et al., 1982) and dextran, plastic and 
collagen beads (reviewed by Butler, 1988). Microcarrier cultures 
up to 1,000 litres have been used to grow Vero cells for the 
production of polio vaccines (Montagnon et al., 1983).
Heterogeneous systems are characterised by a non-uniform 
distribution of the cultured cells. Heterogeneous systems were 
first developed to accommodate the needs of anchorage-dependent 
cells. The growth capacity of Petri dishes and static flasks was 
increased by increasing the surface area available for growth. 
Roller bottles, roller bottles with glass rods or spiral film 
inserts, multiplate systems and bioreactors packed with glass 
spheres are commonly used. Providing that they contain enough 
culture media, such systems are limited by the maximum surface 
cell concentrations achieved by a particular cell line (ie., 1 0 ® 
- 5 X 10® cell/cm^) .
In more complex heterogeneous systems cells grow in a spatial 
arrangement either entrapped or immured (McCullough and Spier, 
1990) while the culture fluid is recirculated through. Cells are 
thus maintained away form the site where mixing occurs, 
permitting the culture of anchorage-dependent and suspension
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cells. In such systems the formation of gradients of oxygen, 
nutrients and of waste metabolites are inevitable and novel 
designs have been implemented to reduce these gradients and the 
formation of dead spaces.
Heterogeneous systems in which cells are immured by porous 
membranes include flat membrane chambers, hollow fibre cartridges 
and those in which cells are encapsulated within polymeric 
spheres. In these systems the pore size of the separating 
membranes may be accommodated to retain the desired cell-produced 
products thereby having a means of achieving high product 
concentrations (see Table 2.3.0.1.). Monitoring of growth 
conditions in such systems may be difficult as cells cannot 
usually be directly counted. Assessment of cell number and growth 
conditions may be done indirectly, by measuring the oxygen or 
nutrient uptake or the production of a product or waste 
metabolite. Cell concentrations above 10* cell/ml are commonly 
reported (see Table 2.3.0.1.). In other heterogeneous systems 
cells are found entrapped within textured surfaces as ceramic 
matrices (Berg, 1985), polyurethane sponges (Lazar, et al. , 1987) 
and macroporus carriers (Nilsson et al., 1986) or within fibrous 
materials (Litwin, 1985). Such systems also obtain high cell 
concentrations but, as there is not a membrane separating them 
from the circulating medium, their products are not retained.
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2.3.2. CELL CULTURE METHODS
The cell culture systems previously described may be used in 
a variety of modes. Batch cultures are, by definition, closed 
systems in which, following inoculation, cells grow consuming the 
available nutrients and growth factors and releasing waste 
products which accumulate in the media (Figure 2.3.2.1). Static 
flasks, roller bottles and, at a larger scale, stirred tanks and 
airlift bioreactors are the most common culture systems run in 
batch. Typical batch cultures run for 5 to 15 days, reaching cell 
concentrations of 1-4 x 10® cells/ml (Birch et al., 1985).
Fed-batch arose as a modification of the batch culture method 
and is commonly used in stirred tank systems. Fed-batch cultures 
are fed continuously or intermittently with the growth limiting 
nutrient, or whole medium, and as cell numbers increase cell 
product and wastes accumulate. Eventually the available 
bioreactor space is full and the run is left to finish as a batch 
culture.
In perfusion cultures, cells are retained within the culture 
system and fresh medium is perfused through as spent medium is 
removed. In contrast to continuous systems, perfusion systems do 
not aim to maintain steady states and cell numbers increase to 
occupy the available space. Stirred tanks and airlift bioreactors 
may be run in perfusion mode by using filtration or sedimentation 
devices to prevent the outflow of cells. The cell concentrations 
achieved are in the order of 10^  cell/ml. Immured systems, such
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Figure 2.3.2.1.: Common cell culture methods
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as hollow fibres or fiat membranes, and entrapped systems, such 
as encapsulation or ceramic matrices, are though the better 
suited for this mode of operation, and concentrations above 1 0  ^
cell/ml are often achieved.
The advantages of using high cell concentration perfused 
bioreactors for cell culture are not only limited to achieving 
high cell concentrations and high product outputs. The space 
requirements of high concentrated cultures are reduced in 
comparison with conventional bioreactors and labour and 
processing costs are also cut as long term cultures are achieved 
from a single inoculation. High concentration perfusion cultures 
may serve as a source of concentrated cell culture conditioned 
medium obtained for long periods of time and have been used for 
this purpose (Handa-Corrigan et al., 1992).
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2.4. HOLLOW FIBRE BIOREACTORS
Hollow fibre bioreactors (HF) consist of a closed shell which 
is traversed by a bundle of porous hollow fibres (capillaries). 
Cells are usually grown in the extracapillary space (EC) and 
oxygen and fresh media are delivered through the intracapillary 
space by perfusion (IC)(See Figure 2.4.1.).
n R
L------------- - _  _ J
\  \  \  J ,
1 -  V > 7  J
r 1
PI
0
P2
i^P2
Figure 2.4.1.: Hollow fibre cartridge and pressure distribution (EC:
extracapillary side; IC: intracapillary side; PI: inlet pressure; P2: outlet 
pressure).
The first successful HF system for growth of animal cells was 
developed by Knazek et al. in 1972 (Figure 2.4.2.). Two types of 
cell culture units were used. A 1.3 cm^ volume ultrafiltration 
cell with 30 kDa cut-off fibres and a second with a 50 kDa 
cut-off fibres enclosed in a 421 mm^ shell. The culture units 
were mounted in parallel in a perfusion circuit which included 
a media reservoir and an oxygenator.
Mouse fibroblasts and human choriocarcinoma cells producing human
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chorionic gonadotropin (hCG) were grown. The medium from the 
perfusion system was replaced every 1-4 days and the media from 
the EC, containing hCG, was collected weekly. From the hCG titre 
obtained the calculated cell concentrations were approximately 
7.2 X  10^ cells/ml, closer to in vivo tissue cell concentrations 
(ie. 1 0  ^cells/ml) than any previous in vitro culture system.
R oller
pump]  ■
rir*
H a rv e s t
port
J__________ I__
H o llo w  f ib re  un it
J ___________L
6% CO^ In air
Dxygenator
Figure 2.4.2.: Hollow fibre perfusion system (Knazek et ai., 1972).
Hollow fibre systems have since been used in the production of 
cancer (David et al., 1978; Hager et al., 1982) and viral 
antigens (Johonson et al., 1978; Me Aleer, et al., 1983; Ratner 
et al., 1978), gonadotropin (Knazek et al., 1974), insulin (Tze 
and Chen, 1977), plasminogen activator and migration inhibiting 
factor (Ku et al., 1981) and more recently monoclonal antibodies 
(Schonherr et al., 1986; Altshuler et al., 1986).
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The main advantages associated with HF technology include high 
cell concentrations and reduced serum requirements, high product 
concentration, long term runs and almost cell free harvests. A 
single HF run has been said to produce the equivalent amount of 
monoclonal antibody (MCA) as 50 mice (Shonherr et al., 1986). It 
has been argued that HF systems do not offer any advantage over 
lower concentration perfusion systems in terms of product 
obtained per volume of media perfused (Broise et al., 1991). 
These experiments were carried out in the presence of 5% to 2.5% 
FCS which would possibly mask the beneficial effects of high cell 
concentration systems, in addition the perfusion circuit did not 
favour the retention of product and growth factors within the EC 
space.
As heterogeneous systems, the formation of gradients within HF 
cartridges is inevitable. In axially fed closed shell type 
bioreactors there is not a net volumetric flow of media from the 
IC to the EC space and the pressure in the EC remains constant. 
As a consequence of the porosity of the fibres a pressure drop 
along the fibres occurs so that the direction of media flow is 
reversed from EC->IC to IC-*-EC (Bruining, 1989; Thakaran and Chau, 
1986) (See Figure 2.4.1.) . Cells at the media input side are thus 
exposed to a nutrient and oxygen rich environment and those at 
the other end suffer from nutrient and oxygen depletion (Piret 
and Cooney, 1991) and high levels of waste products (Chresland 
et al., 1988). Such axial gradients limit the scale-up of HF 
systems in the direction of medium flow and a number of
—60—
Introduction
alternative hollow fibre bioreactor designs have been developed 
to overcome such problems.
In Flat-bed HF bioreactors media flows normal to the plane of 
the shallow bed of capillaries and an air-COj mixture is 
circulated through the IC (Ku et al., 1981) . The system is
designed for growth of anchorage-dependent cells since the 
nutrient crossflow could result in the wash out of suspension 
cells. Scale-up is limited to a certain bed depth.
The Radial-flow system (Thakaran and Chau, 1986) consists of 
a cylinder with a central core medium distributor surrounded by 
HF's. Oxygenation is carried out through the HF lumen at one end 
and spent medium is removed through the other end. The system is 
also devised for anchorage-dependent cells and scale-up is 
limited by its diameter.
In dual circuit HF units, convection is induced via a 
differential pressure between sets of HF bundles with alternate 
dead ends, resembling an arterial and venous system. Hybridoma 
cells have been grown in such systems and reported to reach 
concentrations of 4.9 x 10^  cells/ml (Gallagher et al., 1987). 
Radial gradients also play an important role in HF bioreactor 
design and optimal fibre spacing would be one which gives a 
maximum overall cell concentration. At cell concentrations 
approaching 1 0  ^ cell/ml it has been suggested through 
mathematical modelling that the optimum HF would be disk shaped 
and only 2-3 inches long (Chresand et al., 1988).
HF cartridges may be set up in different flow configurations.
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These include linear flow, closed loop, and open loop for the IC 
side, and circuit-free, only harvest or linear flow for the EC 
side. In those where media supplements are provided through the 
IC, the molecular weight cut-off of the fibres has proved to be 
an important parameter. For 10 kDa, 50 kDa and 100 kDa cut-off 
fibres, the maximum IgG yields reported were 80, 510, and 740 
jLtg/ml respectively (Altshuler et al . , 1987) . The higher
productivity with the larger pore size fibres was attributed to 
the availability of high molecular weight compounds present in 
the medium. The disadvantage of using such arrangements is the 
potential dilution of the cell products and other factors into 
the circulating media.
The current practice is to operate HF systems in perfusion mode 
using low molecular weight cut-off fibres. Basal medium is 
perfused, in open or closed loops, through the IC to meet the 
cells metabolic demand and maintain adequate physiological 
conditions. The required high molecular weight supplements are 
fed directly to the EC and, together with cell secreted products, 
are retained within the EC space. Harvest is carried out directly 
from the EC. Such systems obtain high product concentrations and 
the need for media supplements is reduced. Optimisation is aimed 
towards obtaining maximum productivity with a minimum consumption 
of media and growth factors.
To overcome the problems associated with the formation of 
gradients and maintain high product concentrations, the Acusyst- 
Jr HF system (Endotronics, USA) incorporates low molecular weight
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cut-off fibres (ie., 6 kDa) and a novel pressurising system
(Figure 2.4.3.). Basal media is perfused through the 1C, in an 
open loop configuration, and media supplements are provided 
directly to the EC.
Media Harvest
Factor 1 EC Out Sample Flush
IC Gas filte r EC Gas filter
Bypass
ODD
ODD 
Bioreactor
ODD ?Outflow IC FLOW
Factor 2 Factor 3
EC FLOW
Inooulate
Bypass
ample Sample
Bellows pump G Ex out GEX
Figure 2.4.3.: Acusyst Junior (Endotronics) flowpath.
During operation of the Acusyst-Jr, the EC and 1C circuit 
pressures are increased alternatively to switch the flow from 
1C->EC to EC->1C simultaneously all along the fibre length. 
Temperature and pH of the 1C loop are constantly monitored and 
automatically corrected.
The complexity of the Acusyst-Jr led to the design of the
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Acusyst-R (Endotronics) or the identical Centronics (New 
Brunswick Scientific) HF system. They do not incorporate a 
pressurising system but in order to reduce the formation of axial 
gradients the flow of media through the bioreactor is 
periodically reversed by means of a pinch valve assembly. This 
theoretically provides cells at both ends of the bioreactor with 
adequate nutrients and efficiently removes waste products (Figure 
2.4.4.).
Outflow Medium Q sample
pump
EG sample
Harvest
Jet pump Temperature  
probe
pump
Factor
Hollow fibre  
BioreactorFluid 
reservoir
Pinch valve
Circulation pump
10 sample
Figure 2.4.4.: The Centronics perfusion circuit,
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Scale-up of HF systems is limited by their own heterogeneous 
nature which leads to the formation of gradients, as previously 
described. Large scale operation can be achieved by running a 
battery of smaller HF units in parallel instead of a large single 
unit. This approach has been adopted in the design of the P3X 
(Endotronics) which incorporates up to 12 HF cartridges.
The Acusyst-Jr and the Centronics hollow fibre systems have 
been thoroughly tested by previous researchers in the laboratory 
(Nikolay et al,, 1991; Handa-Corrigan et ai., 1992), and the 
Acusyst-Jr hollow fibre bioreactors were used to achieve high 
concentration cell cultures during the course of this project.
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3.0. PURIFICATION OF GROWTH FACTORS AND THEIR 
ACTIVITIES
After obtaining the tissue extracts, cell culture conditioned 
media or other sources of material are usually coarsely filtered 
or centrifuged to eliminate large particles. In these processes 
which do not guarantee sterility, samples are usually filter 
sterilised to prevent contamination. Storage of samples is 
usually carried out at -20ec or -70sc. In order to remove the low 
molecular weight contaminants a number of bulk methods like 
dialysis, ultrafiltration, lyophilization and precipitation are 
commonly used. The enrichment of the desired activity usually 
involves fractionation of the resultant materials by a variety 
of chromatographic methods like ion exchange, gel filtration, 
hydroxyapatite columns, hydrophobic and affinity chromatography. 
Further characterization and identification of the separated 
proteins is usually carried out by using electrophoretic methods 
like gel electrophoresis and isoelectric focusing which can only 
handle very small sample volumes but have a high resolution.
3.1. BULK METHODS
Bulk methods are used to concentrate or separate proteins from 
low molecular weight contaminants without discriminating between 
the separated proteins. Ultrafiltration, dialysis, lyophilization 
and precipitation are commonly used for this purpose and are
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described in the following sections.
3.1.1. DIALYSIS
A dialysis membrane permits passage of molecules below a 
certain molecular weight referred to as its molecular weight 
cut-off. Dialysis membranes once loaded with the sample are left 
in a well mixed buffer solution. The difference in concentration 
of solutes on both sides of the membrane is the driving force for 
diffusion of molecules with a molecular weight below the 
molecular weight cut-off point of the membrane. Further reduction 
of the solute concentration can be achieved by changing the 
dialysis buffer. Dialysis membranes range between 1-50 kDa in 
their molecular weight cut-off. Dialysis has been used 
extensively in growth factor work for buffer exchange and removal 
of low molecular weight contaminants from human effusions 
(Podolsky at al, , 1988) and cell culture conditioned media
(Djakiew et al,, 1991; Hofer at al,, 1991; Anzano at al,, 1989; 
Shirasuna at al,, 1988) after gel filtration (Matsuda at al 
1989; Podolsky at al,, 1988), after ammonium sulphate 
precipitation (Miyazaki at al,, 1990), and DEAE-cellulose 
chromatography (Podolsky at al., 1988). The main disadvantages 
of dialysis are the long processing times, the difficulty of 
operating a sterile process and the small volumes involved.
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3.1.2. ULTRAFILTRATION
This is also based on semipermeable membranes with specific 
molecular weight cut-off values. In this case the driving force 
is pressure, provided by pumping the processed fluid, or by an 
inert gas or a vacuum. Membranes may be removable or fixed in 
pressure tight housings to alow for pressurisation. The main 
problem associated with ultrafiltration is the clogging of the 
membrane pores. To overcome this, stirred cell devices are fited 
with a rapidly rotating impeller a short distance from the 
ultrafiltration membrane. In cross-flow devices the media to be 
filtered is circulated tangentially to the membranes to create 
a sweeping action which prevents obstruction of the membrane 
pores. Polysulfone based membranes provide effective flow 
characteristics but those made of regenerated cellulose show the 
least tendency to adsorb proteins. Conditioned media containing 
growth inhibitors have been concentrated with Amicon YM-10 
stirred cells with a 10 kDa cut-off (Lazar et al., 1987), 
Sartorius 10 kDa cut-off membranes (Lenfant at al., 1989), Amicon 
high performance ultrafiltration cells with a cut-off of 1 kDa 
(Matsuda et al., 1989) and other ultrafiltration devices (Erwin 
Jr. et al., 1989). The main limitation of ultrafiltration in the 
concentration of low molecular weight peptides is that the lowest 
available membrane cut-off is 500 kDa (Amicon, USA), and these 
only allow low filtration rates. Most of the currently available 
membranes are not amenable to steam sterilization and chemical
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sterilization may not achieve the desired sterility. If samples 
are to be subsequently used in bioassays, chemical sterilization 
must be followed by thorough rinsing to avoid the carry over of 
the sterilant into the processed sample.
3.1.3. LYOPHILIZATION
Concentration of solutes is carried out by drying the sample 
while in a frozen state; the solvent being removed by
sublimation. Lyophilization, or freeze drying, has been
extensively used for buffer exchange and concentration of many 
growth factors. Lyophilization may be carried out after dialysis 
(Djakiew et ai., 1991; Hofer et ai., 1991; Podolsky et al., 1988; 
Shirasuna et al., 1988; Anzano et al., 1989) gel filtration (Koga 
et al., 1988; Lenfant et al. ,1989) , reversed phase chromatography 
(Koga et al., 1988), octadecyl silane reverse phase HPLC (Koga 
et al., 1988), octade cylsilyl silica chromatography (Lenfant et 
al., 1989), flash evaporation (Lenfant et al., 1989).
Lyophilization is usually carried out prior to growth factor 
activity assays to allow for resuspension of the purified 
proteins in the appropriate buffer or culture medium. It is of 
great advantage for the long term preservation of proteins as the 
storage of lyophilized materials at temperatures above freezing 
is not detrimental.
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3.1.4. PRECIPITATION TECHNIQUES
Proteins may be precipitated by causing perturbations in the 
protein-solvent interactions. This may be done through changes 
in pH, temperature or addition of high salt concentrations or 
organic solvents.
a) Addition of salts: The high molarity of a saturated 
ammonium sulphate ( (NH^ ) 2SO4 ) solution causes most proteins to 
precipitate and it is the most common method of protein 
precipitation. Ammonium sulphate has many advantages, it does not 
have a large heat of solution, it has a low density, and 
concentrated solutions prevent growth of most bacteria. 
Concentrations up to 80% ammonium sulphate have been used on 
centrifuged cell culture conditioned medium for the precipitation 
of growth factor activity (Miyazaki et al., 1990). Fractionation 
of proteins with different solubilities may be carried out by 
step wise addition of ammonium sulphate either solid or in 
solution and the precipitate may be removed by centrifugation. 
Other salts used for protein precipitation are NaCl and NazSO,. 
Precipitation through the addition of salts is a rapid method for 
the non specific concentration of proteins but it usually 
involves a subsequent step, such as dialysis or ultrafiltration, 
for the removal of the salt. Another disadvantage of 
precipitation methods may be protein dénaturation.
b) Addition of solvents: Addition of miscible organic solvents 
may also be used to precipitate proteins. Methanol, ethanol.
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butanol and acetone cause dénaturation at temperatures above oec 
so the process must be carried out below osc, mixing well and 
rapidly to avoid high local solvent concentrations. Addition of 
polyethylene glycol (PEG) (Poison et al., 1964) unlike other 
organic solvents has little tendency to denature proteins even 
at high temperatures and precipitation occurs in less time. PEG 
can also be used for fractionating of proteins on the basis of 
solubility. PEG can be removed by ion exchange, affinity columns 
or ultrafiltration. Exclusion columns may be affected by its 
osmotic effects. Acetonitrile precipitation has been used as an 
initial treatment for conditioned media (Koga et al., 1988). 
Disadvantages of the addition of solvents include protein 
dénaturation and the need of a subsequent step to remove the 
solvent.
3.2. CHROMATOGRAPHIC METHODS
Chromatographic methods may be carried out in bulk or in 
separation columns. The proteins to be purified interact with a 
solid matrix immersed in the appropriate buffer. Elution is 
carried out either by a constant flow of buffer, as in gel 
filtration, or by altering the environmental conditions to affect 
the interaction of the bound proteins with the matrix and become 
free in suspension, as in ion exchange, hydroxyapatite or 
affinity chromatography.
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3.2.1. ION EXCHANGE
Ion exchange chromatography is used for the separation of ionic 
or ionizable compounds. Ion exchange columns consist of a 
stationary and a mobile phase. The stationary phase carries 
ionizable functional groups bound by a displaceable counterion. 
Binding of proteins to the fixed charges involves the 
displacement of the non-fixed ions by the proteins. Elution of 
the bound proteins involves their replacement by a counterion 
with a greater affinity for the fixed charges than the protein. 
Widely used solid phase packings include cellulose, dextrans, 
agarose, and polystyrene. The exchange groups may be weak bases, 
as DEAE (diethylaminoethyl) or PEI (polyethyleneimine), or strong 
bases, as quaternary ammonium groups, and bind and exchange 
anions. The functional groups may also be weak acids, as 
carboxymethyl (CM), or stronger acids as sulphonic acid, and act 
as cation exchangers. The choice as to which type of resin should 
be used greatly depends on the nature of the protein to be 
purified and the nature of the contaminating proteins. Proteins 
contain both negative and positive charges and the isoelectric 
point (pJ) has been defined as the pH at which there is no net 
charge. Anion exchange columns are generally run above the 
protein's pJ and cation exchangers below. Elution mixtures 
include a buffer, the salt used for displacement, and other 
components which may be required for protein stability. Gradient 
elution involves the addition of increasing salt concentrations.
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Chromatofucusing (or isoelectric focusing) by ion exchange 
involves the formation of a pH gradient within the column. As the 
pH gradient moves down the column proteins are selectively 
adsorbed or desorbed according to their pJ.
Ion exchange chromatography has been extensively used for the 
purification of growth factors.
3.2.2, GEL FILTRATION
In gel filtration, fractionation occurs on the basis of the 
relative size of proteins. Porous beads with a discrete pore size 
act as the chromatographic support. Large protein molecules are 
excluded from the internal bead volume and therefore emerge first 
from the column while smaller molecules enter the beads and 
emerge later (Stellwagen, 1990). Gel filtration columns are 
generally described through the definition of a partition 
coefficient K^v where Vq is the elution volume of the excluded 
component, is the elution volume of the included component or 
total fluid volume, and are the elution volumes in between 
these values .
Vc - Vo 
^ A V  -  -
Vt -  Vo
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A typical relationship between K^y and the molecular weight of 
the separated proteins is given by a sigmoidal curve (See Graph 
3.2.2.1.).
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Figure 3.2.2.1.: A) Typical gel filtration elution profile. Component 1 is 
excluded from the matrix and its elution volume is denoted as V q .  Component 
2 is partially excluded from the matrix and its elution volume is denoted as 
Vg. Component 3 is included and its elution position is denoted as V^ . B) 
Sigmoidal dependence of the partition coefficient (K^ y) on the logarithm of 
the sample's molecular weight.
The central linear region of the curve, with K^y values between 
0 . 2  and 0 .8 , determines the fractionation range of a size 
exclusion matrix. The steeper the slope of the sigmoidal 
relationship in the fractionation range, the greater the 
resolving power of a matrix.
Common gel filtration matrices include cross-linked agarose, 
cross-linked polyacrylamide, cross-linked dextran and agarose 
polyacrylamide mixtures. Matrices are packed in columns with high 
aspect ratios (ie., 1:45) and sample volumes do not exceed 5% of 
the total column volume (Pharmacia, 1993).
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3.2.3. HYDROXYAPATITE COLUMNS
The use of hydroxyapatite columns was introduced by Tiselius at 
al, in 1956. Hydroxyapatite crystals (HA) present positive 
(calcium) and negative (phosphate) binding sites on their 
surface. Retention of basic proteins depends on the net charge 
of the column. In phosphate buffers the amino groups, present 
predominantly in basic proteins, are adsorbed by non-specific
electrostatic forces ( H A - P O 4 H^^N-Protein). Basic proteins can
then be desorbed through the replacement of the phosphate buffer 
by NaCl, to render the column neutral, or by CaCl2 , to obtain an 
overall positive column charge (Gorbunoff, 1990). Carboxyl
groups, predominant in acid proteins, bind specifically to 
calcium sites on the column (HA-Ca-OOC-Protein). NaCl and CaCTz 
favour the binding of acidic proteins and are the common buffers 
used in the separation of acidic proteins. Elution of acidic 
proteins is carried out by displacement of their calcium bound 
carboxyls by NaF or PO^ '^ which both form stronger complexes with 
calcium than do the carboxyl groups of the bound proteins do.
3.2.4. HYDROPHOBIC CHROMATOGRAPHY
Hydrophobic chromatography exploits the fact that proteins 
contain hydrophobic amino acids, and that hydrophobic compounds 
tend to naturally aggregate when immersed in water (Reviewed by 
Kennedy, 1990). The properties of water may be modified through 
the addition of salts and organic solvents. Generally, increasing
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the ionic strength increases the hydrophobic interactions. Anions 
and cations may be ranked according to those that highly favour 
hydrophobic interactions to those that decrease hydrophobic 
interactions. For anions, the series is PO/' > SO^ '^ > CH^COO' > Cl"
> Br' > NO3' > CIO4' > I > SCN‘ , and for cations the series is
> Rb"^  > K+ > Na"^  > Cs"^  > Li"^  > > Ca^^ > Ba^ "^ . There are two 
separation methods based on hydrophobic interactions. In 
hydrophobic interaction chromatography the matrix is hydrophillic 
and is substituted with short chain phenyl groups, or the more 
hydrophobic octyl, non polar groups. The mobile phase is usually 
an aqueous salt solution. In reversed phase chromatography the 
matrix used is silica that has been substituted with longer n- 
alkyl chains, usually Cg or C^ g. In this case the matrix is less 
polar than the mobile phase. The mobile phase commonly used is 
water with a less polar organic solvent (Fausnaugh et al. , 1985).
3.2.5. AFFINITY CHROMATOGRAPHY
Affinity chromatography is based on the specific binding 
interactions which take place between some biologicals (Reviewed 
by Mohr and Pommerening, 1985; Ostrove, 1990). Commonly used 
ligands used are protein A, with affinity for IgG antibodies, 
lectins, with affinity for glycoproteins, gelatin, with affinity 
for fibronectin, histones, with affinity for DNA, and antibodies, 
which may be raised against almost any biological, and then used 
as an affinity ligand. To favour ligand-protein interactions the
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ligand may be kept away from the support matrix by using matrix 
bound spacer arms with an equivalent length of 5-15 carbon atoms 
(Lowe, 1973). Elution of bound proteins may be specific or non 
specific. In specific elution the eluent has a greater affinity 
for the ligand than the protein. Non-specific elution is based 
on changes in the conditions such as salt concentrations, pH and 
temperature, which favour the elution of the desired protein. 
Affinity chromatography is a technique that permits specific 
separations. This is an advantage, but may also be a limiting 
factor as the separation of a molecule will depend on the 
availability of the required ligand.
3.3. ELECTROPHORETIC METHODS
Electrophoretic methods are based on the separation of charged 
compounds within an electric field where they migrate towards the 
pole with an opposite charge. Thus, positively charged molecules 
migrate towards the cathode (negatively charged) whilst 
negatively charged molecules migrate towards the anode 
(positively charged). Gel electrophoresis and isoelectric 
focusing are the most commonly used techniques for the 
identification of proteins and for assessing their purity. 
Detection of the migrated molecules may be carried out by 
staining with Coomassie Brilliant Blue R-250 or silver nitrate, 
which can be a hundred times more sensitive than the former stain 
(Merril et al., 1981). Other methods of detection involve
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blotting with ligands with a specific affinity for the protein 
to be detected. These methods are very sensitive but are limited 
by the availability of the ligand which, in most cases is not 
available when searching for novel proteins.
3.3.1. GEL ELECTROPHORESIS
Polyacrylamide gel electrophoresis (PAGE) is based on the 
relative migration of proteins forced through a porous matrix by 
an electric field (reviewed by Garfin, 1990). The porous matrix 
is constructed by copolymerization of acrylamide (CH2=CH-CONH2 ) 
with the cross-linker N,N'-methylenebisacrylamide (CH2=CH-C0 NH- 
CH2-NH-C0 -CH=CH2 ) . The reaction is catalyzed by a free radical 
generating system composed of ammonium persulfate (the initiator) 
and an accelerator, tetramethylethylenediamine (TEMED). As the 
acrylamide concentrations in the gel increase the effective gel 
pore sizes decrease. Gradient gels formed by a gradual change in 
the acrylamide / bisacrylamide proportions present a graded pore 
size and may be used to separate mixtures with broad molecular 
weight differences. Discontinuous systems are also commonly used 
and consist of a large pore stacking gel and a resolving gel 
with smaller pores, where separation takes place (Laemmli, 1970).
Fractionation of native proteins using PAGE is based on the 
protein size, shapes and charges. Sodium dodecyl sulfate PAGE 
(SDS-PAGE) overcomes the limitations of native PAGE by denaturing 
and negatively charging all proteins, so that migration becomes
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predominantly dependent on molecular weight.
3.3.2. ISOELECTRIC FOCUSING
Isoelectric focusing (lEF) separates proteins on the basis of 
their pJ, that is the pH at which the net protein charge is zero 
(reviewed by Garfin, 1990). In lEF molecules are mobilised by an 
electric field and forced to migrate through a pH gradient to 
reach a point where their net charge is zero (ie., pH = pi). 
Polyacrylamide or agarose gels containing carrier ampholytes are 
the common substrates used in lEF. Carrier ampholytes are complex 
synthetic mixtures of synthetic amphoteric buffers that form 
smooth pH gradients in applied electric fields, thus pH gradients 
are formed during the operation together with protein separation.
The staining procedures commonly used are also Coomassie Blue 
and silver staining.
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4.0. ASSAYS FOR GROWTH PROMOTING/INHIBITING ACTIVITY
Assays for unknown growth factors usually involve challenging 
a cell line, which may be that from which the conditioned medium 
was obtained, with the conditioned medium suspected to contain 
the growth factors. The conditioned media to be tested are 
usually pretreated by any of the techniques described previously 
in order to concentrate the proteins present and remove any 
interfering substances resulting from cell metabolism or the 
protein purification steps. Screening of growth inhibitory or 
promoting activity requires an adequate method which is both 
sensitive and amenable to automation. The same growth factor may 
act differently on different cell types and under different 
conditions. Cell lines in the screen should include the cell line 
from which the potential growth factors were isolated (in the 
search for autocrine growth factors), cancerous cells, primary 
cells with normal responses and cell types which may be suspected 
targets in vivo.
4.1.ESTIMATION OF CELL NUMBERS
Cell numbers may be assessed, either by direct cell counts, or 
by indirect measurements of packed cell volume, optical density 
of the cell suspensions or measuring the total DNA, RNA or 
protein content.
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4.1.1. DIRECT CELL COUNTS
Direct cell counts of cells grown in culture in flasks or wells 
either using a haemocytometer and trypan blue exclusion or an 
automatic cell counter are extensively used in the assessment of 
growth factor activities. Cells are exposed to test materials and 
after an incubation time they are harvested and counted. Although 
reliable, this method requires large sample volumes which may not 
always be available. To overcome this problem cells have been 
grown in microwells and counted with automated cell counters 
(Newman et al., 1990; Miyazaki et al., 1990). The reduction to 
smaller volumes and surface areas requires more accurate 
techniques and may lead to greater variability.
4.1.2. MEASUREMENT OF TOTAL DNA
since the amount of DNA per diploid cell in phase is usually 
constant (ie. , 6  x 1 0 '^  ^gr) , the determination of the amount of 
DNA may be used as an indirect method of determining cell number 
(Burton, 1956). Polyploidy and variations in cell cycle 
distribution are the main sources of variability.
4.1.3. MEASUREMENT OF TOTAL RNA
The RNA content may also be used as an indirect measurement of 
cell number. RNA amounts, are not only variable within the cell 
cycle, but cells may grow in size without undergoing cell
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division and hence may have increased RNA content (Baserga,
1984) . Thus, RNA content can be used as an effective indicator 
of cell size rather than cell number (Baserga, 1989).
4.1.4. MEASUREMENT OF TOTAL PROTEIN
As with RNA, the amount of cellular protein is a reasonable 
indicator of cell size but a poor indicator of cell number 
(Baserga, 1989). The determination of protein concentrations can 
be achieved by the Lowry method (Lowry and Rosebrough, 1951; 
Peterson, 1979), the Coomassie Blue binding assay (Bradford,
1976) and through silver nitrate assay methods (Krystal et al.,
1985) .
4.1.5. MTT ASSAY
This assay developed by Mosmann (1983) involves the cleavage 
of a soluble tétrazolium salt, 3,(4,5 dimethylthiazol-2-yl)-2,5 
diphenyltetrazolium bromide (MTT) by dehydrogenases present in 
active mitochondria, into an insoluble formazan precipitate 
(Slater at al., 1963). The MTT assay was originally developed as 
a rapid alternative method to direct cell counting (Mosmann, 
1983) . It involved incubating cells in microwells in the presence 
of MTT, subsequently adding acidified isopropanol to dissolve the 
formazan produced, and reading for absorbency at 570 nm. The 
production of formazan was found to be linearly proportional to
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cell number in the range of 500 to 50,000 cells/microwell 
(Mosmann, 1983; Green et al., 1984). Further work, aimed to 
reduce the sources of variability, have resulted in the use of 
DMSO as the formazan solvent and the complete removal of culture 
media prior to its addition (Twentyman and Luscombe, 1987). 
Amongst others, the MTT assay has been used for the 
quantification of interferon activity (Berg et al., 1990) and 
tumour necrosis factor activity (Vanhaesebroeck et al., 1991) in 
vitro.
4.2. ESTIMATION OF CELL PROLIFERATION
Changes in cell numbers, and thus cell proliferation, may be 
assessed by serial estimation of the cell numbers, as previously 
described, or by more specialized methods. These methods include 
the use of cell cycle blocking agents as colchicine or colcemid 
to measure the mitotic rate, or measurement of incorporated 
labelled compounds into newly synthesised DNA.
4.2.1. DETERMINATION OF MITOTIC RATE
The mitotic rate is the percentage of cells that at a given 
time have undergone mitosis. A number of drugs exist which arrest 
the cell cycle at mitosis enabling their enumeration. Colchicine 
was the earliest of agents used to block mitosis (Dustin, 1936) 
and has subsequently been reviewed (Hooper, 1961). Colcemid is 
a synthetic drug closely related to colchicine but found to be
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less adequate (Tannock, 1966). By exposing cells to appropriate 
doses of colchicine those cells entering mitosis, unable to form 
the mitotic spindle, would accumulate in the metaphase and could 
be counted. The initial demonstrations of the epidermal chalone 
were made by using the colcemid method in cultures of small 
pieces of mouse ear incubated in buffered saline containing 
glucose (Bullough and Laurence, 1960, 1962). Colcemid is less
toxic than colchicine and its effect is reversible up to 4 hours. 
Colcemid has also been used for in vivo assays by direct 
injection in mice (reviewed by Lord, 1974). Nocodazole is also 
used with the advantage that it is less toxic and the arrest is 
reversible before 12 to 16 hours (Zieve et al., 1980).
4.2.2. MEASUREMENT OF DNA SYNTHESIS
Measurement of DNA synthesis may be used to determine the 
number of proliferating cells in a given cell population. 
Radiolabelled thymidine is incorporated into the cell's newly 
synthesised DNA and can be assayed by measurement of incorporated 
radioactivity using a liquid scintillation counter or 
autoradiography. [^ H ]thymidine incorporation assays have been 
used for the identification of growth inhibitory effects in vivo 
on mouse epidermis (Marks, 1973) and mouse liver (Verly, 1958) , 
and in vitro, in short term covers lip cultures of bone marrow 
(Laurence and Eljo, 1971) and a variety of cell lines (Beauchamp 
et al., 1991; Djakiew et al., 1991; Hofer et al., 1991; Colleta
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et al., 1989). Currently, in vitro [^H]thymidine incorporation 
assays are very commonly used for the identification of growth 
promoting and inhibitory effects (Wilson, 1992).
-85-
Introduction
5.0. MEASUREMENT OF CELL ADHESION
The processes involved in the attachment and spreading of 
anchorage-dependent cells in culture have been described in 
Section 2.2.1. Cell adhesion to a substrate may be quantified 
either by measuring the formation or the disruption of the cell- 
substrate interaction.
5.1. MEASUREMENT OF CELL ADHESION FORMATION
The simplest method used to quantify the cell-substrate 
adhesion process involves seeding cells, allowing time for their 
attachment, and washing off those cells that have not adhered on 
to the surface. The remaining cells can be counted and a 
percentage of adhered cells can be calculated (Walther, 1973; 
Suzuki and Sakai, 1992). The cell suspension may also be passed 
through a bed of glass beads (Lackie, 1991) or a coarse filter 
(Schmaltzer and Chien, 1984) and the non-retained or retained 
cells counted. Forming cell adhesion may also be measured by 
passing the cell suspension through parallel- plate chambers 
(Doroszewski, 1980; Owens et al., 1987) or the radial - flow 
devices used in bacterial work (Fowler and McKay, 1980). These 
devices create fluid shear gradients and the maximum shear rates 
at which cells attach will give an indication of the strength of 
the cell-sUbstrate adhesion.
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5.2. MEASUREMENT OF CELL DETACHMENT
Cell adhesion to a substrate may also be assessed by measuring 
the forces required to detach the adhered cells. Detachment 
forces for individual cells may be measured directly using 
micromanipulation techniques (Evans, 1988).
Detachment force gradients may be applied to the attached cells 
through centrifugation (Charo et al., 1985) or the creation of 
fluid shear gradients. Shear force gradients may be achieved in 
parallel rotating plate devices immersed in culture fluid (Weiss, 
1967) or using the parallel-flow plates (Crouch, 1985) and radial- 
flow chambers (Spier et al., 1987) as those described for the 
measurement of cell adhesion (Section 5.1.).
As the process of cell adhesion initially involves non-specific 
cell attachment to the culture surface's adsorbed proteins, and 
non-specific cell adhesion is followed by specific interactions 
involving extracellular matrix proteins and cell surface 
receptors, resulting in cell spreading. The strength of cell 
adhesion may be measured shortly after cells have been seeded, 
to give an indication of non-specific cell adhesion, or after an 
incubation period, to allow for the specific interactions to 
occur. Long delays, however, should be avoided since in batch 
cultures cell death occurring at the later stages will contribute 
to cell detachment (Brydges, 1993). The increase in cell numbers 
during the exponential phase of cell growth has been reported as 
not having an effect on the strength of cell adhesion (Brydges,
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1993). Growth factors have previously been reported to have an 
effect on attachment factors expressed on the cell surface (Heino 
and Massagué, 1989; Santala and Heino, 1991), but direct 
measurement of their effects on the strength of cell adhesion has 
not been reported.
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6.0. OBJECTIVES AND PLAN OF INVESTIGATION
It is now well established that cells in culture at high 
concentrations (1 0  ^ cell/ml) have a reduced requirement for 
exogenous growth factors or the presence of serum for the 
maintenance of their growth. The main objective of the present 
investigation was to confirm whether or not cells grown at high 
concentrations produce growth promoting and inhibiting factors 
in amounts sufficient to affect their own growth (autocrine) as 
well as of other cell types (paracrine).
The plan of this investigation, depicted in a schematic form 
in Figure 6.0.1., is:
a) To adapt a number of cell lines namely BHK, CHO, MG-63
osteosarcoma, AFP-27 hybridoma, and Vero, to grow in 
defined serum-free conditions.
b) To grow serum-free adapted cells at high cell
concentrations in serum-free conditions using hollow fibre 
bioreactors such as the Acusyst-Jr.
c) To process and partially characterize the hollow fibre
conditioned media (HF-CM).
d) To test the cell growth/inhibiting properties of the HF-CM
and its fractions on cell growth, cell metabolism and cell 
adhesion.
e) To characterize the macromolecules responsible for the
observed growth factor activities.
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Adaptation of cell lines 
to serum-free media
High concentration 
cell cultures
Test effects of ceil 
conditioned media on:
- Ceil growth
-  Ceil metabolism
- Ceil adhesion
Characterise the molecules 
responsible for the 
activities observed
Figure 6.0.1.: Outline of the aim of the experimental work.
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7.0. MATERIALS AND METHODS
In this section the materials and methods used in the following 
experimental work are described. A detailed account of the cell 
lines, cell culture methods and test systems used is included.
7.1. CELL LINES
The AFP-27 (Endotronics, USA) is a mouse-mouse hybridoma 
producing IgG2a against human a-fetoprotein. It is routinely 
grown in RPMI-1640 + 5% NBCS. Their passage number is unknown.
The BHK-21 (clone 13) cell line is a subclone of the parent 
line derived from kidneys of five unsexed, one day old syrian 
hamsters (litter 21) after 65 days of continuous propagation 
(MacPherson and Stoker, 1962). Cells are anchorage-dependent and 
were provided by the European Collection of Animal Cell Culture 
(ECACC) (#85011433). They are routinely grown in RPMI-1640 + 5% 
NBCS and their passage number is unknown.
The LL-24 cell line (ECACC, #9073001) is a primary anchorage 
dependent human fibroblastic cell line with an expected life span 
of twenty population doublings. The establishment of an LL-24 
master cell bank was achieved after the cells were passaged five 
times, in RPMI-1640 + 5% NBCS, after their arrival from ECACC.
The CHO-Kl cell line is a subclone of the parent CHO (Chinese 
hamster ovary) continuous cell line (Puck et al.,1958) . The cells 
were provided by ECACC (#85051005) as an anchorage-dependent cell 
line. Until thé establishment of the master cell bank, cells were
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passaged 8  times in RPMI-1640 + 5% NBCS.
The MG-63 cell line, provided by ECACC (#86051601), derived 
from an osteosarcoma of a 14 year-old male (Billiau et al.,
1977) . It reportedly produces high yields of interferon following 
superinduction with polyinosinic acid, polycytidilic acid, 
cyclohexamide and actinomycin-D. Cells are anchorage-dependent 
and were grown in RPMI-1640 + 5% NBCS. They were stored frozen 
in the gaseous phase over liquid nitrogen at their 87th passage.
The Vero cell line was established from the kidney of a normal 
adult African Green monkey. It was provided by ECACC (#84113001) 
as anchorage-dependent and since its arrival it was grown in 
RPMI-1640 + 5% NBCS. Their passage number is unknown.
7.2. CELL CULTURE MEDIUM
RPMI-1640 (Gibco BRL, #074-01800) was obtained as powder and 
made up to contain 4.5 gm/L D-glucose, 2.2 gm/L NaHCOg and 5mM L- 
glutamine. To make up 50 L of medium, 521 gm of RPMI-1640 powder 
were dissolved in 45 L of MQ water (Millipore, UK). To this, 110 
gm of NaHCOg, 125 gm of D-glucose and 21.9 gm of L-glutamine were 
added, and the pH was adjusted to 6.9 with IN NaOH or IN HCl. MQ 
water was then added to make up the final volume to 50 L. 
Sterility was achieved by filtering the media through a 0.22 /zm 
Ultipor N 6 6  filter (Pall, England; #TDSLK 2NFT). Samples were 
then taken for sterility testing and the media was stored in 1  
L and 10 L bottles at 42C.
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RPMI-1640 was used as a basal media and was supplemented with 
2.5 to 5 % New Born Calf Serum (NBCS) (Sera lab., UK; #S-0003a) 
or Foetal Calf Serum (FCS) (Sera lab., UK; #S-0001a) as 
specified.
HL-1^ (Ventrex Lab., USA) is a chemically defined serum free 
medium with a protein concentration of less than 30 /xg/ml. HL-1 
was provided in 500 ml bottles and stored at 4SC. Two weeks prior 
to use it was supplemented with 5mM of L-glutamine. The detailed 
formulation of HL-1 remains a company secret but it is known not 
to contain bovine serum albumin or attachment factors (Ventrex, 
personal communication).
7.3. CELL CULTURE
Unless stated otherwise, cell lines were routinely grown in 
RPMI-1640 supplemented wwh 5% NBCS (Sera lab., UK; #S-0003a). 
Cell lines were grown in static disposable tissue culture flasks 
(Nunc, Denmark). Anchorage-dependent cells were seeded with 
6.5x10^ cells/cm^/0. 6 ml and subcultured as confluency was reached. 
Suspension cells were, seeded with 1.5x10^ cells/ml and not 
allowed to go over 6x10^ cells/ml. For the passage of anchorage- 
dependent cell lines, cells were detached by removing the culture 
media and incubating at 37sc with 3ml/25cm^ of a 0.25% trypsin 
solution (Sigma, #T5650) containing 1% ethylenediaminetetraacetic 
acid (EDTA). After visual observation to ensure that all cells 
were detached, the trypsinised cell suspension was neutralised
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with RPMI-1640 + 5% NBCS and poured into a 50 ml centrifuge tube 
(Falcon, UK). The cell suspension was centrifuged at 440 x g for 
10 minutes and the supernatant discarded. Cells were resuspended 
in RPMI-1640 + 5% NBCS and viable and non viable cells were then 
counted. Suspension cells do not require trypsinisation and were 
directly centrifuged and resuspended for counting. All procedures 
were carried out in a class II laminar air flow cabinet (Gelman, 
UK) .
7.4. STERILITY CHECKS
sterility checks were carried out routinely on all media and 
cell culture supernatants.
a) Cell culture media: For every 50 L batch of RPMI-1640 cell 
culture media filtered, three 500 ml aliquots, taken at the 
beginning, during, and the end of the 0.2 jum filtration process, 
were set aside for sterility checks. From these 500 ml, 50 ml of 
culture media were centrifuged at 1780 x g for 15 minutes and 
after pouring off the supernatant, the remaining 5 ml were plated 
on various solid and liquid media (described under c) in this 
section). The remaining 450 ml were divided in two and left to 
incubate at 20^C and 379C for up to three weeks.
Media bottles to be used were kept at 4^C and before use, were 
left at 372C for 48 hours.
b) Growth curves, MTT tests and attachment experiments: 
Sterility tests were carried out prior to the experiments on the
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serum supplemented media, trypsin-EDTA solution, cell cultures 
and tested samples. Sterility tests were also carried out on the 
cell cultures after completion of the experiments.
c) Sterility tests of samples not exceeding 100 ml: For samples 
not exceeding 100 ml, 4 x 1 ml aliquots were plated on Nutrient 
agar (Oxoid, UK; #CM3) and Saboraud agar (Oxoid, UK; #CM41) and 
also dispensed into Nutrient broth (Oxoid, UK; #CM1) and 
Thioglycollate broth (Oxoid, UK; #CM23). Plates and broths were 
incubated at 379C for 2 weeks. Visual observations to check for 
contaminants were carried out at three day intervals.
7.5. CELL COUNTS
For the determination of viable and non viable cell numbers 1 
ml of cell suspension was diluted 1:5 in a 0.04% trypan blue 
(Flow, UK) saline solution and cells were counted using a 
microscope and a Fuchs-Rosenthal haemocytometer (Weber 
Scientific, UK) (Griffiths, 1985). Four haemocytometer fillings 
were counted for each sample. For each filling, the cells in five 
0.1 mm^ volumes were counted. Between 20 and 80 cells were 
counted per 0.1 mm^ volume. Cell counts showing errors higher 
than 5% between were not considered.
7.6. PRODUCTION OF MASTER CELL BANKS
Anchorage-dependent cell lines were expanded using static cell 
culture flasks (Nunc, Denmark) to inoculate cell factories with
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6000 cm^ available cell culture surface (Nunc). Suspension cells 
were expanded up to a 175cm^ static cell culture flasks (Nunc) 
and then transferred to a magnetically stirred 2 L bottle. After 
the final harvesting the collected cells were centrifuged and 
resuspended in RPMI-1640 + 20% NBCS + 10% dimethyl sulphoxide 
(DMSO) (Sigma, #D-5879) to give a final count of 4 x 10^ cells/ml. 
With the aid of a dispensing syringe over 85 disposable 2 ml 
cryopreservation vials (Nunc) were filled with 1.8 ml of the cell 
suspension and frozen at -20SC for 24 hours before transferring 
them to storage in the gas phase over liquid nitrogen.
7.7. DETERMINATION OF GLUTAMINE AND AMMONIA
For both glutamine and ammonia analysis, an ammonia probe (Kent 
Industrial, UK) was used. The probe measures the ionic charge of 
the ammonium ions present in the sample and expresses it in 
millivolts (-mV) . By adding 100 /zl of 1 M sodium hydroxide 
(NaOH), the ammonia in the samples was converted into measurable 
ammonium ions. Between every sample the probe was rinsed in MQ 
water (Millipore) and allowed to reach a positive mV reading. For 
the determination of ammonia concentration a standard curve was 
prepared from measurements of ammonia in fresh ammonium chloride 
at dilutions of 0.1 M, 0.01 M, 0.005 M, 0.001 M and 0.0001 M. 
100 /il of 1 M NaOH were added to test tubes containing 2 0 ml of 
the standard or sample to be measured. The probe was inserted 
into the liquid, ensuring that no air bubbles were trapped
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against the membrane and, after allowing for stabilization, the 
mV reading was recorded. The concentration of background ammonia 
in the samples was determined from the standard curve. For the 
determination of the glutamine concentration, glutamine in the 
samples was enzymatically converted to free ammonia through the 
following reaction:
glutaminase
Glutamine + H2O ---------------- > Glutamic acid + NH3
3 7 2 c / pH 4.9
For the construction of a standard curve, fresh glutamine 
standards at concentrations of 10 mM, 7.5 mM, 5 mM, 2.5 itiM, and 
1 mM were used. 250 /xl of deionised water, 450 fil of sodium 
acetate pH 4.9, 250 /xl of the standard or sample to be measured 
and 50 fil (5 units/ml) of glutaminase (Sigma, #G8880) from a 
defrosted vial were added to a 20 ml flat bottomed test tube. The 
reaction tubes were incubated in a water bath at 372C for 3 0 
minutes. After incubation the reaction was stopped and ammonia 
was converted into ammonium ions by adding 100 jttl of NaOH. The 
concentration of total ammonia was determined from a plot of mV 
readings against the standard curve. The concentration of 
glutamine in the samples was calculated using the following 
relationship:
[Glutamine] = [Total Ammonia] - [Backgrownd Ammonia]
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7.8. DETERMINATION OF GLUCOSE AND LACTATE
Glucose and lactate were determined with a Micro-Stat GM7 
automated system (Analox, England). The GM7 measured the oxygen 
uptake when oxydoreductase enzymes reacted with their substrates 
as shown in the following equations:
glucose oxidase
Glucose + O2 ---------------------------> Gluconic acid + H2O2
lactate oxydoreductase 
Lactate + O2 ---------------------------> Pyruvate + H2O2
7.9. DETERMINATION OF PROTEIN CONCENTRATIONS
For the determination of protein concentration a modification 
of the Coomasie Blue assay method (Bradford, 1976) was carried 
out. The reagent used contained 60 mg of Coomasie Blue (Sigma, 
#6104-58-1) per litre of 3% perchloric acid in MQ water 
(Millipore). The reagent was kept at 4 2 c and protected from the 
light. For sample analysis, 0.75 ml of sample and 0.75 ml of 
reagent were added in a 1.5 ml disposable semi-microcuvetes 
(Fisons, UK; #CXA-105-030K). Absorbance at 595 was read after 4 
minutes in an Ultrospec 4050 (LKB-Biochrom). Standard curves were 
performed each time, using albumin (Sigma, #A7638) solutions 
ranging between 5 /xg/ml and 50 /xg/ml.
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7.10. HOLLOW FIBRE CELL CULTURES
For the production of conditioned media Acusyst Junior 
automated hollow fibre bioreactors (Endotronics Inc. Mineapolis, 
USA) were used. RPMI-1640 basal media was perfused through the 
intracapillary space (IC) of the hollow fibres and HL-1 was 
perfused into the cell side or extracapillary space (EC). A 
description of the Acusyst-Jr flowpath is given in Section 2.4.
7.10.1. ACUSYST-JR SET-UP
The dissolved oxygen (DO) and pH probes were calibrated 
following the standard procedure described in the Acusyst-Jr 
Operations Manual (Endotronics, USA; Revision D) . For the DO 
probe a 100% saturation of air in culture media was set to 148 
mm Hg. Once calibrated the probes were autoclaved in their 
corresponding cases and attached to the preassembled Acusyst-Jr 
cultureware. The cultureware tray, including the pH and DO 
probes, was fitted into the incubator and the pH, DO, EC 
expansion chamber and IC expansion chamber leads were connected 
to the appropriate sockets. The IC gas, EC gas and GEX gas tubes 
were fitted to their corresponding connectors. The pump segments 
were fitted on their respective pump heads. Following standard 
procedures and led by the prompt screens of the computer 
controller, the Pressurisâtion Test was performed. Subsequently 
the system was filled and flushed following the Fill/Flush prompt 
screens. The cultureware was flushed with 9 L of sterile MQ water
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(Millipore) followed by 1 L of RPMI-1640. After this the EC and 
IC expansion chambers were filled with RPMI-164 0. Following the 
instructions from the prompt screens the Circulation Test was 
performed and after five minutes the system was switched to 
Process Control mode. During the following five days the system 
was flushed with 10 L of RPMI-1640. Two days prior to inoculation 
the media supplement and the EC harvest bottles were attached to 
the system and 500 ml of HL-1 were flushed through the EC.
7.10.2. INOCULATION DETAILS
Cells were expanded in static culture flasks kept at 372C in 
5% COj/air at a relative humidity of 99%. For inoculation, over 
2x10% viable cells were spun down, at 440 x g for 10 minutes, and 
resuspended in 50 ml of HL-1 (Ventrex, USA). Sterility tests were 
set-up on the cell suspension, and 1 ml was used to inoculate a 
static flask control culture containing 35 ml of HL-1.
For inoculation, the Acusyst-Jr was set to inoculation mode and 
was allowed to lower the EC volume. Continuing with the 
inoculation procedure, the EC circuit clamps were shut and, after 
reversing the harvest pump, cells were inoculated into the EC 
space via the harvest line. Once completed, the line was flushed 
with fresh HL-1, the EC circuit clamps were opened again, the 
harvest pump was reversed and a harvest bottle was attached to 
the harvest line.
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7.10.3. OPERATING CONDITIONS
a) Physicochemical parameters: The Acusyst-Jr was set to 
maintain a pH of 7.1 and a temperature of 37.12C. The dissolved 
oxygen (DO) values were checked daily. By manually increasing the 
circulation rates the DO was not allowed to drop below 80 mm Hg.
b) Metabolite concentrations: Samples for the assessment of 
metabolite concentrations were taken three times a week 
(Monday-Wednesday-Friday). The medium delivery and waste removal 
rates were corrected within six hours after sampling to maintain 
metabolite levels within the following limits:
Glucose > 150 mg/dl (8.3 mM)
Glutamine > 2.5 mM
Lactate < 150 mg/dl (16.65 mM)
Ammonia < 2.5 mM
The medium supplement (ie., HL-1) delivery was increased by one 
ml/hr every three days, following the trend of previous hybridoma 
runs in which the monoclonal antibody concentration served as an 
indicator. Harvest of conditioned media was maintained at the 
same rate as the rate of HL-1 supplement delivery.
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7.10.4. DETERMINATION OF METABOLIC RATES
The glucose and glutamine uptake rates (UR), and the lactate 
and ammonia production rates (PR) were determined by applying an 
algorithm developed by Endotronics (Endotronics, USA) shown in 
Figure 7.10.4.1. To ease calculation a computer program including 
these formulae was used.
Gx - (Ft X Ga) - E X (Gx - (Ft x Go))
UR =
1 - E
where: Gx = (Fm x Gm) + (Fs x Gs)
Ft = Fm + Fs (Ft = Fs for protein PR) 
E = exp (-Ft x T / V )
UR: uptake rate (mM/hr)
Gl: glucose or glutamine 
Ga: actual Gl reading (mM)
Gm: concentration of Gl in the medium (mM)
Gs: concentration of Gl in HL-1 (mM)
Go: previous Gl reading (mM)
Fm: medium flow rate (ml/hr)
Fs: HL-1 flow rate (ml/hr)
T: time since last sample (hrs)
V: system volume (only EC for protein PR)
(Ft X Wa) - (Wo X E)
PR =
1 - E
where: Ft = Fm + Fs (Ft = Fs for protein PR) 
E = exp (-Ft X T / V)
PR: production rate (mM/hr)
W: lactate or ammonia
Wa: actual W reading (mM)
Wo: previous W reading (mM)
Fm: medium flow rate (ml/hr)
Fs: HL-1 flow rate (ml/hr)
T: time since last sample (hrs)
V: system volume (only EC for protein PR)
Figure 7.10.4.1.: Algorithm for the determination of Acusyst-Jr metabolic 
uptake rates (UR) and production rates (PR).
The oxygen uptake rates were determined using the algorithm 
shown in Figure 7.10.4.2. The oxygen solubility in culture media 
with air saturation was taken to be 0.0076 mg/ml (Benson and 
Krause Jr., 1976 and Shumpe et al., 1978) and the dissolved 
oxygen pressure at 100% was 148 mm HG.
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( d  - (DO/148)) X 0.0076 x CPR
OUR = -------------------------------
60 X 32
OUR: oxygen uptake rate (mM/Hr)
DO: dissolved oxygen value (mm Hg) 
CPR: circulation pump rate (ml/min)
Figure 7.10.4.2: Determination of oxygen uptake rates within the hollow fibre 
bioreactor.
7.10.5. HARVESTING OF CONDITIONED MEDIUM
Harvest bottles attached to the hollow fibre bioreactors were 
kept in ice boxes during harvesting. Harvest bottles were changed 
regularly at the same time as samples were taken for the 
determination of metabolite concentrations (ie., Monday-
Wednesday-Friday) . After collecting, the hollow fibre conditioned 
media (HF-CM) was centrifuged at 2000 x g for 15 minutes. The 
supernatant was collected and aliquoted aseptically for storage 
at -202C and -70ec.
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7.11. CROSS FLOW ULTRAFILTRATION
Cross-flow ultrafiltration was carried out with an Omega Screen 
Channel Ultrasette fitted with 1 kDa molecular weight cut-off 
polyethersulphone membrane (Filtron, USA; #OS001C70). The 
ultrafiltration (UF) cartridge was linked to a peristaltic pump 
and a reservoir as shown in Figure 7.11.1.. The Ultrasette 
cartridge is not autoclavable and prior to each run the UF 
circuit was autoclaved and the Ultrasette was linked to it in 
a class II laminar airflow cabinet.
U L T R A S E T T E
C l a m p
Pressure
g a u g e A u  X I I I a r y
reservoirFiltrate
reservoir
P o t e n t a t e
Figure 7.11.1.: Cross-flow ultrafiltration circuit (not to scale)
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7.12. STIRRED CELL ULTRAFILTRATION
An Amicon 300 ml magnetically stirred cell, fitted with 76 mm 
diameter 1 kDa cut-off Omega polyethersulphone membranes 
(Filtron, USA; #OM001076), was used as an alternative 
ultrafiltration (UF) system. The system was linked to a 
pressurised air cylinder as depicted in Figure 7.12.1.
ST
sri-i
G a s  
C y I i n d e r  
( A i r )
Pressure
vessel
S T I R R E D  C E L L
S a f e t y  v a l v e
F i I t e r
M a g n e t i c  s t i r r e r
A I R F L O W  C A B I N E T
F i I t  r a t e  
R e s e r v e i r
Figure 7.12.1.: Stirred cell ultrafiltration circuit (not to scale).
The stirred cell was autoclaved and, prior to their assembly, 
UF membranes were sterilized by soaking in 70% ethanol for 2 0
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minutes. The system was flushed by filtering 100 ml of MQ water 
(Millipore) and 100 ml of RPMI-1640 basal media. The stirred cell 
was then loaded with 200 ml of hollow fibre conditioned medium 
diluted 1:2 in basal RPMI-1640.
The system was pressurised at 3 0 psi and left to run until 100 
ml of retentate remained. Another 100 ml of basal medium was 
added to the retentate and the system was run again to reduce the 
retentate volume to 100 ml.
7.13. CENTRIFUGAL ULTRAFILTRATION DEVICE
Macrossep centrifugal devices fitted with 100 kDa cut-off Omega 
polyethersulphone membranes (Filtron, USA; #OD100C3 6), and with 
a maximum capacity of 25 ml, were used as yet another means of 
achieving ultrafiltration of the hollow fibre conditioned media. 
Prior to their use, the macrossep was flushed twice with MQ water 
(Millipore) and then by RPMI-1640. Ultrafiltration was carried 
out at 152C and 2000 x g.
7.14. POLYACRYLAMIDE GEL ELECTROPHORESIS
The Low Molecular Weight Marker kit (Pharmacia-LKB, #17-0471- 
01) and the Peptide Molecular Weight Marker kit (Pharmacia-LKB, 
#1860-101) were reconstituted in 20 ml of 10 mM Tris/HCl + ImM 
EDTA pH 8.0, dispensed in 0.5 ml vials and kept at -202C.
A xlO concentrated denaturing solution was made up by adding 
25 gm SDS (Sigma, #L-4390) and 50 ml 2-mercaptoethanol (BDH
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#1045921) to 10 ml xlOO Buffer (IM Tris + O.IM EDTA) (Sigma, #T- 
9285) and adding MQ (Millipore) water up to 100 ml.
A XlOO concentrated bromophenol blue solution was made by 
adding 1 gm of bromophenol blue to 100 ml of MQ water. The 
bromophenol blue was left to dissolve and the solution was 
centrifuged at 1780 x g for 100 minutes. The supernatant was 
collected and filtered through a 0.2 /xm filter. The solution was 
kept at 4 2 c.
A volume of 90 /xl of sample/standard was dispensed in an 
Eppendorf tube containing 10 /xl of the denaturing reagent. The 
Eppendorf tubes and its contents were heated at 100 2 c for 5 
minutes in a water bath. The Eppendorf tubes and their contents 
were cooled and 1 /xl of bromophenol blue reagent was added.
For protein separation, gradient 10-15 (Pharmacia-LKB, #17- 
0540-01) and high density gels (Pharmacia-LKB, #) were used in 
combination with SDS buffer strips (Pharmacia-LKB, #17-0516-01) 
on a PhastSystem (Parmacia-LKB) gel electrophoresis device. Gels 
were loaded with eight 1 /xl samples and run following the 
manufacturer's instructions for each gel (Pharmacia PhastSystem 
separation technique files #110 and #112).
Gels were silver stained in the PhastSystem developing unit 
(Pharmacia-LKB) according to the manufacturers instructions 
(Pharmacia phast system development technique files #210 and 
#211).
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7.15. MTT ASSAY
To perform the MTT assay, cells were seeded on Linbro 96 well 
flat bottom cell culture treated plates (Flow) at different cell 
concentrations and in a total volume of 100 /xl of media per 
microwell. Plates were incubated at 37sc in 5% CO2 . The cells 
used were within the passage after thawing from the master
cell banks. Upon assaying, 10 /xl of MTT stock solution, 
containing 2.5 mg/ml of 3, (4,5 dimethylthiazol-2-yl)-2,5 diphenyl 
tétrazolium bromide (MTT) (Sigma, #M-2128) in PBS, were added to 
each well. After 4 hours incubation at 37sc the supernatant was 
removed by inverting the plates and 100 /xl of dimethyl sulphoxide 
(DMSO) (Sigma, #D-5879) were added, and after at least 5 minutes 
the plates were read twice at 640 nm on a micro-ELISA reader 
(Dynatech MR600).
7.16. GROWTH CURVES
Growth curve experiments were performed using 25 cm^ disposable 
tissue culture flasks (Nunc). Cells from the master cell banks 
were thawed into 80 cm^ flasks containing 50 ml RPMI-1640 + 5% 
NBCS, after 5 hours the medium was replaced with fresh RPMI-1640 
+ 5% NBCS. Upon reaching confluency cells were expanded into two 
175 cm^ flasks containing 100 ml RPMI-1640 + 2.5% FCS. When cells 
reached confluency they were trypsinised, resuspended in RPMI- 
1640 + 2.5% FCS and counted. Cells were then further diluted to 
obtain 3.66 x 10'^  cell/ml. The resulting cell suspension was
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divided in 189 ml aliquotes and to each of them 21 ml (10% of the 
final volume) of sample were added. From each of these 
suspensions twenty 25 cm^ flasks were seeded with 10 ml each, to 
give a final cell number of 3.3 x 10^  cell/flask. Flasks were 
incubated at 37sc in 5% COjand counted in duplicate at 24 hour 
intervals.
7.17. CELL DETACHMENT ASSAY
For the cell detachment assay, cells were seeded at the same 
cell concentrations and identical procedures were followed as 
those used for the growth curve experiments. Cells were grown in 
56cmf cell culture polystyrene Petri dishes (Falcon, UK; #3003) 
and left to incubate at 379C in 5% CO2 . After 48 hours cells were 
subjected to a laminar shear force using a Cell Detachment Device 
(CDD) (Spier et al,, 1987; Brydges, 1993) (Described in Figure 
7.17.1.). A circular zone of detachment was created. The radius 
of the detachment zone, known as the critical radius, was 
measured four times. For each test sample, eight replicate cell 
culture dishes were set up. Therefore, a total of 32 critical 
radii measurements were carried out for each sample. The critical 
shear stress required to detach cells was calculated using the 
relationship:
To = 3QU / rh^
To = surface shear stress Q = flow rate (nf/sec), U = viscosity
(Kg/m^/sec), r = critical radius (m) and h = gap between the CCD and the 
substrate (m).
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F l u i d
F l o v
M e t e r
R e s e r v o i r
T o  f l u i d
d i s p e n s i n g
n o z z l e
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LOU:
CELL C UL T U R E  SU RF AC E
Figure 7.17.1.: Set up,of the cell detachment device (a) and detail of the fluid dispensing nozzle (b).
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7.18. GEL FILTRATION
Gel filtration was carried out using a 60 cm x 2.5 cm column 
packed with approximately 3 00 ml of Sephacryl-IOOHR (Pharmacia- 
LKB) . The column was mounted on an Fast Protein Liquid 
Chromatography (FPLC) automated system (Pharmacia-LKB) and was 
eluted with MQ water (Millipore) at a flow rate of 1 ml/min. Four 
millilitre samples were injected and 5 ml fractions were 
collected. The protein elution profiles were followed on-line by 
measuring the absorbance at 280 nm.
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8.0. RESULTS AND DISCUSSION
In the following sections the experiments carried out to 
characterize the growth promoting/inhibiting activities which may 
be present in high concentration cell cultures are presented and 
discussed in the light of the data obtained.
8.1. ADAPTATION OF CELLS TO SERUM-FREE MEDIA
Serum contains a large number of factors which affect cell 
growth and metabolism (Reviewed in Section 2.2.3.) . These factors 
represent a large number of macromolecules secreted by various 
cell types and tissues into the blood stream in the body.
Hence, in order to detect and isolate growth factors from in 
vitro cell cultures of individual cell lines it is important to 
avoid the presence of exogenous growth factors which may be 
introduced by the presence of serum in the culture media. To 
achieve this cells have to be adapted to grow in defined serum- 
free conditions.
i) Cell lines: Five cell lines namely BHK-21, Vero, CHO, AFP-27 
hybridoma and the MG-63 human osteosarcoma, were used in this 
study for adaptation to defined serum-free culture conditions. 
These cell lines were employed because they have been the subject 
of a number of previous research projects in our laboratory and 
were readily available. Most of them have been extensively used 
in the biotechnology industry for the production of biologicals 
(Summarised in Table 8.1.1.).
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Among these cell lines, the MG-63 osteosarcoma cell line has 
also been used as an in vitro model in tumorgenesis studies. It 
has been reported that MG-63 cells do not express the p53 tumour 
suppressor gene (Chandar at al. , 1992) and that they produce and 
are susceptible to a number of growth factors. Among the factors
Cell Line Morphology 
(in 5% PCS)
Uses
BHK
(Baby Hamster Kidney 
cells)
fibroblastoid The BHK cell line has been grown in suspension at 
10,000 L scale and is used in the manufacture of factor 
VIII and foot and mouth and rabies vaccines.
Vero
(African Green Monkey 
Kidney cells)
fibroblastoid The Vero cell line is widely used in the production of 
inactivated polio and rabies vaccines for human use.
CHO
(Chinese hamster 
ovary cel Is)
fibroblastoid The CHO cell line is currently used in the expression 
and production of recombinant products such as tissue 
plasminogen activator (tPA), erythropoietin (EPO) and 
factor VIII for their in vitro large scale production.
AFP-27 hybridoma 
(Produces antibodies 
against alpha-foeto- 
protein)
spherical 
growing in 
suspension
The AFP-27 hybridoma cell line is currently grown in 
our laboratory as a model for metabolic studies of 
hybridoma cells. The production of antibodies from 
hybridoma cells is of great commercial importance, both 
as reactives for in vitro assays and potentially as (part 
of) therapeutics.
MG-63
(human osteosarcoma 
cel Is)
fibroblastoid The MG-63 osteosarcoma cell line has been extensively 
used as an in vitro model to study human bone cancers.
Table 8.1.1.: Cell lines used in the adaptation to HL-1 defined serum-free 
media and their relevance in the biotechnology industry.
MG-63 cells produce are the granulocyte chemotactic protein 
(Proost et ai., 1993), M-CSF (Ohtsuki et ai., 1992), basic FGF 
(Nishikawa et ai., 1993) and TGF-6 (Kohase et ai., 1987). MG-63 
cells have also been found to be susceptible to growth factors 
such as IL-4 (Riancho et ai., 1993), IGF factor (Poliak et ai., 
1990), FGF, TGF-B, EGF, PDGF and heparin binding growth factor 
(Mioh and Chen, 1989), and autocrine growth promotion mechanisms
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by FGF and TGF-B have been suggested (Nishikawa et al,, 1993; 
Kohase et al,, 1987).
The other cell lines used in this study have been commonly 
employed in the biotechnological production of a large number of 
biologicals. However, little work has been carried out on these 
cells with respect to the growth factors they may produce and 
to which they may also be susceptible. BHK cells have been 
reported to be responsive to IGF-I (Hsu and Olefsky, 1992) and 
FGF (Ross and Balard, 1988). There are no reports as to the 
growth factors that Vero cells may produce or to which they are 
susceptible.
11) Serum-free media: A worldwide market survey revealed that by 
1989 there were some 43 different companies supplying serum-free 
media (Ratafia, 1989) and some examples are shown in Table 7.1.2. 
The choice of HL-1, as a serum-free medium to be used in this 
work, was based on previous studies on the AFP-27 hybridoma cell 
line. From the several commercially defined serum-free low- 
protein media formulations tested, the AFP-27 cell line was only 
successfully adapted to grow in HL-1 medium (Ventrex, USA). HL-1 
has also been reported to support growth of cells of different 
origin, including hybridomas, human carcinomas, Vero and CHO cell 
lines (HL-1 product information leaflet, 1988). Because of its 
low protein content (<30 /ig/ml) and its availability in the 
laboratory, HL-1 was used in this investigation.
Additives commonly included in defined media formulations are 
albumin, insulin, transferrin, ethanolamine and casein. Growth
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factors such as EGF, FGF, PDGF and IGF-1, may be required for the 
growth of non-transformed cells and are also incorporated in some 
defined media for these cell lines.
MEDIA MANUFACTURER PROTEIN
COMPOSITION
CELLS CULTURED
UltraCULTURE BioWhittaker
<#12-725B)
Contains albumin, 
insulin,
transferrin, other 
factors*
lymphoid, epithelial, 
fibroblastic and 
hybridoma cell lines
Nutridoma-SP Boehringer Manheim 
(#1011375)
Contains albumin, 
insulin,
transferrin, other 
factors*
Myeloma, 
lymphoblastoid, 
hybridoma and primary 
cultures.
QBSF-51 Sigma (#03003) Albumin 
Transferrin 
(Added Insulin)
Multipurpose
Hybridoma medium GIBCO BRL 
(#041-00124)
Proprietary
information
Hybridoma cell lines
HL-1 Ventrex, USA 
(#77201)
No bovine serum 
albumin or 
attachment factors
lymphoid, fibroblastic 
and hybridoma cell 
I i nes
Table 8.1.2.: Some commercially available defined serum
media (*: Not revealed by the manufacturers).
-free cell culture
The media composition and specific protein composition of HL-1 
remains proprietary information and despite several attempts to 
obtain information on the protein composition of HL-1 it was only 
revealed that it did not contain bovine serum albumin or cell 
attachment factors.
HL-1 was originally developed by Ventrex for the cultivation 
of hybridoma cell lines. Hybridoma cells do not usually have a 
requirement for growth factors and, as these are expensive medium 
components, it is unlikely that HL-1 will contain any growth 
factors.
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ill) Adaptation of cells to serum-free medium: The adaptation of 
AFP-27 hybridoma, BHK-21, Vero, CHO and MG-63 osteosarcoma cells 
to HL-1 serum-free medium was performed in a number of steps 
(Figure 8.1.1.).
C E L L  L I N E S
C u l t u r e
M e d i a
A FP B H K V e r o C H O M G - 6 3
R P M I - 1 6 4 0 i i i I
+5% N B C S D a y  0 . D a y  0 D a y  0 D a y  0 D a y  0
H L - 1 ; i I ;
+5% NBCS Da y  7 D a y  6 D a y  7 D a y  3 D a y  5
H L - 1 ; ; I ; i
+2% N B C S D a y  14 D a y  12 D a y  17 D a y  22 D a y  14
H L - 1 I I 4 I i
+1% N B C S D a y  17 D a y  16 D a y  24 D a y  25 D a y  17
H L - 1 ; ; i i
+ 0 . 5 %  N B C S D a y  25 D a y  19 D a y  30 D a y  35 D a y  28
HL-1 1 1
F U L L A D A P T A T I O N TO S E R U M F R E E  M E D I U M
Figure 8.1.1.: Steps followed in the adaptation of the AFP-27, BHK, Vero, CHO 
and MG-63 cell lines to HL-1 (Ventrex) serum free medium.
Cells which were initially growing in RPMI-164 0 and 5% NBCS 
were subcultured in HL-1 containing 5% NBCS. After reaching 
confluence, cells were stepwise passaged at a seeding
— 116 —
Results and Discussion
concentration of about 10^  cell/cm^ in HL-1 medium with the serum 
content being reduced to 2%, 1% and 0.5% respectively.
The "adaptation time" for growth in serum containing medium to 
HL-1 medium varied depending on the different cell lines. For the 
AFP-27 hybridomas and MG-63 cells it took about 4 weeks, 3 weeks 
for BHK cells, and 5 weeks for Vero and CHO cells. The 
differences in the "adaptation times" could be due to differences 
in the inherent or transformed nature of these cells. Transformed 
cells, having escaped from the normal regulatory mechanisms, are 
known to become less dependent on growth factors (Mulder and 
Childress-Fields, 1990).
During the process of adaptation to HL-1 of the BHK, Vero, CHO 
and MG-63 cells, at serum concentrations of 1% and 0.5%, some 
cells in the monolayer cultures were found not to adhere to the 
culture surface and to remain in suspension. At each passage, the 
cells which remained in suspension were removed and grown 
separately as suspension cells in stirred flasks. This resulted 
in two clones from each of the anchorage-dependent cell lines, 
one growing in suspension and the other remaining anchorage 
dependent. The medium formulation thus appears to have a crucial 
effect on the anchorage dependency of cells grown in vitro. The 
absence of attachment factors in HL-1 is most probably the direct 
cause for loss of anchorage dependency of the suspension clones. 
In addition, growth factors have also been known to have an 
effect on the expression of attachment factor receptors on the 
cell surface (Heino and Massagué, 1989; Santala and Heine 1991).
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Therefore, it is possible that the absence or presence of certain 
growth factors in HL-1 may have had an influence on cell adhesion 
via changing the pattern of expression of cell-surface adhesion 
receptors.
Batch cultures of the HL-1 adapted BHK, MG-63 and Vero cells 
resulted in an increase in the doubling times and a decrease in 
the maximum cell concentrations achieved, indicating an overall 
decrease in cell growth of the HL-1 adapted cells (Table 8.1.3).
RPMI-1640 + 5% NBCS HL-1
Doubling
time
(hours)
Maximum 
cell number 
(celIs/cnf)
Doubling
time
(hours)
Maximum 
cell number 
(celIs/cmf)
BHK 10.9 1.76 X 10% 17.4 1.08 X 10®
MG-63 14 1.84 X 10% 26.6 0.96 X 10®
Vero 19.7 2.12 X 10® 43.3 1.00 X 10®
Table 8.1.3.: Doubling times and maximum cell
densities of anchorage dependant BHK, Vero and MG-63 
cells prior to adaption in 5% NBCS, and after 
adaption to HL-1.
There are no previous reports on anchorage-independent growth 
of MG-63 and Vero cell lines. Since Vero cells are an approved 
cell system for the production of polio and rabies vaccines for 
human use, the establishment of a Vero cell line which may be 
grown in suspension and in large scale homogeneous systems is of 
great commercial interest. The Pasteur Institute (France) and the 
Cuban government have already shown interest in acquiring the HL- 
1 adapted Vero suspension cell line from our laboratory.
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The CHO, BHK, MG-63, Vero, AFP-27, cell lines have been known 
to be adapted to a number of different defined serum-free media 
(Ham, 1965; Macpherson and Stoker, 1962; Nishikawa, 1993). 
However, a systematic study regarding the adaptation of all these 
cell lines to grow in a single serum-free medium like HL-1, has 
not been carried out previously. In this investigation all cell 
lines, namely CHO, BHK, MG-63, Vero and AFP-27, were successfully 
adapted to HL-1 media without having to undergo the lengthy 
process of designing a specific medium formulation for each cell 
line individually.
The reasons for the easy and successful adaptation of the five 
different cell lines to a single culture medium may be owing to:
- Composition of HL-1.
- Adaptation protocol.
- Transformed nature of the cells.
iv) Storage of serum-free adapted cell lines: HL-1 adapted cells, 
those growing attached and in suspension, were stored frozen in 
the gas phase over liquid nitrogen following the same protocol 
as previously used for the storage of serum supplemented cells. 
The storage media contained HL-1 with 2 0% NBCS and 10% DMSO. Upon 
revival of frozen cells in HL-1 all the adapted cells, with the 
exception of the CHO cells, continued to grow satisfactorily in 
HL-1. The attempts to revive CHO cells in HL-1 failed. The CHO 
cell could be revived and grown only in the presence of serum.
-119-
Results and Discussion
The CHO cell line was not included in further studies because of 
this complication.
Once the master cell banks of HL-1 adapted suspension and 
anchorage-dependent cell clones were established, cells were 
certified to be mycoplasma-free by an independent laboratory 
(European Collection of Animal Cell Cultures, Porton Down, 
Salisbury). It should be mentioned here that during the 
adaptation process, as the environmental conditions are modified 
the cells which adapt more easily to the new conditions are 
selected. As a result of this, the adapted cell lines may differ 
considerably from their original counterparts. Although the new 
serum-free adapted cells should be characterised and re­
designated appropriately, this was not carried out during the 
course of this investigation.
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8.2. fflG H  CONCENTRATION CELL CULTURES
Several systems are available for the growth of animal cells 
at high concentrations (10* cell/ml). These have been reviewed in 
the Introduction of this thesis and include hollow fibres, 
ceramic matrices, flat membrane systems and encapsulation. Hollow 
fibre (HF) systems have been extensively tested in our laboratory 
and proved to be robust, reliable, amenable to automation and 
able to provide adequate culture conditions and long term 
sterility (Nikolay et al, 1991). For these reasons and their
availability in our laboratory, HF systems were used to obtain 
high cell concentration conditioned media from HL-1 adapted BHK, 
MG-63 and Vero cells. The AFP-27 hybridoma cell line was not used 
as the antibody it secretes could interfere with the future 
isolation of other proteins in their conditioned media.
Several strategies (a-c below) may be followed to maintain 
adequate levels of nutrients and to avoid the accumulation of 
waste products within the hollow fibre cartridge:
a) Perfusion of excess medium without any measurement or 
control of the concentration of metabolites.
b) Regular sampling of the system and subsequent correction of 
the medium delivery so that metabolite concentrations are 
maintained within set values.
c) On-line measurements of metabolic parameters and automatic 
correction of media delivery and waste removal, such that 
as many parameters as possible are controled.
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Strategy "a" is commonly used (Ku at al., 1981) and the rates 
of media delivery and waste removal are usually empirical. 
Strategy **c" involves complex and expensive apparatus and, since 
on-line probes for assaying metabolites can not be sterilized by 
autoclaving, their use compromises the overall sterility of the 
system. Strategy "b" is a realistic and practical approach which 
is a compromise between the total lack of control and the fine 
control offered by on-line systems. In this work strategy "b" was 
adapted for the cultivation of serum free BHK-21, MG-63
osteosarcoma and Vero cells in Acusyst-Jr hollow fibre (HF) 
bioreactors (depicted in Plate I on page 129). Cells growing in 
the HF extracapillary space (EC) were supplied directly with HL-1 
medium, while basal RPMI-1640 was perfused through the 
intracapillary space (IC). As previously described in Section 
2.4. , in the Acusyst-Jr HF system the rates of media delivery and 
waste removal may be adjusted throughout the length of the run 
to suit the growing cells. The control strategy followed, 
involved sampling the IC for three times a week to determine 
glucose and glutamine concentrations, as indicators of nutrient 
levels, and lactate and ammonia concentrations, as indicators of 
accumulated metabolic wastes. The aim was to maintain the 
concentration of glucose above 150 mg/dl (8.3 itiM) ; glutamine 
above 2.5 mM; lactate below 150 mg/dl (16.65 mM) ; and ammonia 
below 2.5 mM. This strategy had been previously reported for the 
cultivation of hybridoma cells in HF bioreactors (Andersen and 
Gruenberg, 1986; Handa-Corrigan et al., 1992).
- 1 2 2 -
Results and Discussion
Serum-free hollow fibre cell cultures of the BHK, Vero and MG- 
63 osteosarcoma have not been reported previously and will be 
described in the following sections. The aim of carrying out 
serum-free high concentration cell cultures of these cell lines 
was to produce a sufficient amount of concentrated cell 
conditioned media for further studies on their biological 
activities.
8.2.1. BHK HOLLOW FIBRE CELL CULTURE
An Acusyst-Jr was inoculated with a total of 2.59 x 10* viable, 
serum-free adapted, anchorage-independent BHK-21 cells. After 170 
hours, cells were clearly visible within the hollow fibre 
cartridge and the run was extended to a total of 850 hours.
During the length of the run, glucose levels were successfully 
maintained above 150 mg/dl (8.3 mM) and lactate was maintained 
below 150 mg/dl (16.65 mM) (Figure 8.2.1.1.). Glutamine and 
ammonia concentrations were, however, often found to be below or 
above their set-point concentrations (Figure 8.2.1.2.). Between 
375 and 475 hours glutamine values fell below 0.5 mM and ammonia 
accumulated above 3 mM. The process control strategy for 
glutamine and ammonia was not maintained within the specified 
set-points during these periods due to insufficient medium 
delivery. This is not an unexpected scenario when off-line 
measurements are used for the process control. The rate of medium 
delivery which needs to be implemented in order to maintain the
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Figure 8 . 2 . 1 . 1 Metabolite concentrations within the BHK hollow fibre cell culture 
(Glucose: + ; Lactate: ).
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Figure 8.2.1.2.: Metabolite concentrations within the BHK hollow fibre cell culture 
(Glutamine: a  ; Ammonia: X ).
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Figure 8.2.1.3.: Metabolic profiles of the BHK hollow fibre cell culture 
(Glucose: ■ ; Lactate: -|- ; Glutamine: ^  ; Ammonia: 0 ) . Shaded bars
represent the periods were the HF-CM collected was used for further 
experiments. (UR: uptake rate; PR: production rate).
Figure 8.2.1.4.: Oxygen
uptake rate of the BHK 
hollow fibre cell culture.
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culture within specified metabolic set points is difficult to 
assess when only a limited number of estimations are performed.
Figure 8.2.1.3. shows the calculated hollow fibre cartridge 
metabolic uptake and production rates (UR and PR) for glucose, 
lactate, glutamine and ammonia. These results indicate a general 
increase in the overall metabolic activity, and presumably also 
the cell number, through out the length of the run. This was also 
accompanied by increased oxygen uptake rates as the run 
progressed (Figure 8.2.1.4.).
In total, a volume of 4.7 L of HL-1 was used in the EC side in 
this run, and an equivalent amount of cell conditioned media was 
collected. A total of 188 L of basal RPMI-1640 was perfused 
through the intracapillary circuit, generating an equal amount 
of waste media.
8.2.2. MG-63 HOLLOW FIBRE CELL CULTURE
An Acusyst-Jr was inoculated with a total of 0.7 x 10^  viable 
serum-free anchorage-independent MG-63 osteosarcoma cells. Cells 
became visible, accumulating in the underside of the HF 
cartridge, as early as 150 hours. By 528 hours the cartridge was 
packed with cells taking over almost all the available hollow 
fibre cartridge extracapillary space (See Plate II).
Figures 8 . 2 . 2.3. and 8.2.2.4. show that there was a steady 
increase in all uptake and production rates up to 500 hours. At 
506 hours a fault in the media delivery system was detected. This
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Figure 8.2.2.1.: Metabolite concentrations within the MG-63 hollow fibre cell culture 
(Glucose: + ; Lactate: ^  ).
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Figure 8.2.2.2.: Metabolite concentrations within the MG-63 hollow fibre cell culture 
(Glutamine: a  ; Ammonia: X ).
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Figure 8.2.2.3.; Metabolic profiles of the MG-63 hollow fibre cell culture 
(Glucose: ■ ; Lactate: -|- ; Ammonia: # ; Glutamine: ^  ; Protein: ♦ ) .
Shaded bars represent the periods were the HF-CM collected was used for 
further experiments. (UR: uptake rate; PR: production rate).
Figure 8.2.2.4.: Oxygen
uptake rate of the MG-63 
hollow fibre cell culture.
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Plate I: Acusyst-Jr (Endotronics, USA) hollow fibre bioreactor.
Plate II: Hollow fibre cartridge after 528 hours of inoculation with MG-63 cells.
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inadequate supply of medium led to the concentrations of glucose 
to drop to almost 10 mM and of glutamine to 0.25 mM. At the same 
time the concentration of lactate rose to above 25 mM and that 
of ammonia to above 3.5 mM (Figures 8.2.2.1. and 8.2.2.2.). These 
conditions were followed by a subsequent decrease in all the 
metabolic rates including the oxygen uptake rate, suggesting that 
the cell culture was dying.
After 550 hours the oxygen uptake rate increased rapidly, and 
by 670 hours the remaining metabolic rates showed clear signs of 
recovery from the media delivery problems. Between 675 and 850 
hours, metabolite concentrations were again found to have 
exceeded the established limits. This relatively poor process 
control was reflected in fluctuating uptake and production rates.
To test if MG-63 cells, at high cell concentrations, were able 
to grow in medium completely devoid of growth factors, at 715 
hours the HL-1 delivery was stopped. Eight hours later the oxygen 
consumption rate started to steadily decrease (Figure 8.2.2.4.) 
and a marked increase in protein production rate was observed 
(Figure 8.2.2.3). These effects were probably due to cell death 
and the subsequent release of intracellular proteins upon cell 
lysis. At 931 hours the run was terminated. Thus, MG-63 cells 
despite being highly transformed, were found not to be able to 
grow in the complete absence of growth factors even when the 
cells were growing at high cell concentrations.
In this run, 4.5 L of HL-1 were used and an equivalent volume 
of cell conditioned media was collected. The maximum protein
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concentration achieved was greater than 2.2 mg/ml. The 
intracapillary space was perfused with a total 200 L of RPMI-1640 
and the same amount of waste was generated.
8.2.3. VERO HOLLOW FIBRE CELL CULTURE
An Acusyst-Jr was inoculated with a total of 1.3 x 10^  viable 
serum-free, anchorage-independent, Vero cells. Up to 450 hours 
there was a general increase in all the metabolic rates (Figure
8.2.3.3. and 8.2.3.4.). Glucose and lactate were maintained 
within the established limits during most of the cultivation 
period (Figure 8.2.3.1.). At 425 hours the glutamine 
concentration fell to 1.3 mM indicating that the culture was 
nearly depleted of glutamine (Figure 8.2.3.2.). This inadequate 
provision of the culture requirements for glutamine may be the 
direct cause of the subsequent decline in the ammonia production 
rate at 450 hours. Between 500 and 600 hours the media 
recirculation pump failed several times, causing a decline of all 
metabolic rates and a rise in the protein production rate. At 547 
hours the recirculation pump was replaced by an external 
peristaltic pump. This resulted in a rapid recovery of the cells, 
as evidenced by the increases in the oxygen uptake rates and 
other metabolic rates. A power cut occurred at 708 hours, causing 
the stoppage of all pumps in the system for approximately eight 
hours, led to a drastic decline in oxygen consumption. The cells 
did not recover from the last technical failure.
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Figure 8.2.3.1.: Metabolite concentrations within the Vero hollow fibre cell culture 
(Glucose; +  ; Lactate: ^  ).
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Figure 8.2.3.2.: Metabolite concentrations within the Vero hollow fibre cell culture 
(Glutamine: o  ; Ammonia: X ).
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Figure 8.2.3.3.: Metabolic profiles of the Vero hollow fibre cell culture 
(Glucose: . ; Lactate: -j- ; Ammonia: m ; Glutamine ^  ; Protein: ♦ ) .
Shaded bars represent the periods were the HF-CM collected was used for 
further experiments. (UR: uptake rate; PR: production rate)
Figure 8.2.3.4.: Oxygen
uptake rate of the Vero 
hollow fibre cell culture.
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In the Vero HF run 3.3 L of HL-1 was used and an equivalent 
volume of extracapillary cell conditioned media was generated. 
The maximum protein concentration achieved was approximately 1.2 
mg/ml. A total of 12 0 L of RPMI-1640 was perfused through the 
intracapillary space and an equivalent volume of waste was 
produced.
8.2.4. SUMMARY OF HOLLOW FIBRE CELL CULTURES
The HL-1 adapted BHK, MG-63 osteosarcoma and Vero cell lines 
were successfully grown in the Acusyst-Jr hollow fibre (HF) 
bioreactors. Serum-free hollow fibre cultures of these cell lines 
have not yet been reported elseware.
The hollow fibre cartridges used in these experiments contained 
fibres with a claimed molecular weight cut-off of 6 kDa 
(Endotronics, USA). This allowed for the delivery of basal media 
components such as glucose, glutamine and amino acids, and the 
removal of accumulated metabolic waste products like ammonia, 
lactate and amino acids, through the fibre pores whilst retaining 
macro-molecules larger than 6 kDa in the cell side. HL-1 was 
supplied directly to the extracapillary space (cell side) as the 
only exterior source of proteins, and those factors retained by 
the 6 kDa cut-off porous fibres were continuously harvested and 
designated as hollow fibre conditioned media (HP-CM). HL-1 
contains below 0.03 mg/ml of total protein (Ventrex, USA) and the 
concentration of total protein within the harvested HF-CM reached
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a maximum of 1 mg/ml in the Vero cells hollow fibre culture and 
2.2 mg/ml in the MG-63 cells culture. Thus, the protein content 
after conditioning by cells within the HF cartridge increased by 
33 fold in the case of Vero HF and 83 fold in the case of MG-63 
HF cell culture.
The increase in protein concentrations could be attributed to 
the secretion by the growing cells and to products released as 
a result of cell lysis within the hollow fibre cartridge .
Since the HF system is a shell-in-tube arrangement, the cells 
immured within it could not be removed and counted. Specific 
oxygen uptake rates have been reported to be dependent on cell 
numbers, and independent of cell growth rates (Kimura et al., 
1987). The maximum cell numbers achieved in the HF cartridges can 
therefore be indirectly estimated from the measured oxygen uptake 
rates. Assuming that the average oxygen consumption values of 
cells in culture to be 0.23 mg/10^  cells/hour (Spier and 
Grifiths, 1984), the estimated number of cells in the HF 
cartridge could be calculated from the maximum oxygen uptake 
rates observed during the HF cell cultures (Table 8.2.4.1.).
Cell 
11 nes
Maximum HF cartridge 
Og consumption (mM/hr)
Estimated maximum 
total number of 
cells (a)
Maximum EC (b) cell 
concentration (cell/ml)
BHK 2.29 1.00 X 10’“ 1.11 X 10°
Vero 3.12 1.36 X 10’° 1.51 X 10°
MG-63 2.74 1.21 X 10’° 1.33 X 10°
Table 8.2.4.1.: Estimation of the cell numbers achieved in the HF 
runs based on their maximum oxygen consumption rates (a: Based on 
Spier and Griffiths, 1984; b: Extracapillary (EC) volume = 90 ml).
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These results are comparable with previous reports bn hybridoma 
cell cultures in Acusyst-Jr HF bioreactors, which describe cell 
concentrations of 10^  cell/ml and 1-2 x 10^ cells per HF 
cartridge (Tyo, et al., 1988). The oxygen uptake rates of the 
hollow fibre cartridges steadily increased during the initial 
phases of all three HF runs. From these rates and, once again, 
assuming an average oxygen consumption of 0.23 mM/10^ cells/hour, 
the average cell growth rates within the HF cartridge were 
calculated (shown in Table 8.2.4.2.). From these estimations, 
cell lines can be listed according to their maximal growth rates 
as follows: Vero > MG-63 > BHK. Since maximal growth requires
the maintenance of fully optimised conditions through out the 
length of the HF cell cultures, the calculated growth rates may 
not be fully representative of the performance of the cells in 
serum-free media.
HF Run Time interval 
(hours)
Maximum growth rate 
(x10° cells/hour)
Corr.
Coefficient
BHK 314 - 785 0.170 0.986
MG-63 99 - 722 0.200 0.987
Vero 98 - 450 0.303 0.944
Table 8.2.4.2: Calculation of the growth rates achieved within the 
hollow fibre cartridge, based on the average oxygen consumption 
values during the shown time intervals. Linear regression analysis 
resulted in the shown correlation coefficients.
As described earlier, the optimisation strategy followed aimed 
to maintain the concentration of key metabolites at specific set- 
points such as 150 mg/dl (8.3 mM) or above for glucose, 2.5 mM
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or above for glutamine, below 150 mg/dl (16.65 mM) for lactate, 
and below 2.5 mM for ammonia, by adjusting the rates of media 
delivery and waste removal. These ideal optimisation conditions 
were not achieved at all times during the HF cell cultures grown 
in the present investigation. These discrepancies could be due 
to inadequate media delivery as a result of system failures or 
due to the empirical estimates of the system's nutrient 
requirements. However, it is expected that with repeated HF cell 
culture and experience, the process control strategy for each 
cell line can be improved significantly. This has been shown 
previously in the case for monoclonal antibody production in HF 
reactors using this control strategy (Handa-Corrigan, 1992).
Except during the times when there were unexpected equipment 
failures, the dissolved oxygen levels were successfully 
maintained above 70 mm Hg (0.0036 mg/ml). As described earlier 
in Section 2.4., the heterogeneous nature of HF systems leads to 
the formation of axial and longitudinal nutrient and waste 
gradients. It cannot be overlooked that either oxygen or severe 
nutrient limitation or waste accumulation may have occurred at 
localized sites within the HF cartridge. Despite short periods 
of possible nutrient limitation or waste accumulation the 
metabolic profiles of these runs indicate that under these 
conditions cultures achieved high cell concentrations.
For further experimental purposes, only samples which were 
obtained during periods where the metabolite concentrations were 
within their set-points were used (shown in Graphs 8.2.1-3.3).
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8.3.FRACTIONATION OF CELL CONDITIONED MEDIA
The removal of low molecular weight contaminants from 
biological fluids and the concentration of the remaindering 
macromolecules that they contain can be carried out by 
ultrafiltration or dialysis procedures using porous membranes, 
or by precipitation or lyophilization (reviewed in Section 3).
Ultrafiltration does not involve the addition of chemicals, as 
do precipitation techniques. Furthermore, ultrafiltration allows 
rapid fractionation of complex mixtures on the basis of molecular 
size. In this work, ultrafiltration was initially used for the 
separation of macromolecules from low molecular weight molecules 
such as lactate, ammonium and amino acids from the hollow fibre 
conditioned media. For this purpose, two different 
ultrafiltration devices fitted with 1 KDa cut-off filter 
membranes were tested:
a) An inbuilt cross-flow ultrafiltration device in which the 
membrane filters were not removable.
b) An autoclavable stirred-cell with removable disk filters.
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8.3.1. THE CROSS-FLOW ULTRAFILTRATION UNIT
Cross-flow ultrafiltration has been described in Section 3.1.1. 
and the full set-up details of the Ultrasette (Filtron) cross- 
flow cartridge are described in Section 7.11. In the first 
instance, the system was standardised to determine the 
appropriate operating conditions.
a) Flow rate: After flushing the system for one hour with 2
L/min of distilled water, the filtrate and circulation flow rates 
were measured (Table 8.3.1.1.)
Back pressure 
(psi)
Input flow 
rate (L/min)
Filtrate rate 
(ml/min)
30 1.20 1.6
30 1.48 1.6
35 0.84 2.1
35 1.78 2.1
Table 8.3.1.1.: Ultrasette flow rate standardization
with MQ (Millipore) water.
The rate of filtration was not affected by the input flow rate 
of the fluid but it increased as the back pressure was increased. 
This was expected since the pressure is the driving force through 
the filter and the fluid cross-flow is only aimed towards 
preventing fouling of the filter due to the retained molecules.
b) Sterilization of the Ultrasette: The Ultrasette unit is not 
autoclavable. In order to run a sterile process, chemical 
sterilization of the Ultrasette was carried out using a number
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of sterilizing solutions at different concentrations, as 
recommended by the suppliers (Elgar, U.K.) (Table 8.3.1.2.). All 
solutions used were previously autoclaved and after each 
sterilizing procedure the cartridge was stored in 0.1 M sodium 
hydroxide. After seven attempts to sterilize the Ultrasette 
cartridge, it failed to pass the sterility test. The final 
attempt to sterilize the Ultrasette with an alternative 
manufacturer's recommended sterilant Elgalite UFC-13 (Elgar, 
U.K.) also failed to achieve sterility and resulted in a rapid 
increase in the filtrate rate from 2.1 ml/min to 10 ml/min. The 
inability to chemically sterilize the Ultrasette could be due to 
its complex internal construction and the possible existence of 
dead spaces that were difficult for the sterilant to access.
Sterilant Exposure time 
(min)
Input flow 
rate (L/min)
Back pressure 
(psi)
Sterility tests 
FIL RET
1M Sodium hydroxide/ 
1M Hydrochloric acid
20
15
2.15
2.30
0
0 Fail Fai I
1M Sodium hydroxide 30 2.15 0 Fai I Fai I
1M Sodium hydroxyde 30 1.48 30 Fail Fai I
400 ppm Sodium 
hypochlorite
30 2.15 0 Fail Fai I
400 ppm Sodium 
hypochlorite
30 0.840 30 Fai I Fail
1000 ppm Sodium 
hypochlorite
180 1.70 20 Fai I Fai I
1M Sodium hydroxide/ 
1000 ppm Sodium 
hypochlorite
30
480
1.70
1.70
20
20 Fail Fai I
Elgalite UFC-13 
cleaning fluid
30 1.78 35 Fai I Clear
Table 8.3.1.2.: Ultrasette sterilizing procedures and results of the sterility 
tests of the resultant filtrate (FIL) and retentate (RET).
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c) Integrity testing: The rapid increase in the filtrate rate as 
a result of sterilization with Elgalite UFC-13 suggested that 
the integrity of the membrane filter may have been compromised. 
To verify this, a solution of albumin (67 kDa) was circulated 
through the retentate side and the resultant filtrate was 
collected. The filtrate was found to contain 28.8% of the albumin 
from the original circulated solution. This indicated a rejection 
value for albumin of 71.2% and suggested therefore a failure in 
the integrity of the filter.
The Ultrasette system was discarded as an unsuitable filtration 
device for the purposes of this study.
8.3.2. STIRRED-CELL ULTRAFILTRATION
The stirred-cell ultrafiltration device was set up as described 
in Section 7.12. A trial test was performed by "concentrating" 
340 ml of basal RPMI-1640 medium down to 100 ml of retentate and 
240 ml of filtrate. In theory, any component with a molecular 
weight greater than 1 kDa present in the RPMI-1640 medium should 
be concentrated by 3.4 times in the retentate. Sterility checks 
on the filtrate and retentate media did not show any signs of 
contamination.
To determine whether the stirred-cell or the fitted 
ultrafiltration membranes had introduced any contaminating 
factors which may affect cell growth, a cytotoxycity assay was 
carried out on the processed basal RPMI-1640. The growth curve
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of AFP-27 hybridomas grown in RPMI-1640 +4.5% NBCS was compared 
to that of AFP-27 cells grown in 85% RPMI-1640 +4.5% NBCS + 10% 
of stirred cell filtrate or retentate (See Table 8.3.2.1.). At 
a 99% confidence level, the Least Significant Difference (LSD) 
test (described in Appendix II) ranges for all the points in the 
growth curves overlapped, indicating that there were no 
significant differences in cell growth when cells were grown in 
10% of RPMI-1640 and the stirred cell filtrate and retentate.
Thus the stirred-cell and the fitted ultrafiltration membranes 
did not appear to have any cytotoxic effects on cells in culture.
2 hrs. 24 hrs. 48 hrs. 72 hrs. 96 hrs. 115 hrs. 135 hrs
Control (cell/ml x10°) 1.480 a 2.307 a 3.654 a 7.465 a 8.615 a 2.835 a 0.715 a
Filtrate (cell/ml x10°) 1.560 a 2.287 a 3.530 a 7.247 a 8.922 a 3.110 a 0.907 a
Retentate (cell/ml x10°) 1.515 a 2.296 a 3.504 a 7.370 a 8.921 a 2.991 a 0.787 a
LSD 99% 0.215 0.126 0.234 0.390 0.432 0.541 0.467
Table 8.3.2.1.: Stirred cell cytotoxicity assay. Cell numbers of batch
cultures of AFP-27 hybridoma cells grown in RPMI-1640 + 4.5%NBCS (Control) 
were compared to that of AFP-27 cells grown in 85% RPMI-1640 +4.5% NBCS + 10% 
of the stirred cell RPMI-1640 filtrate (Filtrate) and retentate (Retentate). 
Values represent the average of eight cell counts from two replica cultures 
per sample. Different letters in the same column indicate significant 
differences (p<0.01) according to LSD (Least Significant Difference) test .
The stirred-cell system, fitted with a 1 kDa cut-off filter 
disk was therefore selected for further work for the separation 
of low molecular weight components from the hollow fibre 
conditioned media. At a pressure of 30 psi, filtrate flow rates 
in the region of 0.5 ml/min were achieved with this device.
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7.3.3. CENTRIFUGAL ULTRAFILTRATION DEVICE
Macrosep (Filtron, USA) centrifugal ultrafiltration devices 
with 100 kDa cut-off membranes were used for further 
fractionation of the hollow fibre conditioned media (HF-CM). 
Filtration rates decreased with time (See Figure 7.3.3.1.) and 
in 90 minutes 2 0 ml of HF-CM were concentrated by five times to 
approximately 4 ml of retentate and 16 ml of filtrate.
Collected filtrate (ml)
20
15
10
5
0
0 15 30 45 7560 10090
Filtration rate (ml/min)
Time (minutes)
0 15 30 45 60 75 90 100
Time (minutes)
Figure 8.3.3.1.: Macrosep (100 kDa cut-off) collected filtrate volumes and 
filtration rates for HF-CM.
In centrifugal ultrafiltration devices, the problem of membrane 
fouling is reduced as larger molecules present in the retentate 
are pulled away from the ultrafiltration membrane by the 
centrifugal force. Nevertheless, the observed decreases in 
filtration rates during the ultrafiltration process indicated
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that membrane fouling due to protein adsorption could have been 
the problem. Nevertheless, the Macrosep device was used routinely 
for the fractionation of high molecular weight (100 kDa) 
macromolecules from the hollow fibre conditioned media.
8.3.4. ANALYSIS OF ULTRAFILTRATION SAMPLES
Characterisation of various ultrafiltration samples was carried 
out by measuring a) the levels of waste metabolites like lactate 
and ammonia, b) the total protein content, and c) by analysis 
using polyacrylamide gel electrophoresis.
a) Concentration of waste metabolites: The accumulation of
lactate and ammonia has been shown in many cases to have a 
detrimental effect on cell growth (Reviewed in Section 2.2.3.). 
The running conditions of the hollow fibre systems aimed to 
maintain the concentration of these key indicator waste 
metabolites below 150 mg/dl for lactate and 2.5 mM for ammonia, 
and only the medium harvested during the optimised growth 
conditions periods was used.
The IkDa cut-off ultrafiltration process carried out on the HF- 
CM resulted in the depletion of lactate and ammonia 
concentrations by a factor of five in the retentâtes and a factor 
of two in the filtrates. Similar dilutions of lactate and ammonia 
were observed upon filtering the HF-CM through the 100 kDa cut­
off membranes.
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b) Total protein concentration: The total protein content of 
samples was estimated by a colorimetric assay which involves 
binding of Coomassie Brilliant Blue G-250 dye to proteins 
(Bradford, 1976). The performance of the stirred-cell, fitted 
with the IkDa cut-off membrane, and the centrifugal 
ultrafiltration device with 100 kDa cut-off membranes, was 
evaluated by determining the protein concentration in the 
resulting filtrate and retentate fractions (Figure 8.3.4.1.).
120
( 1 .2 6  m g /m l)
1 0 0 -
8 0 -
c
‘<D
o RET
6 0 -a
X FIL
o
RET
2 0 -
HF-CM 1 kDa c u t-o ff 1 00  kDa c u t-o ff
Figure 8.3.4.1.; Percent of the total protein in the Vero HF-CM 
recovered in the filtrates (FIL) and retentâtes (RET) resulting 
after 1 and 100 kDa ultrafiltration.
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The total protein content recovered from the 1 kDa 
ultrafiltration was 1 mg (at 0.005 mg/ml) in the filtrate and 66 
mg (at 0.66 mg/ml) in the retentate. Since the total protein 
content in the original hollow fibre conditioned media (HF-CM) 
was 126 mg (at 1.263 mg/ml), only 53% of the total original 
protein was recovered in the filtrate and retentate. Therefore 
ultrafiltration with 1 kDa membrane resulted in a loss of half 
of the total protein content. Similarly, in the case of the 100 
kDa membrane filter, the filtrate contained 9 mg (at 0.045 mg/ml) 
of protein and the retentate 5.7 mg (at 0.57 mg/ml), resulting 
in an overall recovery of 4 6% of the original protein. Thus 
filtration with the centrifugal device, with a larger pore size, 
resulted in greater protein losses than those occurred with the 
stirred cell. As shown in Table 8.3.4.1., the amount of fluid 
processed per surface area of the filters was greater, over twice 
the volume, in the centrifugal device, and this corresponded with 
the greater protein losses per surface area observed.
Stirred Cell 
(1 kDa cut-off)
Centrifugal Device 
(100 kDa cut-off)
Membrane surface area 
(nnm^ )
4536.4 490.3
Processed fluid filtered 
per surface area (jiil/mm^ )
44.1 102.0
Protein losses per 
surface area (/ig/mm^ )
13.1 35.9
Table 8.3.4.1.: Performance of the ultrafiltration devices 
regarding the volumes of filtered fluid and protein losses 
per surface area of the filter.
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The ratio of protein concentration within the filtrates and 
retentâtes differed for 1 kDa and 100 kDa cut-off membranes 
(Figure 8.4.1.3.). When the hollow fibre conditioned media was 
separated using the 1 kDa cut-off membrane, 98.4% of the 
recovered protein was found in the retentate and 1.6% was found 
in the filtrate. When the conditioned media was separated by the 
100 kDa cut-off membrane, 38.8% of the recovered protein was 
retained and 61.2% was found in the filtrate. This was expected 
as larger pore sizes would allow more proteins to pass through 
the filter.
Theoretically, the filtrate from the IkDa membrane should 
contain molecules which are below IkDa in size and the retentate 
those molecules above IkDa. Similarly 100 kDa filtration should 
have resulted in the separation of proteins below and above 100 
kDa in the retentate and filtrate, respectively.
c) Gel electrophoresis of ultrafiltration samples: Sodium
dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
is a common analytical method used in the analysis of the 
molecular weights of proteins. SDS-PAGE in combination with 
silver staining was used to characterise various samples obtained 
from the hollow fibre cell conditioned media before and after 
ultrafiltration procedures.
The filtrates and retentâtes resulting from the 1 kDa and 100 
kDa cut-off membrane filtration were run on a gradient 
polyacrylamide gel (10-15%) (Plate III). The resolution of 
gradient gels is not as good as that obtained in homogeneous
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Phosphorylase b (90 kDa)
Albumin (67 kDa)
Ovalbumin (43 kDa)
- Carbonic anhydrase (3 Q kDa)
' Soyabean Trypsin inhibitor (20 kDa
aLactalbumin (14 kDa)
Dye front
Plate III: SDS-PAGE (Phast gel gradient 10-15) developed by silver staining. Lane 
1: LMW Standard; 2: Vero 1 kDa HF-CM Filtrate; 3: Vero 100 kDa HF-CM Retentate 
4: Vero 100 kDa HF-CM Filtrate; 5: Vero 1 kDa HF-CM Retentate; 6: Vero HF-CM; 
7: HL-1; 8: LMW Standard.
Myoglobin (16.95 kDa) 
Myoglobin I and II (14.40 kDa)
Myoglobin I (8.16 kDa) 
Myoglobin II (6.12 kDa)
m
Myoglobin III (2.51 kDa) 
Dye front
Plate IV: SDS-PAGE (Phast gel high density) developed by silver staining. Lane 1: 
PMW Standard; 2: HL-1; 3: Vero HF-CM; 4: Vero 100 kDa HF-CM Filtrate; 5: Vero 100 
kDa HF-CM Retentate; 6: Vero 1 kDa HF-CM Retentate; 7: Vero 1 kDa HF-CM 
Filtrate; 8: PMW Standard.
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gels, but they are useful for the separation of protein mixtures 
with a broad range of molecular weights. Standard molecular 
weight markers were run in lanes 1 and 8. Vero hollow fibre 
conditioned media showed 25 or more different discernible bands 
with molecular weights ranging from greater than 90 kDa to less 
than 14 kDa. The 1 kDa retentate sample showed a similar banding 
pattern as the original hollow fibre conditioned media. The 1 kDa 
filtrate only showed two very faint bands with estimated 
molecular weights of 25.2 and 25.7 kDa respectively.
Ultrafiltration samples from the 100 kDa cut-off membrane 
resulted in a retentate containing a similar banding pattern as 
the hollow fibre conditioned media. In the filtrate, proteins of 
less than 28.5 kDa showed the same banding pattern as the HF-CM. 
Above 28.5 kDa, only three bands, of 54.8, 60 and 65 kDa were 
detected in the filtrate. These bands were fainter than their 
counterparts found in the HF-CM and this indicated that these 
molecules were partially retained by the 100 kDa cut-off UF 
membrane. Thus, ultrafiltration through the 100 kDa membrane 
resulted in the exclusion of proteins with a molecular weight 
larger than 65.5 kDa, and not those over 100 kDa as stated by the 
manufacturer.
In order to further characterise the lower molecular weight 
components in the HF-CM and the ultrafiltration filtrates and 
retentâtes, samples were run on a high density polyacrylamide gel 
(Plate IV). More or less similar protein bands were observed in 
these gels as those found in the gradient gels. However, some
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slight differences in the low molecular weight components were 
detected. The 1 kDa filtrate appeared free of proteins and the 
retentate lacked the last two bands which were present in the HF- 
CM and were estimated to be 11.9 and 11 kDa in molecular weight. 
Presumably these smaller peptides were present in the filtrate 
at low concentrations and were not detectable on silver staining, 
or they were lost owing to adsorption onto the membrane filters.
The filtrate and retentate resulting from 100 kDa filtration 
also presented a similar band pattern as found in the gradient 
gel, but three extra bands, not detected in the HF-CM were also 
found. These low molecular weight bands, present in the 100 kDa 
filtrate and retentate, were estimated to be 9.7, 8.9 and 7.9 kDa 
in molecular weight. Another well marked band, with an estimated 
molecular weight of 4.7 kDa appeared in the 100 kDa filtrate. 
These bands were not detected in the HF-CM sample and were 
considered to be the result of protein degradation or 
contaminants due to the ultrafiltration process.
The composition of HL-1 (Ventrex) serum-free media remains, to 
date, a company secret. SDS-PAGE revealed the presence of only 
two different proteins in this medium. One, more concentrated, 
with an estimated molecular weight of 7 6.6 kDa, and the other, 
with an estimated molecular weight of 68.5 kDa. It is likely that 
these bands may be transferrin with a molecular weight of 80 kDa 
and albumin with a molecular weight of 67 kDa. Albumin and 
transferrin are both common additives in defined media 
formulations and although the manufactures state that HL-1 does
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not to contain bovine serum albumin it may contain albumin from 
other sources such as ovalbumin or human albumin.
8.3.5 DISCUSSION OF ULTRAFILTRATION EXPERIMENTS
Membrane ultrafiltration was used to fractionate the cell 
conditioned media obtained from the hollow fibre cell cultures. 
Commercially available ultrafiltration devices are usually not 
steam sterilizable and thus need to be sterilized chemically or 
with radiation. The use of radiation requires purpose built 
facilities which are not common in research laboratories.
In this work, chemical sterilization was able to achieve the 
sterility of the stirred cell but not of the Ultrassete cross- 
flow unit. Chemical sterilization thus appeared to be effective 
on devices of a simpler construction with easier access for the 
sterilant. In addition repeated attempts to chemically sterilize 
the Ultrassete resulted in failure of the integrity of the filter 
membranes, indicating that exposure to the sterilizing chemicals 
is a harsh method which may only be carried out for a limited 
number of times.
Commercial ultrafiltration membranes claim to have strict 
exclusion values and to adjust to their referred molecular weight 
cut-off. In these studies filter membranes of 1 kDa cut-off, 
resulted in the almost complete removal of protein from the 
filtrate and filter membranes of 100 kDa cut-off resulted in the 
exclusion of proteins above 65 kDa in molecular weight. Thus, in
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practice the strict exclusion of proteins above the claimed 
molecular weight cut-off was not observed and this was attributed 
to a number of reasons:
a) Molecular weight may not always correspond with protein size.
b) The impossibility of manufacturing ultrafiltration membranes 
with identical pore sizes throughout.
c) Adsorption of proteins to the working membrane may reduce its
filtration capabilities and result in the exclusion of 
otherwise filterable proteins.
Non-specific protein adsorption and membrane fouling are 
recognised problems in ultrafiltration. Protein adsorption is 
mediated by electrostatic and hydrophobic interactions between 
proteins and membrane surfaces (Hu at al., 1993). Both of the 
ultrafiltration systems used were fitted with low protein-binding 
Omega polyethersulphone membranes (Filtron, USA). Previous 
reports on microporous polysulphone membranes describe non­
specific protein adsorption values of 1-3 x 10^ /xg/mm^ (Hu at 
al., 1993). Thus the protein losses occurring during 
ultrafiltration of HF-CM could not be solely attributed to 
protein adsorption but also to membrane fouling as a result of 
the ultrafiltration operating conditions. Indeed, greater protein 
losses occurred when larger amounts of fluid were processed per 
surface area of filter membrane, and this cannot be attributed 
to non-specific adsorption but to fouling of the membrane.
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8.4. EFFECTS OF HF-CM ON CELLS IN CULTURE
The high cell concentration conditioned media and their 
fractions from the hollow fibre cell cultures of serum-free 
adapted BHK, Vero and MG-63 cell lines, were collected and 
processed as depicted in Figure 8.4.0.
The effect of HF-CM and its fractions on cells growth and other 
properties was carried out using three different approaches:
1) Direct viable cell counts of batch cell cultures using a 
haemocytometer.
2) The MTT assay which indirectly measures viable cell numbers 
and cellular metabolic activity.
3) A surface-detachment assay which measures the strength of 
cell adhesion to a surface.
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Adaptation of cell lines to HL-1
HL-1 (<30 ug/ml protein)
RPMI-1640 WasteHollow fibre cartridge
1 kDa
Ultrafiltration
Fll. Ret. HF-CM
1-2.6 mg/ml protein 
Lactate < 150 mg/ml 
Ammonia < 2.5 mM
100 kDa 
Ultrafiltration
Ret. Fll.
Further Work:
1 1
Bloassays for cell Growth, Metabolism and Adhesion 
(In 2.25% F08 plus 10% of sample)
Figure 8.4.0.: Outline of the procedures carried out to obtain the hollow 
fibre conditioned media (HF-CM) and its posterior ultrafiltration (Fil: 
Filtrate; Ret: Retentate).
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8.4.1. EFFECTS OF HF-CM ON CELL NUMBERS
To assess the effect of various hollow fibre conditioned media 
(HF-CM) on cell growth, growth curves were plotted on batch 
cultures of LL-24, BHK, MG-63 osteosarcoma and Vero cells in the 
presence of the HF-CM obtained from the BHK, MG-63 osteosarcoma 
and Vero cell lines. As previously discussed in Section 4 of this 
thesis, cell division may be assessed by measuring the uptake of 
labelled compounds, such as radiolabelled thymidine, into newly 
formed DNA or through repeated estimates of cell numbers. Cell 
numbers may be determined either directly through cell counting 
or indirectly by measuring packed cell volumes, MTT conversion, 
and protein, DNA and RNA contents. Direct viable cell counting 
of trypsinised cells using a haemocytometer is the routine method 
used in our laboratory for growth curve experiments.
The cell lines challenged with the HF-CM and its fractions were 
grown in RPMI-1640 + 2.25% FCS, with an added 10% of HF-CM and 
its 1 kDa filtrates and retentâtes. Control cultures contained 
10% of HL-1 +2.5% FCS in RPMI-1640. In another control culture, 
cells were grown only in RPMI-1640 + 2.25% FCS, with no other 
supplements. Each growth curve experiment (an asterisk in Table
8.4.1.1.) was carried out in duplicate and each point in the 
growth curves represents the mean of eight different cell counts 
(ie., four counts per replica sample).
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HF-CM
BHK Vero MG-63
Cells challenged
LL-24 * -
BHK *** *** ***
Vero * *
MG-63 * *
Table 8.4.1.1.: Cell lines challenged with the BHK, Vero
and MG-63 hollow fibre conditioned media (HF-CM) and its 
1 kDa filtrates (the asterisks represent the number of 
times the experiment was repeated).
Growth curves were taken to be significantly different from 
each other when cell numbers were found to be significantly 
different according to the Least Significant Difference (LSD) 
test (n=8; p<0.01) (described in Appendix II) in three
consecutive time intervals.
a) Effect of BHK HF-CM on cell growth; In order to determine 
the effect of the BHK HF-CM on cell growth, LL-24, BHK, Vero and 
MG-63 cells were challenged with the BHK cell HF-CM and its 1 kDa 
separated fractions.
Neither the BHK HF-CM nor its 1 kDa ultrafiltration fractions 
had any effect on the growth of LL-24 cells (Figure 8.4.1.1.).
In comparison with HL-1, the BHK HF-CM exhibited a growth 
promoting effect on BHK cells themselves and this growth 
promoting factor appeared to be retained by 1 kDa cut-off filter 
membrane (Figure 8.4.1.2.). The control BHK cell cultures, 
growing in RPMI-1640 + 2.25% FCS, did not show significant cell
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447592 a,b 
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520636 a 
542074 a 
478333 a 
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490840 a 
518320 a 
460360 a 
523280 a
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Figure 8.4.1.1.: Effect of BHK cell conditioned media on LL-24 cell growth.
All batch cultures were carried cut in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED), The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cm^). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: HL-1 = HF-CM = FIL = RET = MED
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Figure 8.4.1.2.: Effect of BHK cell conditioned media on BHK cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 10% 
IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cmf). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (FIL = MED) < HL-1 < (HF-CM = RET)
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growth, however cells remained attached and viable. BHK cells 
have been previously reported to be susceptible to IGF (Hsu and 
Olefsky, 1992) and FGF (Ross and Ballard, 1988) but there are no 
reports on growth promoting factors being produced by BHK cells 
themselves. As BHK cells are transformed it is not unlikely that 
they may be producing a number of growth factors including IGF, 
TGP-B and FGF.
The BHK HF-CM IkDa filtrates and retentâtes had no effect on 
the growth of MG-63 cells as cells grew similarly to those grown 
in culture media (Figure 8.4.1.3.). Addition of HL-1 resulted in 
a growth promotion effect. This was attributed to factors in HL-1 
which may have been depleted during the hollow fibre cultivation. 
The addition of BHK HF-CM to MG-63 cells resulted in a inhibition 
of growth after 168 hours of culture. Neither the 1 kOa filtrate 
or retentate from the BHK HF-CM showed this effect on MG-63 cell 
growth. The loss of the inhibitory effect in the BHK HF-CM upon 
fractionation by ultrafiltration could be due to a number of 
reasons as follows:
I) Dilution of low molecular weight waste metabolites 
during ultrafiltration.
II) Loss of the putative proteinaceous factor(s) owing to its 
adsorption to the membrane filters.
III) Loss of activity of the putative proteinaceous factor(s) 
owing to degradation during processing.
Iv) Separation in the filtrate and retentate of factors acting 
in synergy, or loss of one of the factors.
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Figure 8.4.1.3.: Effect of BHK cell conditioned media on MG-63 cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% PCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cm^). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: HF-CM® < (FIL = RET = MED) < HL-1 (a: this only holds
for the last two time intervals).
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i) Low molecular weight cell-originated waste metabolites such 
as lactate and ammonia have been extensively reported to have a 
detrimental effect on cell growth (Reviewed in Section 2.2.3.). 
As previously described, these molecules present in the HF-CM are 
diluted during the ultrafiltration process by 5 times in the 
retentate and twice in the filtrate. The dilution factor may 
account for the loss of their MG-63 cell inhibitory activity in 
the 1 kDa cut-off BHK HF-CM filtrates and retentâtes. During the 
hollow fibre cultivations the optimisation strategy ensured that 
the HF-CM obtained from the hollow fibre cultures contained below 
2.5 mM of ammonia and 150 mg/dl (16.65 mM) of lactate. Assuming 
these maximal values, the 1:10 dilution of the test samples 
carried out upon setting up the growth curve experiments would 
result in a maximal concentration of 0.25 mM for ammonia and 1.7 
mM for lactate. There are no published reports on the effects of 
lactate and ammonia on the MG-63 cell line, but generally cell 
lines are not affected by such low concentrations (Reviewed in 
Section 2.2.3.). Furthermore, the susceptibility to ammonia has 
been previously reported to decrease upon transformation (Visek 
et al.f 1972) and it is unlikely that the highly transformed MG- 
63 cell line was affected by lactate and ammonia present in the 
BHK HF-CM while the Vero and BHK cells were not affected.
ii) If the growth inhibitory activities are due to specific 
proteinaceous materials, the absence of inhibition by the 
filtrates and retentâtes could be attributed to protein losses 
occurring during the ultrafiltration process and resulting in
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reduced concentrations of the growth inhibiting factor (s) present 
in the HF-CM. As previously discussed almost half of the total 
protein present in the HF-CM is lost during the ultrafiltration 
processing and some proteins may be adsorbed preferentially.
Growth factors are active at low concentrations (in the range 
of 10^ - 10*^  mg/ml) (Sigma, 1993; Boehringer Chemical Company, 
1993) therefore the loss of the growth inhibitory activity is 
unlikely to be solely due to adsorption during ultrafiltration 
processing.
ill) Protease activities are commonly found in cell culture 
conditioned media and in cell lysates (Dignam, 1990), and they 
may have been involved in rendering the growth inhibitory factors 
inactive during the six to seven hours (at 15 to 2 0sc) of the 
ultrafiltration process. If this were the case it may be argued 
that proteases in the BHK HF-CM would inactivate the growth 
inhibitor proteins at the time of carrying out the growth curves 
experiments. This did not appear to be the case as the growth 
inhibitory activity in the HF-CM was found to be preserved during 
the growth curve experiments and was found to be most active at 
the end. The conservation of the growth inhibitory activity 
during the growth curve experiments may result from the 
protective role of the 2.25% of FCS present in the culture media. 
Serum protein not only provides an alternative source of protein 
for protease action but serum also contains a number of protease 
inhibitors (including a-antiplasmin, plasminogen activator 
inhibitor and antithrombin-III).
-162-
Results and Discussion
iv) Loss of the MH-63 growth inhibitory activity in the BHK HF- 
CM may also be due to the separation in the filtrate and 
retentate of factors which act in a synergistic fashion. TGF-B 
has been reported to inhibit proliferation of MG-63 cells in 
synergy with EGF, PDGF, and HBGF-1 (Hyroyuki and Chen, 1989). 
TGF-B is normally secreted bound to a large molecular weight 
precursor (235 kDa) which would prevent its passage through the 
1 kDa membrane filter while smaller growth factor molecules would 
be allowed through. TGF-B is produced by many transformed and 
non-transformed cell lines (Roberts and Sporn, 1990) and thus may 
be responsible for the observed inhibition of the BHK HF-CM on 
MG-63 cell growth. Other growth factors such as IL-1, TNF-a and 
IFN-V have also been reported to have antiproliferative effects 
on MG-63 cells (Jia and Kleinerman, 1991) and it has not yet been 
established whether these factors are produced by BHK cells. It 
is unlikely though, that BHK cells would be producing TNF-a as 
it is not normally produced by fibroblasts (Vilcek and Lee, 1991) 
or IFN-X which is normally produced by T lymphocytes and natural 
killer cells (Vilcek, 1990). IL-1 is mainly produced by 
monocytes, granulocytes and lymphocytes but it has also been 
reported to be produced by epithelial and connective tissue cells 
(Schmidt and Tocci, 1990), including dermal fibroblasts (Le et 
al., 1987). The BHK cell line derives from kidney cells and it 
is possible that they may be producing IL-1 which would inhibit 
MG-63 cells. The observed growth inhibition on MG-63 cells may 
also be owing to growth factor binding protein(s) in the BHK
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conditioned media. DNA synthesis of MG-63 cells has been 
previously reported to be inhibited by IGFBP (IGF Binding 
proteins) which bind to IGF and neutralize its growth promoting 
activity (Campbell and Novak, 1991).
The BHK HF-CM and its 1 kDa retentate had a growth promoting 
effect on Vero cells and this effect was also found when Vero 
cells were exposed to HL-1 (Figure 8.4.1.4.). It is therefore 
likely that the growth promoting effects in HL-1 and the BHK HF- 
CM are due to the similar factor(s) and that these macromolecules 
were retained by the 1 kDa cut-off filter membrane. As previously 
discussed (Section 8.3.4.), albumin and transferrin are likely 
to be part in HL-1 formulation and may be responsible for the 
growth promoting effect of HL-1, the BHK HF-CM and the BHK HF-CM 
IkDa retentate, on Vero cells.
In summary, the BHK HF-CM does not, under the test conditions, 
affect growth of LL-24 or Vero cells but stimulates BHK cell 
growth and inhibits growth of MG-63 cells. There are no reports 
on the growth factors produced by BHK cells, but several known 
factors may be involved in these activities. IGF, TGF-B and FGF 
may be responsible for the autocrine stimulation of BHK cell 
growth and TGF-B and IL-1 for the inhibition of MG-63 cell 
growth. As the stimulatory effect on BHK cells was retained by 
a 1 kDa cut-off filter while the inhibitory effect on MG-63 cells 
was not, it is unlikely that these effects are mediated by a 
single growth factor.
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Figure 8.4.1.4.: Effect of BHK cell conditioned media on Vero cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cmf). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (FIL = MED) < (HL-1 = HF-CM = RET)
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b) Effect of Vero HF-CM on cell growth: To determine the effect 
of Vero HF-CM on cell growth, LL-24, BHK, Vero and MG-63 cells 
were challenged with the Vero HF-CM and its 1 kDa separated 
fractions. The Vero HF-CM or its 1 kDa ultrafiltration fractions 
did not significantly affect growth of Vero cells (Figure 
8.4.1.5.) or of the MG-63 cells (Figure 8.4.1.6.). For both cell 
lines, HL-1 was found to have a growth promoting effect over the 
Vero HF-CM and its fractions. This was attributed to the presence 
of growth promoting factors in HL-1 which had been depleted by 
Vero cells during the hollow fibre cultivation and were therefore 
not present in sufficient concentration in the Vero HF-CM.
The Vero HF-CM, however, inhibited the growth of LL-24 cells 
(Figure 8.4.1.7.) and promoted the growth of BHK cells (Figure 
8.4.1.8.). The inhibitory effect of Vero HF-CM on LL-24 cell 
growth was not found in the 1 kDa filtrate or retentâtes. This 
observation is similar, but more pronounced, to that previously 
described in point a) for the inhibitory effect of the BHK HF-CM 
on MG-63 cells and may be explained in the same way, ie. , through 
losses due to adsorption to filter membranes, proteolytic 
degradation of the factors involved, and separation of factors 
acting in synergy. There are no reports as to what growth factors 
Vero cells may be producing or which growth factors affect the 
growth of LL-24 cells. Vero cells are transformed kidney cells 
and their growth inhibitory activity may be due to previously 
described growth inhibitors or a novel factor. TGF-B has been 
found to be produced by a number of transformed and non-
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Figure 8.4.1.5.: Effect of Vero cell conditioned media on Vero cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cnf). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (HF-CM = FIL = RET = MED) < HL-1
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Figure 8.4.1.6.: Effect of Vero cell conditioned media on MG-63 cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cmf). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (HF-CM = FIL = RET = MED) < HL-1
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Figure 8.4.1.7.: Effect of Vero cell conditioned media on LL-24 cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cm^). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: RET «  (HF-CM = FIL = MED) < HL-1
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Figure 8.4.1.8.: Effect of Vero cell conditioned media on BHK cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cmf). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (FIL = MED) «  (HL-1) «  (HF-CM = RET)
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transformed cell lines (Roberts and Sporn, 1990) and to have 
growth promoting and inhibiting effects depending on the cell 
type challenged (Sporn and Roberts, 1987). Most cell types carry 
receptors for TGF-5 (Roberts and Sporn, 1990) and TGF-B present 
in the Vero HF-CM may be responsible for the inhibition of growth 
of LL-24 cells.
Unlike the inhibitory effect on LL-24 cell growth, the putative 
growth promoting factor(s) in Vero HF-CM affecting BHK cells was 
retained by 1 kDa cut-off membrane filters. Addition of Vero HF- 
CM 1 kDa filtrates did not promote growth, indicating that the 
filtrates did not contain growth affecting factors or that they 
were not present at high enough concentrations.
To further characterise the effect of Vero HF-CM on BHK cells, 
another set of growth curves were carried out on BHK cells in the 
presence of the Vero HF-CM and its 1 kDa (Figure 8.4.1.9.) and 
100 kDa (Figure 8.4.1.10) filtrates and retentâtes. The serum 
used in the medium supplementation for these growth curves was 
of a different batch than that previously used, and had a more 
potent stimulatory effect on BHK cell growth than that observed 
on earlier BHK growth curves (see former Figures 8.4.1.8.). The 
use of this more potent foetal calf serum resulted in a general 
increase in the cell numbers achieved in all growth curve 
experiments. Nevertheless, BHK cells incubated in Vero HF-CM and 
its retentate still grew to higher cell concentrations than the 
HL-1 and basal media controls. Hence, the growth stimulatory 
effect of Vero HF-CM and its retentate on BHK cell growth was
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Figure 8.4.1.9.: Effect of Vero cell conditioned media on BHK cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS* with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED) (The asterisk indicates 
that a different batch of serum was used in these experiments). The values in the table correspond to those 
in the graph above and represent the mean of eight cell counts (viable veils per cmf). Different letters 
in the same column indicate significant differences (p<0.01) according to LSD (Least Significant Difference) 
test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: MED < HL-1 < (HF-CM = RET)
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Figure 8.4.1.10.: Effect of Vero cell conditioned media on BHK cell growth 
(100 kDa ultrafiltration fractions).
All batch cultures were carried out in RPMI-1640 + 2.25% FCS* with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% 100 kDa HF-CM filtrate (FIL); 10% 100 kDa HF-CM retentate (RET); No additives (MED) (The asterisk 
indicates that a different batch of serum was used in these experiments). The values in the table correspond 
to those in the graph above and represent the mean of eight cell counts (viable cells per cnf). Different 
letters in the same column indicate significant differences (p<0.01) according to LSD (Least Significant 
Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: MED < FIL < (HF-CM = RET) < HL-1* (a: higher initial 
growth rate but lower maximum cell concentration).
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reproducible besides the effect of a different batch of serum in 
the media. The BHK growth promoting activity present in the Vero 
HF-CM was not only present in the retentate resulting from the 
1 kDa cut-off ultrafiltration (See Figure 8.4.1.8-9), but it was 
also present in the retentâtes obtained from the 100 kDa cut-off 
ultrafiltration (Figure 8.4.1.10.) . As described earlier, the 100 
kDa cut-off membrane retained proteins above 65 kDa. It can be 
concluded that BHK cells were stimulated to grow by factors above 
65 kDa in molecular weight which are present in the Vero HF-CM. 
The 100 kDa filtrate was also found to promote cell growth in 
comparison with the control containing only basal media and may 
thus contain a growth promoting factor different to that in the 
100 kDa retentate.
As seen from Figure 8.4.1.11. growth factors generally have 
molecular weights considerably lower than 65 kDa and unless bound 
to, or forming part of, a larger protein they would be excluded 
by the 100 kDa ultrafiltration membrane (65 kDa effective cut­
off) . It is possible that the high molecular weight product with 
growth promoting effects observed in the Vero HF-CM may be a 
growth factor, such as IGF or GM-CSF, bound to a larger protein 
or forming part of a larger precursor molecule as occurs with 
TGF-B. These complexes are usually inactive in their high 
molecular weight forms and are rendered active through 
proteolytic cleavage.
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Figure 8.4.1.11.: Growth factors organised according to their molecular
weights (molecular weight is given in kDa in the brackets following each 
growth factor). The lines across represent the cut-off points of the 
ultrafiltration membranes used in the processing of the conditioned media. 
EGF: Epidermal growth factor; IGF: Insulin like growth factor; TGF-alpha:
Transforming growth factor alpha; IL-1: Interleukin-1; TNF-aipha: Tumour
necrosis growth factor alpha; ANG: Angiogengin; TGF-beta: Transforming growth 
factor-beta; IL-6: Interleukin-5; G-CSF: Granulocyte colony stimulating
factor; FGF: Fibroblast growth factor; OSM: Oncostatin-M; PDGF: Platelet
derived growth factor; M-CSF: Macrophage colony stimulating factor; LIF:
Leukaemia inhibitory factor; GM-CSF: Granulocyte-macrophage colony stimulating 
factor (Compiled from Sporn and Roberts, 1990 and R&D Systems (UK) product 
catalogue 1994).
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IGF binding proteins (IGFBP) have been reported to bind to IGF 
and other proteins to form 150 kDa complexes (Rechler and 
Nissley, 1990). IGFBP have been found in cell culture 
supernatants of various cell lines including normal MDBK kidney 
epithelial cells (Szabo et al., 1988) and may be produced by Vero 
cells (monkey kidney cells). Release of IGF from its binding 
proteins is mediated by proteases present in serum (Rechler and 
Nissley, 1990) , and if the complex was present in the conditioned 
media its cleavage may have occurred during the growth curve 
experiments containing 2.25% FCS. The growth promoting activity 
of the 100 kDa ultrafiltration filtrates may be due to 
proteolysis of the IGFBP complex during ultrafiltration resulting 
in some free IGF (7.6-16 kDa) which could filter through the 
membrane. Proteases are common in cell culture media (Dignam, 
1990) and are likely to be present in the hollow fibre 
conditioned media.
TGF-B is normally secreted in a high molecular weight (237 kDa) 
inactive form (Roberts and Sporn, 1990). Activation of the TGF-B 
precursor to render the active low molecular weight form (25 kDa) 
can occur through acidification, alkalinization or proteolysis 
(Lyons et al., 1988). The large molecular weight TGF-B precursor 
may be responsible for the activities observed in the 100 kDa 
ultrafiltration retentâtes, activation may be due to proteolysis 
and/or pH changes during the growth curve experiments.
As previously described for the IGF, the partial dissociation 
of the TGF-B precursor into the 25 kDa active form during
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ultrafiltration may explain the growth promoting activity of the 
100 kDa ultrafiltration filtrate.
EGF and the GM-CSF are also found as part of larger precursor 
molecules. EGF as part of a membrane bound 13 0 kDa glycoprotein 
and the GM-CSF secreted as part of molecules with molecular 
weights up to 200 kDa. EGF is a potent mitogen for fibroblasts, 
but fibroblasts do not usually secrete EGF (Carpenter and Wahl, 
1990) and thus it is unlikely that EGF is responsible for the 
growth promotion activity of the tested conditioned media. The 
GM-CSF is normally produced by haematopoietic cells, although it 
has been reported to be secreted by fibroblast cell lines, and 
its action, with the exception of some epithelial and bone cells, 
is restricted to haematopoietic cells (Reviewed by Burgess, 
1990) . Thus GM-CSF is not likely to be responsible for the growth 
promoting activity of the Vero conditioned media upon BHK cells.
Overall, amongst the known growth factors, the IGF and/or TGF-B 
appear to be the most probable candidates for the growth 
promoting activities of the Vero HF-CM on BHK cells.
b) Effect of MG-63 HF-CM on cell growth: To determine the effect 
of MG-63 HF-CM, growth curves of BHK, Vero and MG-63 cell lines 
were plotted. The MG-63 HF-CM was found to have no effect on the 
growth of MG-63 cells themselves (Figure 8.4.1.12). Autocrine 
regulatory mechanisms have been suggested in MG-63 cells 
secreting basic FGF (Nishikawa et al.,1993) and IFN-B (Kohase et 
al., 1987). The experiments carried out on MG-63 cells did not
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Figure 8.4.1.12.: Effect of MG-63 cell conditioned media on MG-63 cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25%FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 10% 
IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cmf). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (HF-CM = FIL = RET = MED) < HL-1
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show that MG-63 HF-CM stimulated MG-63 cell growth. This 
discrepancy is probably due to the serum-free, protein-free (only 
including bFGF) conditions in which the reported experiments were 
carried out (Nishiwaka et al., 1993).
Addition of the MG-63 HF-CM to Vero cell cultures resulted in 
the inhibition of growth by the HF-CM and its 1 kDa retentate 
(Figure 8.4.1.13.). The MG-63 cell line has been reported to 
produce FGF (Nishikawa et al., 1993) and TGF-B (Kohase et al., 
1987) and also granulocyte chemotactic protein (Proost et al., 
1993) and M-CSF (Ohtsuki et al., 1992). There are no reports on 
the effect of these factors on Vero cells, but it is unlikely 
that the inhibition of Vero cell growth by MG-63 HF-CM is 
mediated by the granulocyte chemotactic protein or the M-CSF, as 
these factors exert their activities primarily on haemopoietic 
cells. FGF is promoter of fibroblast cell growth and division 
(Baird and Bohlen, 1990) and it is also unlikely that it is 
inhibiting the growth of Vero cells.
Amongst the known factors to be produced by MG-63 cells, TGF-B 
is a likely candidate that may be responsible for the growth 
inhibitory activity on Vero cells. TGF-B has been extensively 
reported to have growth promoting or inhibiting activities 
depending on the cells tested (Roberts and Sporn, 1990).
As the BHK and Vero HF-CM previously tested, MG-63 HF-CM and 
its 1 kDa cut-off membrane filtration retentâtes had a growth 
promoting effect on the BHK cell line (Figure 8.4.1.14.). As 
described earlier, MG-63 cells have been reported to produce FGF
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Figure 8.4.1.13.: Effect of MG-63 cell conditioned media on Vero cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cm^). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (HF-CM = RET) < (HL-1 = FIL = MED).
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Figure 8.4.1.14.: Effect of MG-63 cell conditioned media on BHK cell growth.
All batch cultures were carried out in RPMI-1640 + 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 
10% IkDa HF-CM filtrate (FIL); 10% IkDa HF-CM retentate (RET); No additives (MED). The values in the table 
correspond to those in the graph above and represent the mean of eight cell counts (viable cells per cmf). 
Different letters in the same column indicate significant differences (p<0.01) according to LSD (Least 
Significant Difference) test.
Highlights of the data assuming that growth curves were significantly different when they were found to 
be different over three consecutive time intervals: (FIL = MED) «  HL-1 < (HF-CM = RET).
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(Nishikawa at al., 1993) and TGF-5 (Kohase at al,, 1987) and BHK 
cells are known to be susceptible to IGF (Hsu and Olefsky, 1992) 
and FGF (Ross and Ballard, 1988). Thus, any of these factors may 
be involved in the growth promotion of BHK cells by MG-63 HF-CM.
From the above experiments it cannot be elucidated whether the 
growth promoting effect on BHK cells found in the BHK, Vero and 
MG-63 HF-CM were due to the same factor. It is possible that this 
may be the case, as the three HF-CM originate from transformed 
cell lines with a fibroblastic morphology. Factors which may be 
produced by the three cell lines and may have a growth 
stimulatory effect specifically on BHK cells could include IGF, 
FGF and TGF-B.
A summary of the observed effects on cell growth of the hollow 
fibre conditioned media and their 1 kDa filtrates and retentâtes, 
together with the possible factors involved is given in Table 
8.4.1.2.
The previous discussion on the effect on cell growth of the HF- 
CM has focused on the possible involvement of known growth 
factors. It is possible that the observed effects on cell growth 
may be due to molecules which have not been identified as yet.
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LL-24
BHK
MG-63
Vero
LL-24
BHK
MG-63
Vero
BHK
MG-63
Vero
Significant differences in growth 
(cell numbers)
BHK HF-CM
HL-1 = HF-CM = FIL = RET = MED 
(FIL = MED) «  HL-1 «  (HF-CM = RET) 
HF-CM < (FIL = RET = MED) < HL-1 
(FIL = MED) < (HL-1 = HF-CM = RET)
Vero HF-CM
HF-CM «  (FIL = RET = MED) < HL-1 
(FIL = MED) «  HL-1 «  (HF-CM = RET) 
(HF-CM = FIL = RET = MED) < HL-1 
(HF-CM = FIL = RET = MED) < HL-1
MG-63 HF-CM
(FIL = MED) «  HL-1 < (HF-CM = RET) 
(HF-CM = FIL = RET = MED) < HL-1 
(HF-CM = RET) «  (HL-1 = FIL = MED)
Factors in the HF-CM 
which may be involved.
No effects 
TGF-B, FGF, IGF 
TGF-B, IL-1, IGFBP 
Albumin, transferrin
TGF-B
TGF-B, FGF, IGF 
Albumin, transferrin 
Albumin, transferrin
TGF-B, FGF, IGF 
Albumin, transferrin 
TGF-B
Table 8.4.1.2.: Comparative effects on LL-24, BHK, MG-63 and Vero cell growth 
(cell numbers) of the hollow fibre conditioned media (HF-CM), the HF-CM 1 kDa 
filtrates (FIL), the HF-CM 1 kDa retentâtes (RET), HL-1 (HL-1), and culture 
media with no additives (MED), and the factors which may be involved in these 
activities. (TGF-B: Transforming growth factor beta; FGF: Fibroblast growth 
factor; IGF: Insulin like growth factor; IL-1: Interleukin-1; IGFBP: Insulin 
growth factor binding protein).
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8.4.2. EFFECT OF VERO HF-CM ON THE MTT ASSAY OF BHK 
CELLS
The MTT assay was originally developed as a rapid alternative 
method to direct cell counting (Mosmann, 1983; Green et al,, 
1984). As described earlier (Section 4.1.5.), the assay is based 
on the cleavage of the soluble tétrazolium salt 3, (4,5 
dimethylthiazol-2-yl)-2 , 5 diphenyl tétrazolium bromide (MTT) into 
an insoluble coloured formazan by dehydrogenases present in the 
mitochondria of active cells (Slater, at al,, 1963) and the
direct correlation of the dehydrogenase activity with cell 
numbers. The dehydrogenase activity of a cell population, may be 
affected not only by cell numbers but also by changes in the 
metabolic activity of individual cells, thus leading to incorrect 
estimates of cell numbers.
Because of the inherent variability of the MTT assay, this 
chapter will deal first with the standardisation of the assay 
where two different cell lines were used, and secondly it will 
describe and discuss the effect of Vero cell HF-CM on BHK cells. 
The underlying problems concerning the use of the MTT assay 
procedure will be elucidated during the course of experiments 
described in this chapter.
a) Standardization of MTT test procedure:
The initial experiments were carried out with BHK and MG-63 
cell lines. In order to asses the reliability of MTT test, the 
relative amounts of formazan produced from MTT by the cells, as
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a function of their mitochondrial dehydrogenase activities, were 
correlated with viable cell counts carried out on replica 96 well 
plates. The two variable parameters in these experiments included 
cell concentration and incubation time before the colorimetric 
assessment of formazan produced following exposure of cells to 
MTT.
BHK cell studies: Data on the BHK cell counts (Figure 8.4. 2.1.) 
revealed that cells did not grow when they were seeded at 
concentrations of 10^  cells/well, presumably because they were 
below the minimum inoculation concentration necessary for cell 
growth. Seeding with 5-2 0 xlO^ cells/well resulted in linear 
increases in cell numbers. This is the region of exponential cell 
growth which normally occurs in batch cultures. When seeding with 
3 0 xlO^ and 4 0 xlO^ cells/well, the cell numbers increased 
linearly up to 72 hours incubation and after this period, a 
decrease in the growth rate occurred. This decrease was 
attributed to contact inhibition effects within the cell 
monolayer and/or the depletion of nutrients and accumulation of 
waste products in the media. Seeding with 50 xlO^ cells/well 
resulted in rapid increases in cell numbers up to 48 hours 
incubation. After this, in the time period between 48 and 72 
hours, the rate of increase in cell numbers declined and by 9 6 
hours cell numbers fell as a result of cell death.
The MTT assay depicted in Figure 8.4.2.2., showed that at 48 
hours the MTT conversion (assayed by measuring absorbance at 54 0 
nm) increased with higher cell numbers. Increases in cell numbers
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Figure 8.4.2.1.: Viable cell counts of BHK cell cultures seeded with 1,000 cells ( 9 ), 5,000 cells ( O ), 
10,000 cells ( X ), 20,000 cells ( 0 ), 30,000 cells ( A  ), 40,000 cells ( X ) and 50,000 cells ( O  ) per 
microwell, and incubated for 48, 72 and 96 hours. Cells were grown in 100 /il of RPMI-1640 +2.25% PCS per 
microwell. Plotted points represent the mean values from eight cell counts of four replica wells. The error 
bars represent the Standard Deviation from the mean (The absence of error bars in some of the points 
indicates that the SD was smaller than the symbol used in the representation of the mean; ie.: SD < 15x10^).
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Figure 8.4.2.2.: MTT absorbency of BHK cell cultures seeded with 1,000 cells ( v  ), 5,000 cells ( □ ), 
10,000 cells ( X  ), 20,000 cells ( 0 ), 30,000 cells ( A  ), 40,000 cells ( % ) and 50,000 cells ( O  ) per 
microwell, and incubated for 48, 72 and 96 hours. Cells were grown in 100 /il of RPMI-1640 +2.25% PCS per 
microwell. Plotted points represent the mean values of MTT assays on eight replica wells. The error bars 
represent the Standard Deviation from the mean (The absence of error bars in some of the points indicates 
that the SD was smaller than the symbol used in the representation of the mean; ie.: SD < 0.03).
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between 48 and 72 hours of incubation were paralleled with 
increases in MTT conversions for those microwells initially 
seeded with 10^  to 50 xlO^ cell/well. For these incubation times 
the MTT data showed a good correlation with cell numbers, with 
a linear correlation coefficient of 0.988 between cell numbers 
ranging from 40 xlO^ to 400 xlO^ cell/well and MTT formazan 
absorbance in the range of 0.3 to 1 (Figure 8.4.2.3.). Thus, the 
MTT assay can be used on BHK cells after 48 and 72 hours of 
incubation as an indirect estimate of cell numbers when cells are 
in the exponential growth phase. However, cell numbers did not 
correlate with MTT formazan absorbance at all times. Between 72 
and 96 hours in wells which were initially seeded with 5 xlO^ to 
30 xlO^ cells, the MTT conversion values declined whilst cell 
numbers increased. This was possibly a result of a decrease in 
the metabolic rate or in the cytoplasmic volume of cells due to 
contact inhibition phenomena and the lack of available space for 
cell growth. The drastic reductions in MTT conversion values 
observed at 96 hours in wells initially seeded with 4 0 xlO^ and 
50 xlO^ cells were paralleled with a decline in cell numbers and 
were attributed to cell death occurring within the microwells.
Previous reports have indicated linear relationships between 
100 cells and 50 xlO^ cells/well and MTT conversion values 
(Mosmann, 198 3). This has been shown to be greatly dependant on 
the cell line and the test conditions used (Carmichael et al., 
1987; Denizot and Lang, 1986; Vistica et al., 1991). Therefore
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Figure 8.4.2.3.: Line of best fit (Correlation Coefficient: 0.998) for MTT absorbance and viable cell 
nimbers after incubation of BHK cells for 48 (y) and 72 (o) hours.
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it is important that prior to its use the MTT assay must be 
standardised for each cell line and culture condition.
MG-63 cell studies: Similar experiments on MG-63 cells
indicated that seeding with 30 xlO^ to 50 xlO^ cells/well resulted 
in maximum cell numbers in the range of 6-7 xlO^ cells/well after 
48 hours incubation and after this cell numbers declined (Figure
8.4.2.4.). Inoculation of microwells at concentrations of 10^ to 
20 xlO^ cells/well resulted in an increase in cell numbers after 
48 hours and a further increase after 72 hours of incubation.
In general, growth curves for MG-63 cells showed a pattern 
similar to that described for BHK cells. MG-63 cells, however, 
grew more rapidly and to higher cell numbers. Cell numbers also 
declined earlier than those in BHK experiments, with a decrease 
in cell numbers after 72 hours in micro-wells initially seeded 
with 20 xlO^ cells and after 48 hours in micro-wells initially 
seeded with 3 0 xlO^ cells. The more rapid growth and higher cell 
concentrations achieved are not unexpected since the MG-63 is a 
transformed tumorigenic cell line.
The MTT assay carried out in parallel (Figure 8.4.2.5.) with 
the forementioned cell growth experiments showed significant 
differences in MTT conversion values when wells were seeded with 
10^  to 10 xlO^ cells. When wells were seeded with over 10 xlO- 
cells, there was no significant differences in the MTT conversion 
values. Only wells seeded with 5 xlO^ and 10 xlO^ cells showed 
significant increases in MTT conversion values between 48 and 7 2
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Figure 8.4.2.4.: Viable cell counts of MG 63 cell cultures seeded with 1,000 cells ( v  ), 5,000 cells 
( o ), 10,000 cells ( X ), 20,000 cells ( 0 ), 30,000 cells ( A  ), 40,000 cells ( % ) and 50,000 cells 
( O )  per microwell, and incubated for 48 , 72 and 96 hours. Cells were grown in 100 /il of RPMI-1640 +2.25% 
PCS per microwell. Plotted points represent the mean values from eight cell counts of four replica wells. 
The error bars represent the Standard Deviation from the mean (The absence of error bars in some of the 
points indicates that the SD was smaller than the symbol used in the representation of the mean; ie.: SD 
< 15x103).
A B S  ( 5 4 0 n m
9
8
7
6
5
4
3
2
0
36 48 60 72 84 96 1 0 8
G .
I n c u b a t i o n  t i m e  ( h o u r s )
Figure 8.4.2.5.: MTT absorbance of MG-63 cel I cultures seeded with 1,000 cells ( V  ), 5,000 cells ( O  ), 
10,000 cells ( X ), 20,000 cells (0 ), 30,000 cells ( A  ), 40,000 cells ( %  ) and 50,000 cells ( O  ) per 
microwell, and incubated for 48, 72 and 96 hours. Cells were grown in 100 /il of RPMI-1640 +2.25% PCS per 
microwell. Plotted points represent the mean values of MTT assays on eight replica wells. The error bars 
represent the Standard Deviation from the mean (The absence of error bars in some of the points indicates 
that the SD was smaller than the symbol used in the representation of the mean; ie.: SD < 0.03).
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hours. Seeding at higher cell concentrations or incubating for 
longer periods of time resulted in a decline in MTT conversion 
values. This may be correlated with the declining cell numbers, 
as observed in the MG-63 growth curves.
In summary, the MTT assay can be a reasonable measure of cell 
numbers during the exponential phase of cell growth. MTT 
conversion values, did not correlate with cell numbers when 
cultures approached high cell concentrations or cell death. The 
reasons for this may be related to a decrease in the cell sizes 
at high cell concentrations or changes in their metabolism and 
mitochondrial activity.
b) Effect of Vero HF-CM on the MTT assay of BHK cells;
The MTT assay and direct cell counts were carried out to assess 
the effect of Vero HF-CM and its 100 kDa ultrafiltration 
fractions on the growth and metabolism of BHK cells in culture.
The BHK growth curves followed trends similar to those 
described previously in Section 8.4.1. (Figure 8.4.1.10.). During 
the first 72 hours BHK cells incubated in 10% HL-1 grew faster 
than in other media conditions, however, after this period cell 
growth declined sharply. The Vero HF-CM or its 100 kDa retentate 
caused BHK cells to grow to the highest cell concentrations 
followed by a drastic decline in cell numbers at 168 hours. 
Exposure to the Vero HF-CM 100 kDa filtrate resulted in reduced 
BHK cell growth compared to BHK cells exposed to HL-1, HF-CM or
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Figure 8.4.2.6.: Viable cell counts of BHK cells grown in the presence of Vero hollow fibre conditioned 
medium (HF-CM) and its 100 kDa ultrafiltration fractions. Growth curves were carried out in RPMI-1640 + 
2.25% FCS with 10% of HL-1 ( X  ), HF-CM ( <> ), 100 kDa HF-CM Filtrate ( A  ), HF-CM 100 kDa Retentate ( X  ) 
or with no additives ( O  ).
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Figure 8.4.2.7.: MTT assay on BHK cells grown in the presence of Vero hollow fibre conditioned medium (HF- 
CM) and its 100 kDa ultrafiltration fractions (Sample errors did not exceed 5%). The MTT assays were carried 
out in RPMI-1640 + 2.25% FCS with 10% of HL-1 ( X  ), HF-CM ( 0 ), 100 kDa HF-CM Filtrate ( A  ), HF-CM 100 
kDa Retentate ( % ) or with no additives ( O ) .
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HF-CM 100 kDa retentate. Cells grown in Vero HF-CM filtrate grew 
to higher cell concentrations compared with those grown in the 
control media (RPMI-1640 + 2.25% FCS and no other additives). 
This could be attributed to the presence of low concentrations 
of Vero HF-CM high molecular weight proteins in the 100 kDa 
filtrate.
The MTT assay carried out in parallel to the BHK cell growth 
curve experiments showed differences in MTT conversion values 
between different samples after incubation for 72 hours (Figure 
8. 4. 2. 7.) . The MTT conversion values for different samples tested 
may be arranged in this order: 100 kDa HF-CM retentate > HF-CM 
> HL-1 > 100 kDa HF-CM filtrate > No Additives. These results 
indicate that the presence of HF-CM or its 100 kDa 
ultrafiltration fractions had some effect on the MTT conversion 
values of BHK cells in culture. These results may be a reflection 
of increases in cell numbers or may be due to changes in cell 
size and metabolic activity.
In order to determine the metabolic activity of the BHK cells 
grown in various Vero HF-CM fractions, the MTT conversion values 
per 10^  cells were calculated after 72 hours of incubation (shown 
in Figure 8.4.2.8.). For the same number of cells different MTT 
conversion values were observed for cells incubated in media 
containing 10% of HL-1 or 10% of the Vero HF-CM or its 100 kDa 
HF-CM filtrates and retentâtes. Cells present at higher 
concentrations and presumably growing at a faster rate (eg., in 
the presence of HL-1) showed the lowest MTT conversion values per
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Figure 8.4.2.8.: "MTT conversion" per 10® cells. Calculated from the results previously described in Figures 
8.4.2.6. and 8.4.2.7. at 72 hours of incubation. MED: Control with culture media only (RPMI-1640 + 2.25% 
FCS); HL-1: Culture media with 10% HL-1; HF-CM: Culture media with 10% HF-CM; FIL: Culture media with 10% 
100 kDa HF-CM filtrate; RET: Culture media with 10% 100 kDa HF-CM retentate. Error bars represent the 
standard deviation obtained from 64 (8 x 8) calculations. Different letters on different bars indicate 
significant differences according to student t-test (n=64) p<0.01.
-194-
Results and Discussion
cell. When cells numbers were lower, and cells were presumably 
growing at slower rates (eg., with no added factors) the MTT 
conversion value per cell increased. The inclusion of the HF-CM 
and its fractions resulted in intermediate MTT conversion values 
per cell, with slightly higher values for cells exposed to the 
Vero HF-CM 100 kDa filtrate than those exposed to the Vero HF-CM 
or its 100 kDa retentate.
The MTT conversion value per cell could be affected by changes 
in cell size, ie., a reduction of cytoplasmic volume and 
consequently the total number of mitochondria, or by a change in 
the metabolic activity of the cells.
Generally, higher growth rates are associated with an increase 
in cell metabolism (Miller et al., 1989). This does not appear 
to be the case in these experiments, as the presence of HL-1 and 
the HF-CM, which increased cell growth rate, did not increase the 
MTT conversion value per cell which is an indicator of the 
dehydrogenase activity per cell. Increased growth rates may cause 
a reduction in the average cytoplasmic volume as cells divide 
when they reach a certain size. As previously reported in this 
section and shown in Figure 8.4.2.3., the MTT assay on BHK cells 
was found to be linear in the range of 50 xlO^ to 500 xlO^ 
cells/well and at different growth rates. Thus, the differences 
observed in the MTT conversion values per cell, could not be 
accounted for by differences in growth and were attributed to 
changes in cell size or metabolic activity due to the added HL-1 
or Vero HF-CM and its 100 kDa cut-off ultrafiltration fractions.
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8.4.3. QUANTITATIVE CELL DETACHMENT ASSAYS
As discussed previously in Section 2.2.1., anchorage dependant 
animal cells in culture require hydrophillic surfaces for their 
attachment (reviewed by Handa-Corrigan et al. , 1992). Cell
attachment may be also be enhanced by presence of proteins on 
the culture surface. The previous use of a surface for cell 
culture (Culp, 1974) , or its treatment with cell culture 
conditioned medium (Stampfer et al., 1981) have been found to 
promote cell adhesion. More specifically, attachment is favoured 
by the addition of extracellular matrix proteins such as collagen 
(Elsdale and Bard 1972) or fibronectin (Gilchrest et al., 1980). 
Other proteins such as albumin are not specifically bound to the 
cells and have been found to reduce cell adhesion (Tamada and 
Ikada, 1993). In order to determine whether the previously 
observed differences in cell growth on the addition of hollow 
fibre conditioned media (HF-CM) were related to changes in the 
cellular adhesion properties, the strength of cell adhesion to 
cell culture treated polystyrene was measured.
For the purpose of these experiments a simplified detachment 
assay was used (Spier et al., 1987; Brydges 1993). The assay 
measured the strength of cell adhesion of cells grown on standard 
polystyrene tissue culture dishes and allowed for their 
cultivation in media including various samples to be tested.
a) Standardization of the assay: To determine the flow rates 
to be used in the cell detachment assay, MG-63 cells growing on
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tissue culture polystyrene dishes, incubated for 48 hours, were 
subjected for 5 seconds to a range of different flow rates (See 
Figure 8.4.3.1.). At flow rates above 400 ml/minute there is a 
clear linear relationship between the input flow rate and the 
radius of the cell detachment zone. At flow rates below 400 
ml/minute, this relationship does not hold. This can be 
attributed to undefined fluid flow patterns occurring at the 
outlet of the cell detachment device and is in accordance with 
previous reports (Spier et al., 1987). For the purpose of further 
experiments a flow rate of 800 ml/minute, which falls within the 
defined linear region, was used.
C l e a r  z o n e  d i a m m e t e r  ( m m )
4 0 0  6 0 0  8 0 0  1 0 0 0
F l o w  r a t e  ( m l / m i n )
1 2 0 0 1 4 0 0
Figure 8.4.3.1: Standardization of flow rates for the cell detachment assay,
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b) Assay of hollow fibre conditioned media: The surface shear 
stress force required for the detachment of LL-24 (Figure 
8.4.3.2), BHK-21 (Figure 8.4.3.3.), MG-63 osteosarcoma (Figure
8.4.3.4.) and Vero cells (Figure 8.4.3.5.) grown in 10% of 
various HF-CM were compared to controls containing only cell 
culture media (RPMI-1640 + 2.25% FCS). Amongst the tested cell 
lines, the finite LL-24 epithelial cells required the maximum 
force for their detachment (8.5 N/m^ for cells grown in culture 
media). The transformed MG-63 cell line was found to require the 
minimum force for their detachment (5.7 N/m^ for cells grown in 
culture media). These results are in accordance with the general 
observation that transformed cells are less dependant on a
surface for growth (Tucker et al., 1981). The BHK-21 and Vero
cell lines generally required similar forces for their detachment 
(7.0 - 7.3 New/m^ for cells grown in culture media). This is not 
unexpected as these cells are transformed. No significant
differences in the strength of cell adhesion were noticed upon
the addition of any of the HF-CM (from BHK-21, MG-63 and Vero) 
to MG-63 or Vero cells.
In comparison with cells grown only in culture media, the 
strength of adhesion of LL-24 and BHK cells was found to be 
significantly reduced upon the addition of various HF-CM. Similar 
decrease in the strength of BHK and LL-24 cell adhesion was found 
regardless of the tested HF-CM. This indicated that the observed 
effects were not specific for any of the tested HF-CM.
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Figure 8.4.3.2.: LL-24 detachment assay. The assay was carried out in RPMI-1640 + 2.25% FCS with: 10% BHK 
HF-CM (BHK); 10% MG-63 HF-CM (MG-63); 10% Vero HF-CM (VERO); No additives (MED). Different letters on 
different bars indicate significant differences (p<0.05) according to LSD (Least Significant Difference) 
test.
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Figure 8.4.3.3.: BHK-21 detachment assay. The assay was carried out in RPMI-1640 + 2.25% FCS with: 10% BHK 
HF-CM (BHK); 10% MG-63 HF-CM (MG-63); 10% Vero HF-CM (VERO); No additives (MED). Different letters on 
different bars indicate significant differences (p<0.05) according to LSD (Least Significant Difference) 
test.
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Figure 8.4.3.4.: MG-63 detachment assay. The assay was carried out in RPMI-1640 + 2.25% FCS with: 10% BHK 
HF-CM (BHK); 10% MG-63 HF-CM (MG-63); 10% Vero HF-CM (VERO); No additives (MED). Different letters on 
different bars indicate significant differences (p<0.05) according to LSD (Least Significant Difference) 
test.
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Figure 8.4.3.5: Vero detachment assay. The assay was carried out in RPMI-1640 + 2.25% FCS with: 10% BHK HF- 
CM (BHK); 10% MG-63 HF-CM (MG-63); 10% Vero HF-CM (VERO); No additives (MED). Different letters on different 
bars indicate significant differences (p<0.05) according to LSD (Least Significant Difference) test.
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c) Effect of HF-CM 1 kDa and 100 kDa ultrafiltration filtrates 
and retentâtes: Since the strength of cell adhesion of BHK cells, 
compared to other cell lines, was found to be the most affected 
by the presence of various HF-CM, BHK cells were chosen to 
further characterize the effect of various HF-CM on the strength 
of cell adhesion.
The BHK cell adhesion assays including HL-1 and various HF-CM 
IkDa filtrates and retentâtes from BHK (Figure 8.4.3.6), MG-63 
osteosarcoma (Figure 8.4.3.7), or Vero cells (Figure 8.4.3.8) 
showed similar trends. BHK cells grown in the presence of HL-1, 
the HF-CM, or the 1 kDa HF-CM retentâtes, showed a marked 
decrease in the strength of cell adhesion in comparison to BHK 
cells grown in culture media (RPMI-1640 + 2.25% FCS) with no 
other additives. Culture of BHK cells in the presence of 1 kDa 
HF-CM filtrates from all the tested cell lines resulted in a 
similar strength of cell adhesion as that found for BHK cells 
grown in cell culture media (RPMI-1640 + 2.25% FCS) alone. These 
results indicate that there may be some factors present in the 
HF-CM which cause a reduction in the strength of cell adhesion 
and that these factors were retained by the 1 kDa membrane.
In summary, when BHK cells are cultivated in the presence of 
serum (ie. 2.25% FCS), the addition of HL-1, HF-CM or the HF-CM 
retentâtes resulted in a similar reduction in the strength of 
cell adhesion. This reduction in the strength of cell adhesion 
could be owing to soluble factors present in these samples.
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Figure 8.4.3.6.: BHK detachment assay in the presence of BHK HF-CM. Assays were carried out in RPMI-1640 
+ 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 10% 1 kDa HF-CM filtrate (IkDa FIL); 10% 1 kDa HF-CM 
retentate (IkDa RET); No additives (MED). Different letters on different bars indicate significant 
differences (p<0.05) according to LSD (Least Significant Difference) test.
LSD 95%: 0.46
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Figure 8.4.3.?.: BHK detachment assay in the presence of MG-63 HF-CM. Assays were carried out in RPMI-1640 
+ 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 10% 1 kDa HF-CM filtrate (IkDa FIL); 10% 1 kDa HF-CM 
retentate (IkDa RET); No additives (MED). Different letters on different bars indicate significant 
differences (p<0.05) according to LSD (Least Significant Difference) test.
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Figure 8.4.3.8.: BHK detachment assay in the presence of Vero HF-CM. Assays were carried out in RPMI-1640 
+ 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 10% 1 kDa HF-CM filtrate (IkDa FIL); 10% 1 kDa HF-CM 
retentate (IkDa RET); No additives (MED). Different letters on different bars indicate significant 
differences (p<0.05) according to LSD (Least Significant Difference) test.
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Figure 8.4.3.9.: BHK detachment assay in the presence of Vero HF-CM. Assays were carried out in RPMI-1640 
+ 2.25% FCS with: 10% HL-1 (HL-1); 10% HF-CM (HF-CM); 10% 100 kDa HF-CM filtrate (lOOkDa F); 10% 100 kDa 
HF-CM retentate (lOOkDa R); No additives (MED). Different letters on different bars indicate significant 
differences (p<0.05) according to LSD (Least Significant Difference) test.
-203-
Results and Discussion
As described previously in Section 7.10., the various hollow 
fibre conditioned media (HF-CM) were generated in hollow fibre 
bioreactors supplemented through the extracapillary side with HL- 
1 media. It is likely that the factors in the HF-CM and the HF-CM 
1 kDa retentâtes, responsible for the forementioned reduction in 
the strength of cell adhesion could have been derived from HL-1 
itself. These observations therefore suggest that the conditioned 
media from high cell concentration hollow fibre bioreactors did 
not contain factors which, under the test conditions, affected 
the strength of cell adhesion of BHK cells. It is clear, however, 
that there were some factors present in HL-1 that significantly 
affected the strength of BHK cell adhesion. Similar results on 
BHK cell detachment to those described for the 1 kDa filtrates 
and retentâtes were obtained from the 100 kDa Vero HF-CM 
filtrates and retentâtes (Figure 8.4.3.9.). The smaller 
differences observed among these samples could be attributed to 
the use of a different batch of serum in making up the culture 
media. These results indicate that the factors in the HF-CM, and 
presumably in HL-1, causing the observed reductions in the 
strength of cell adhesion were retained by the 100 kDa cut-off 
membrane and were thus larger than 65.7 kDa.
As described earlier in Section 8.4.1., the growth promoting 
effects of the Vero HF-CM's were retained by the 1 and 100 kDa 
ultrafiltration membranes. In Figure 8.4.3.10., the growth rates 
and the maximum cell densities achieved by BHK cells in batch 
cultures are plotted against the observed strengths of cell
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Figure 8.4.3.10.: Surface shear stress against the growth rates 
(-■-) and maximum cell densities (-^-) achieved by BHK cells 
grown in RPMI-1640 + 2.25% FCS in the presence of: 10% HL-1 
(HL-1), Vero HF-CM (HF-CM), Vero HF-CM IkDa filtrate (FIL), 
Vero HF-CM retentate (RET), and without additives (MED).
adhesion. Generally increased strength of cell adhesion 
correlated with a decrease in the maximum cell concentrations and 
growth rates achieved. Compared to cells grown in HF-CM, HF-CM 
1 kDa retentate and HL-1, cells grown in cell culture media or 
in the presence of the HF-CM filtrate showed a high strength of 
cell adhesion (in the order of 6.55 - 7.10 N/m^) and extremely 
low growth rates (<0.1 hr'^ ) and maximum cell densities (<10"^  
cells/cm^) . However, cells in the latter conditions remained
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attached and viable for over 190 hours. The addition of HL-1, HF- 
CM or the HF-CM 1 kDa Retentate was necessary to promote BHK cell 
growth, and the observed increase in cell growth was paralleled 
by a reduction in the strength of cell adhesion.
From these results it can be concluded that:
a) There are factors present in HL-1 and the Vero HF-CM which 
caused a reduction (between 2 0% and 35%) in the strength of 
BHK cell adhesion.
b) That HL-1 has a growth promoting activity on BHK cells and 
that conditioning of the HL-1 by Vero cells in hollow fibre 
cultures caused greater stimulation of BHK cell growth than 
that by HL-1 alone (approximately by 45%).
From the experiments on BHK cells growing in culture media, 
or in presence of HL-1 or the Vero HF-CM and its ultrafiltration 
fractions it can be concluded that increased growth resulted in 
a reduction in the strength of cell adhesion, or vive-versa.
This observation may be explained in a number of ways:
i) That there are non-specific surface-active molecules in 
HL-1, and the Vero HF-CM, which adsorb onto the culture 
surface and compete with specific cell adhesion molecules 
such as fibronectin. Proteins compete for adsorption onto 
surfaces such that, abundant low molecular weight proteins 
initially adsorbed to a surface, are gradually replaced in 
time by less abundant high molecular weight proteins (Handa-
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Corrigan, personal communication). Non-specific protein 
adsorption, such as that of albumin and IgG, have been 
previously reported to reduce cell attachment (Tamada and 
Ikada, 1993; Brydges, 1993).
HL-1 contains approximately 3 0 jug/ml of protein and SDS- 
PAGE analysis of HL-1 revealed only two distinct bands. The 
most intensely stained band with a calculated molecular 
weight of 68.5 kDa (see Section 8.3.4.) is likely to be 
albumin (with a molecular weight of 67 kDa). Albumin has 
previously been reported to inhibit cell adhesion and 
stimulate cell proliferation (Brydges, 1993), and may be 
responsible for the reduction in the strength of cell 
adhesion and the stimulation of growth of cells grown in HL-1 
and the Vero HF-CM.
ii) The general decrease in cell adhesion observed in the 
case of cells showing increased growth may be explained by 
the presence of growth promoting factors in HL-1 and Vero HF- 
CM. Upon cell division, cells become spherical and their 
strength of adhesion is greatly reduced. Once division is 
completed cells spread again forming new cell-substrate bonds 
and their strength of cell adhesion has been found to 
increase with time (Grinnell, 1972). Growth rate is inversely 
related to the generation time, and cells with low growth 
rates ie., long generation times, have longer intervals for 
the establishment of cell-substrate interactions and would 
be expected to attach more strongly. Thus the presence of
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growth promoting factors would result in a decrease in the 
strength of cell adhesion.
Whether cells grow better as a result of their reduced 
attachment or whether their strength of cell adhesion is reduced 
due to an increase in growth can not be elucidated from these 
experiments. In any case, cell growth and attachment appear to 
be intimately related and the molecular mechanisms of this 
relationship are yet to be solved.
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8.5. FRACTIONATION OF HOLLOW FIBRE CONDITIONED MEDIA
As described earlier in Section 3.2., fractionation of complex 
protein mixtures may be carried out in a number of ways. Proteins 
may be separated according to their different solubilities by 
precipitation with salts or organic solvents. Fractionation of 
protein mixtures may also be carried out on the basis of their 
different affinities for a matrix, as in ion exchange, 
hydrophobic, hydroxyapatite or affinity chromatography. Gel 
filtration technique separates proteins on the basis of their 
size and is amenable to scale up. It does not involve the 
precipitation of proteins or their binding to the separation 
matrix both of which may result in loss of activity. Elution of 
the fractions during gel filtration does not involve changes in 
the environmental conditions which may affect protein activity 
and it may be carried out in almost any buffer.
Gel filtration has been extensively used in the separation of 
growth factor activities (Miyazaki et al., 1990; Matsuda et al., 
1989; Koga, 1988; Ronning, 1990) and was employed in this 
investigation for the fractionation of the hollow fibre 
conditioned media. Details of the column set up and operation 
procedures have been previously described in Section 7.18.. 
Briefly, a 300 ml column (60cm x 2.5cm) was packed with 
Sephacry 1-100 (Pharmacia) and run at a flow rate of 1 ml/minute.
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a) Calibration of the gel filtration column: Standard molecular 
weight markers were individually loaded on the column and 
processed similarly to the samples. Their elution times were 
recorded and plotted (see Figure 8.5.1.). Linear regression 
analysis resulted in a correlation coefficient value of 0.924 and 
thus, an acceptable linear relationship between molecular weight 
and elution time.
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Figure 8.5.1.: Elution times of albumin, carbonic
anhydrase and cytochrome-c from the 300 ml Sephacryl-100 
gel filtration column run at a flow rate of 1 ml/minute.
b) Separation of hollow fibre conditioned media: Vero HF-CM was 
loaded onto the column and 5 ml fractions were collected. 
Absorbance at 280 nm was recorded to obtain a protein elution 
profile in time (see Plate V). The absorbance profile showed a 
sharp breakthrough peak at 122 minutes followed by a broad peak
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between 130 and 145 minutes. After 280 minutes, two major peaks 
each consisting of two fused peaks were eluted. After 350 
minutes, a decline in absorbance indicated that complete elution 
of sample proteins had occurred. As shown Plate V, the respective 
column fractions were pooled and protein concentrations 
determined, the results are given in Table 8.5.1. Pooled 
fractions contained protein concentrations between 1.5% and 4% 
of the original HF-CM.
FPLC Pooled 
fractions
Protein concentration 
(/ig/ml)
A 38.66
B 40.42
C 15.26
0 0.30
D 16.80
P 0.42
E 2.18
HF-CM 950
Table 8.5.1.: FPLC pooled fractions and their total
protein concentrations.
c) Effect of pooled gel filtration fractions of Vero HF-CM on 
BHK cells: BHK cells were cultivated in 10% of the Vero HF-CM, 
its 100 kDa filtrates and retentâtes, and the pooled gel 
filtration fractions (A-E) (Figure 8.5.2.). Cells grown in the 
presence of the Vero HF-CM, or its 100 kDa retentâtes, achieved 
the highest cell concentrations. Cells grown in the presence of 
HL-1 showed high initial growth rates but the maximum cell 
numbers achieved were lower (approximately by 30%) than those 
reached by cells grown in the HF-CM or its 100 kDa retentate.
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Figure 8.5.2.: BHK cells grown for 24, 72, 120 or 168 hours in cell culture media (RPMI-1640 + 2.5% PCS) with 
no other additives (MED) or in 10% of the following samples: Vero hollow fibre conditioned media (HF-CM); 
Vero HF-CM 100 kDa filtrate (FIL); Vero HF-CM 100 kDa retentate (RET); HL-1 media (HL-1); Vero HF-CM FPLC 
fractions A (A), B (B), C (0), D (D) and E (E).
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BHK cells grown in the presence of only cell culture media 
(RPMI-1640 + 2.25% PCS) achieved low maximum cell concentrations, 
similar to those obtained when grown in the presence of the gel 
filtration fractions C, D and E. Compared to these, higher cell 
concentrations were achieved when cells were grown in the gel 
filtration fraction pools A and B.
Thus, it appears that the growth promoting activity of the HF- 
CM was retained by 100 kDa cut-off membrane and was eluted, 
presumably in a dilute form, in the gel filtration fraction pools 
A and B.
Pooled fractions A and B, eluted at 122 and 140 minutes 
respectively, were the first two to be eluted from the gel 
filtration column. Pool A, being the first one to emerge was 
likely to contain molecules which had been completely excluded 
from the gel filtration matrix. Based on the calibration curve 
(Figure 8.5.1.), the molecular weight for pool B ranged between 
75 and 95 kDa. Thus it appears that the macromolecules which had 
an effect on cell growth were larger than 75 kDa. Pooled 
fractions with calculated molecular weights below 75 kDa did not 
have significant effects on BHK cell growth.
These results are in accordance with those obtained from growth 
experiments with the 100 kDa cut-off membrane filtration samples. 
In these, the retained proteins with molecular weights above 65 
kDa (see Section 8.3.4.) were found to be responsible for the 
observed increases in cell growth and a reduced strength of cell 
adhesion.
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In summary, gel filtration and membrane ultrafiltration 
separation experiments indicated that the components in the Vero 
HF-CM responsible for the promotion of growth were above 75 kDa 
and 65 kDa respectively in molecular weight.
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9.0. CONCLUSIONS
The objective of this work was to adapt a number of cell lines 
to serum-free conditions and grow them at high cell 
concentrations in order to characterise the growth promoting and 
inhibiting factors they may be producing in these conditions.
Five cell lines, BHK, Vero, MG-63, AFP-27 and CHO, were 
successfully adapted to grow in serum-free conditions in HL-1 
medium. During the adaptation process two sub-populations were 
obtained from the BHK, Vero and MG-63 cells, one growing in 
suspension and the other remaining anchorage-dependent. The 
former was used in further investigations. Rapidly dividing cell 
lines (short doubling times) took lesser time for their adaption 
to serum free conditions than the slower dividing cells. Adaption 
of cells to serum-free conditions slowed their growth by 38% to 
55%, as calculated from their doubling time values.
The Acusyst-Jr (Endotronics, USA) hollow fibre system was 
successful for growing different cells for extended periods of 
time, ranging between 650 to 900 hours, and achieving cell 
concentrations between 1.1 xlO^ to 1.5 xlO^ cells/ml. These cell 
concentrations were higher by three orders of magnitude when 
compared with the cell concentrations achieved in low density 
culture systems. The optimisation strategy followed in the hollow 
fibre cultures was aimed to maintain glucose above 150 mg/dl; 
glutamine above 2.5 mM; lactate below 150 mg/dl; and ammonia 
bellow 2.5 mM; by sampling three times a week and making the
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necessary corrections in the rates of nutrient delivery and waste 
removal. These metabolic levels were not maintained at sometimes 
due to the lack of previous experience in growing these cell 
lines, the inability to forecast the requirements of different 
cells in time and equipment failures.
The hollow fibre cultivations achieved a conditioned medium 
cell enrichment factor (L of HF-CM / L of RPMI-1640 perfused) of 
36 to 44 fold.
For the removal of low molecular weight waste products from the 
HF-CM, the use of a simple stirred cell filtration system fitted 
with a 1 kDa molecular weight cut-off membrane was found to be 
more suitable than the more complex Ultrassete cross-flow device. 
Despite the use of low protein adsorption polyethersulphone 
membranes (Filtron, USA) ultrafiltration resulted in the loss of 
46% of the total protein from the processed HF-CM. This could be 
due to membrane fouling occurring during the ultrafiltration 
process.
The HF-CM from BHK, Vero and MG-63 cells were tested for their 
effect on the growth of BHK, Vero, MG-63 and LL-24 cell lines.
The findings on growth promoting activities observed in the 
present work can be summarized as follows:
1) All HF-CM showed a cell growth promoting effect on BHK
cells but not on any of the other cell lines tested.
The growth promoting factors were retained by 1 kDa cut-off 
filter membranes and therefore could not be related to the 
presence of nutrients such as glucose and glutamine.
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2) The BHK cell growth promoting activities of the HF-CM
from the BHK, Vero and MG-63 cells could be related to the 
putative presence of FGF, IGF or TGF-B type growth factors 
in these samples.
3) The fact that only BHK cells showed a growth promoting
response could be ascribed to the initial poor growth of 
these cells in the test conditions.
A number of growth inhibiting activities were also found in the
BHK, Vero and MG-63 HF-CM and these can be summarized as follows.
1) The BHK HF-CM, Vero HF-CM, and MG-63 HF-CM showed cell
growth inhibiting effects on Vero, MG-63 and LL-24 cells in 
this order.
2) The growth inhibitory effects observed in the HF-CM were
specific with regards to the cell lines which responded to 
these inhibitory effects, indicating that the factors 
involved in each case were of a different nature. The cell 
growth inhibiting activity in the above mentioned HF-CM 
could be attributed, amongst other un-identified factors, 
to the putative presence of TGF-B and IL-1 type growth 
inhibiting factors.
3) None of these cells appear to produce any autocrine 
cell-growth inhibiting factors as none of the HF-CM from a 
cell line had any effect on the same cell line.
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4) The growth inhibitory activity in the MG-63 HF-CM was 
retained by the 1 kDa cut-off filter membrane, whereas the 
growth inhibitory activity in the BHK and Vero cell HF-CM 
were lost during the filtration process. This loss of 
activity could be due a) to non-specific adsorption of the 
active molecules to filter membranes, b) to their 
susceptibility to degradation by proteolytic enzymes in the 
HF-CM and c) to the separation by the filter membrane of 
factors acting in a synergistic fashion.
5) The fact that none of the HF-CM showed a growth 
inhibitory effect on BHK cells could be due to their poor 
growth in the test conditions.
The MTT assay for BHK and MG-63 cell lines indicated that 
formazan production declined drastically as cells reached their 
maximum concentrations. Despite this, for BHK cells, MTT formazan 
production was linearly related with cell numbers in the range 
of 4 X 10"* to 4 X 10^ cells per microwell. Similar experiments 
using MG-63 cells showed that under the test conditions, the MTT 
assay can not be used to determine MG-63 cell numbers.
The MTT assay carried out after 72 hours on BHK cells exposed 
to Vero HF-CM and its 100 kDa cut-off filtrates and retentâtes 
demonstrated that the MTT conversion value per cell was lower for 
cells at lower cell concentrations and presumably growing at a 
slower rate.
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The strength of cell adhesion was measured with a cell- 
detachment device (CDD) which proved to be simple, reliable, 
rapid, and flexible in its use. Cells grown in 2.25% FCS, 
required 8.5, 7.4, 7.0 and 5.7 New/m^ detachment force in the
case of LL-24, BHK, Vero and MG-63 cells respectively.
The BHK, Vero and MG-63 HF-CM had no effects on the strength 
of cell adhesion of MG-63 or Vero cells, but caused a 20 to 35% 
reduction in the strength of cell adhesion of LL-24 and BHK 
cells. In BHK cells this reduction was the same as that caused 
by HL-1 and thus could not be attributed to cell secreted factors 
present in the HF-CM. For BHK cells, the strength of cell 
adhesion was found to be inversely related to cell growth.
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10.0. CRITICAL APPRAISAL OF THE APPROACH USED IN THE 
PRESENT WORK
The findings from this investigation, however, evoke a number 
of questions which have not been answered satisfactorily because 
of the inherent design of the project.
a) As the HF-CM were generated in HL-1 media, whose
composition is not known to us, the effects of the cell 
derived products could not be unequivocally separated from 
those of HL-1.
b) The heterogeneous nature of the hollow fibre system
cannot ensure wether the factors contained in the HF-CM 
were of secretory origin or intracellular materials 
resulting from cell lysis.
c) The 6  kDa molecular weight cut-off fibres within the 
hollow fibre cartridge do not exclude the possibility that 
polypeptides smaller than this may be involved in the 
negative autocrine growth control mechanisms originally 
proposed in this thesis.
d) With regards to the growth promoting and/or growth
inhibiting factors, all cell lines used were "transformed" 
cells. Whether these cell lines regulate their growth by 
producing autocrine growth regulatory molecules or by 
intracellular changes in the growth regulatory mechanisms 
cannot be explained by the experimental approach used in 
this investigation.
- 2 2 1 -
------------------------------------------------  Critical Appraisal
e) The choice of cell lines used in this work was not based
on their involvement in human diseases but from the point 
of view of cell technology. An alternative approach could 
have been adopted by choosing the cell lines associated 
with a clinical disorder in which growth factors are 
suspected to be involved. Similarly the choice of cell 
lines used to test the HF-CM medium, could have been 
rationalised in the sense that they were potential targets 
for the growth factors produced and which may play a role 
in the development of the pathogenesis of the disease 
involved.
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11.0. FURTHER WORK
Regarding the adaptation of cell lines to serum-free media, 
further work should aim to characterise the adapted cell lines 
with respect to chromosomal and isoenzyme analyses and DNA 
fingerprinting, as this may result in the establishment of new 
sub-clones of these cell lines. It would be interesting to 
compare, by means of immunofluorescence, the pattern of integrin 
and ECM proteins expression in the anchorage-dependent and 
suspension sub-clones. Differences in these subclones may help 
to elucidate the mechanisms by which some cells have a strict 
requirement for a surface to grow and how this may be 
manipulated.
To avoid reversion of serum-free adapted cells to serum 
requirement, while stored over liquid nitrogen, alternative 
freezing mixtures, devoid of serum, currently being developed in 
our laboratory should be tried. These include albumin and 
surfactants such as Pluronic F- 6 8  and polyvinylpirrolidone in 
their formulation.
Further work regarding the growth promoting and inhibiting 
activities observed should aim firstly to reproduce these 
activities from low concentration cell conditioned media obtained 
from static flasks or stirred cultures in a defined medium of 
known composition. Co-culture systems, in which cells are 
separated by porous membranes may also be used to confirm the 
effects of the Vero, BHK and MG-63 cell lines on each other and
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on other cells.
If the growth controlling activities described in this work are 
not found in low cell concentration conditioned media it may be 
due to the low cell concentrations. In that case a hollow fibre 
system should be used to produce high cell concentration 
conditioned media used. Hollow fibre systems such as the 
Centronics (New Brunswick) are simpler in construction and less 
costly than the Acusyst-Jr and are recommended.
Several factors, including FGF, IGF, IL-1 and TGF-B, have been 
proposed as the potential mediators of the growth promoting and 
inhibiting activities found in BHK, MG-63 and Vero HF-CM. Their 
presence in HF-CM may be tested by means of ELISA or Western 
blotting procedures using commercially available antibodies which 
specifically bind to these growth factors (R&D Systems, UK). If 
these factors are found to be present in the HF-CM, 
neutralization of the growth promoting/inhibiting activity of the 
HF-CM, by means of specific antibodies to individual growth 
factors, would indicate wether or not these factors were actually 
responsible for the activities observed in the HF-CM. 
Neutralization of receptors which are considered to be involved 
may not be highly suitable as different growth factors exert 
their effects via the same cell surface receptor.
If the activities observed in the HF-CM could not be related 
to any previously known growth factors, future work should aim 
to further fractionate the HF-CM using alternative procedures 
which do not cause loss of the active components. As previously
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discussed, the growth inhibiting activities of the BHK and Vero 
HF-CM on MG-63 and LL-24 cells respectively were lost during the 
ultrafiltration process. Future work in pursuing these factors 
should aim to preserving activities by minimizing their 
proteolytic digestion.
Preparative gel filtration can be used to fractionate HF-CM. 
In this work the growth promoting activity of Vero cell line was 
found to elute in the breakthrough peak of a Sephacryl-100 
(Pharmacia) gel filtration column. Future work following this 
activity should involve the use of larger pore size gel 
filtration matrices such as Sephacryl-3 00.
PAGE analysis in native and denaturating conditions, of the 
chromatographic gel filtration fractions with the activity of 
interest, should be carried out at preparative scale to obtain 
material sufficient for partial sequencing of the protein(s) 
involved. With the knowledge of a 20 to 50 amino acid sequence 
of these proteins, synthetic oligonucleotide probes can be 
synthesised and used to screen cDNA libraries of the cells 
involved in order to clone these genes. The proteins can then be 
produced in recombinant systems for further studies and for the 
production of specific antibodies.
Growth factors such as a-IFN, EPO, G-CSF, GM-CSF and IL-2 are 
currently being used in the treatment of disease and other growth 
factors such as EGF, PDGF, FGF and IGF-1 are undergoing clinical 
trials (reviewed by Shamel and Keough, 1994). Therefore, the 
discovery of novel growth factors may lead to their future use
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as therapeutics. Purified growth factors are being incorporated 
in defined media formulations (reviewed by Schneider, 1994) and 
novel growth factors also have a potential in this field.
By using the appropriate cell lines, the test system 
established in this work could be used to study paracrine 
effects of growth regulating factors produced by different cell 
types involved in the pathogenesis of breast, bone and other 
cancers.
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Growth Factor Source Affected cells References
ENDOTHELIAL CELL 
GROWTH SUPPLEMENT
Bovine pituitary and 
neural tissue
Vascular endothelial, 
hybridoma cells, 
kératinocytes, Balb/c 
3T3, hamster embryo
Maciag et al.. 1979; 
Pintus et al.. 1983. 
Gilchrest. et al.. 
1984; Olander et 
al.. 1980.
EPIDERMAL GROWTH 
FACTOR
Mouse submaxi 11ary 
gland*, hiwian kidney.
Premature eyelid opening 
and incisor eruption in 
neonatal rats*, 
fibroblasts, glia 
mammary, epithelial,
HeLa granulosa, 
chondrocytes, ovary, 
myeloma, prostate, and 
many others.
Cohen, 1962* 1964; 
Tavlor et al.. 1972: 
Savage and Cohen, 
1972; Carpenter and 
Whahl, 1990".
FIBROBLAST GROWTH 
FACTOR (ACIDIC)
Brain and pituitary 
extracts*
Mitogenic for 
fibroblasts,
endothelial, epithelial, 
bone, etc.
Thomas et al.. 1980 ; 
Gambarini and 
Gimenez-Gailego et 
al., 1986.
FIBROBLAST GROWTH 
FACTOR (BASIC)
Brain and pituitary 
extracts*
Mitogenic for 
fibroblasts,
endothelial, epithelial, 
bone, etc.
Gospodarowicz, 1974*, 
1975: Bohlen et al.. 
1984; Baird and 
Bohlen, 1990".
GRANULOCYTE COLONY 
STIMULATING FACTOR 
(G-CSF)
Macrophages, monocytes, 
fibroblasts, 
endothelial cells, bone 
stroma cells, many 
carcinoma cell lines.
Stimulates colony 
formation from bone 
marrow cells. Regulates 
proliferation and 
differentiation of cells 
of the neutrophilic 
granulocyte lineage
Metcalf, 1985;
Sachs, 1987; Nagata, 
1990".
GRANULOCYTE MACROPHAGE 
COLONY STIMULATING 
FACTOR (GM-CSF)
Conditioned medium from 
mouse L-cells and mouse 
lung cells.
Stimulates cells in the 
granulocyte, macrophage, 
and eosinophil lineages
Burgess, 1990".
INSULIN LIKE GROWTH 
FACTORS (Type I and 
II)
Human plasma* Chick embryo 
fibroblasts, Balb/c 3T3 
cells, cartilage cells.
Froesch et al.. 
1967*; Dughaday et 
ai., 1972; 
Rinderknecht and 
Humbel 1976; Rubin 
et al.. 1987;
Rechler and Nissley, 
1990".
INTERLEUKIN-1 
(alpha and beta)
Mainly monocytes, and 
also kératinocytes, 
endothelial cells, 
fibroblasts and T and B 
lymphocytes
Proliferation of T and B 
cells; stimulates 
production of tissue 
degrading enzymes in 
fibroblasts; other 
effects on hepatocytes, 
endothelial cells and 
macrophages
Schmidt and Tocci, 
1990"; Dinarello, 
1984".
INTERLEUKIN-2 T cells Growth stimulatory for T 
and B cell; also affects 
macrophage and NK cells
Moraan et al.. 1976; 
Hatakeyama and 
Taniguchi, 1990".
(Continues on the next page) -271-
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INTERLEUKIN-3 T cells* Proliferation and 
differentiation of 
various haematopoietic 
progenitor cells.
Ihle et al.. 1981* 
Ihle, 1990".
INTERLEUKIN-4 T cells* T cells and B cells *, 
macrophages, mast cells, 
fibroblasts.
Howard et al.. 1982* 
Yokota et al.. 1990".
INTERLEUKIN-5 T cells* Thymocytes, B cells*, 
eosinophiIs
Honjo and Takatsu, ■ 
1990".
INTERLEUKIN-6 T cells, monocytes, 
fibroblasts
B cells, T cells, 
hybridomas, neural 
cells, haematopoietic 
stem cells
Hirano and 
Kishimoto, 1990"
MACROPHAGE COLONY 
STIMULATING FACTOR
Serum, urine, liver, 
placenta, bone marrow 
stromal cells.
Macrophages, monocytes Stanlev et al.. 
1976; Sherr and 
Stanley, 1990".
NERVE GROWTH FACTOR Mouse submaxi Ilary 
gland, prostate and 
snake venoms
Nerve cells Bueker, 1948; Levi- 
Montalcini and 
Hamburger, 1951, 
1953: Varon et al.. 
1967; Bocchini and 
Angeletti, 1969.
PLATELET DERIVED 
GROWTH FACTOR
Platelets*, endothelial 
cells, activated 
macrophages, smooth 
muscle cells, activated 
macrophages and many 
transformed cells.
Mitogenic for 
fibroblasts, smooth 
muscle cells and glial 
cel Is
Kohler and Lipton, 
1974*: Ross et al.. 
1974"; Rutherford and 
Ross, 1976; Busch et 
al., 1976: Raines et 
al., 1990*.
STEM CELL FACTOR Fibroblasts, nerve, 
liver, Sertoli and 
endothelial cells, and 
macrophages and 
oocytes.
Mast cells, neurons Godin et al.. 1991; 
Manovova et al.. 
1993; Temeles et 
al., 1993; 1991;
Hi rata et al.. 1993.
TRANSFORMING GROWTH 
FACTOR ALPHA
Human melanoma ^ 
conditioned media and 
other transformed and 
non transformed cell 
lines, kératinocytes, 
brain cells and many 
others
Mediates effects by 
binding to EGF 
receptors. (See 
Epidermal growth factor 
for cell types)
Marquard and Todaro, 
1982*; Derynck et 
ai., 1987; Coffey et 
^ . ,  1987; Wilcox 
and Derynck, 1988; 
Bradshaw and 
Cavanaugh 1990".
TRANSFORMING GROWTH 
FACTOR BETA
Human platelets* and 
placenta* bovine 
kidney* conditioned 
media from many 
transformed and non­
transformed cell lines
Multifuncional. Affects 
differentiation and 
transformation. 
Stimulates
(mesenchymally derived 
cells) or inhibits 
(hepatocytes, T and B 
lymphocytes, 
kératinocytes and many 
epithelial cells) 
mitosis.
Assoian et al..
1983*: Frolik et al.. 
1983*; Roberts et 
ai., 1983* Sporn et 
^ . ,  1987; Roberts 
and Sporn, 1990".
Appendix I: Summary of the better characterised growth factors, their sources and activities (The asterisk 
superscripts indicate the source and reference were these growth factors were originally isolated; the "R" 
superscript indicates that the marked references are reviews on the particular growth factor).
(The references in this table are included in the "Reference Section" of this thesis)
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APPENDIX n
The least significant difference test (LSD) was first described by R.A Fisher* 
(1960). The LSD test consists of a one-way analysis of variance by means of 
a Students t test using a pooled error variance and testing for a rejection 
of the Null hypothesis of no difference among several population means.
A statistical model for this type of study may be written as:
r lf....,a
Xjj= /J + Tj + £ij (1)
j — l,....,n;
where each observation Xy is made up of the grand mean effect fu, a treatment 
effect Tj, and a random error effect e^ . Therefore the total variation among 
Xij's, is partitioned into three components, one for each component effect. 
Variation of these three components is given by the sum of squares (SS) and 
include the sum of squares due to treatments (SStr), the sum of squares due 
to error (SSe) and the sum of errors due to the grand mean (SSto).
SSto = SS (Xij - X)^ = SS X^ij - CF (2)
SStr = Si nj (Xi, - X)^ = S; n; X^,. - CF (3)
SSto = SS (Xy - (4)
CF = X% ./N
The analysis-of-variance table for this model is as shown in Table A. The DF 
column is known as the degrees of freedom. The mean squares (MS) column is an 
estimate of the variance contributed by its source to the total.
Source of variance DF SS MS F ratio
Total
Between treatments 
Within treatments
N-1
a-1
N-a
SSto (see 2) 
SStr (see 3) 
SSe (see 4)
MStr
MSe
MStr/MSe
Table A: One-way analysis of variance model
The LSD test procedure uses the t distribution successively to judge the 
significance of pairwise comparisons of mean values. An observed paired 
difference dy is compared with its LSD, defined as:
LSD — t(i^ 2).v(Sdij) / where,
Sjy = \j2MSe/n (when n, = ^ = n).
and t(i^2),v the (l-a/2) 100th percentile of the t distribution with v DF 
associated with the MSe in the analysis of variance.
If dy is greater than its LSD, then /v, is significantly different from /jj for 
the chosen level of significance (a) with a probability p = 1-d.
1: R.A.Fisher. (1960). The design of experiments 8*" Ed. Oliver Boyd, Edinburgh.
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